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Abstract 
Oxidative stress and impairment of autophagy can lead to the accumulation and 
aggregation of damaged proteins, a common feature of most age-related 
neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease. 
SQSTM1/p62, a receptor and a substrate of selective autophagy, is implicated in the 
degradation of damaged and polyubiquitinated substrates. Importantly, p62 has been 
detected in many types of protein inclusions found in neurodegenerative diseases, 
together with other disease-related proteins. However, the mechanisms allowing p62 
to selectively recruit and degrade autophagic substrates in conditions of oxidative 
stress remain unknown. The aim of this thesis work is to understand the mechanisms 
underlying the oligomerisation and the aggregation of p62 during oxidation, looking at 
post-translational modifications that can lead to the formation of protein aggregates. 
We found that p62 senses and is regulated by oxidative stress. In response to 
oxidation, two cysteine (Cys) residues C105 and C113 of p62 mediate the formation 
of disulphide-linked conjugates (DLC). The formation of p62 DLC was reduced upon 
antioxidants addition, while inhibitors of the antioxidant system enhanced their 
development. This feature was critical for the function of p62 as an autophagy 
receptor as well as for the accumulation of polyubiquitinated aggregates. Indeed, the 
accumulation and degradation of p62 and its substrates was impaired following 
mutation of the Cys residues implicated in DLC formation, while the interaction 
between p62 and polyubiquitinated substrates was not affected. Oxidation of p62 
was also required for cell survival in conditions of oxidative stress, indicating the 
physiological importance of the correct function of p62 in selective autophagy. In 
addition, formation of p62 DLC was increased in ageing and age-related 
neurodegenerative diseases, possibly as a compensatory mechanism to protect cells 
in increased oxidative conditions. 
In conclusion, we reveal a new mechanism of p62 oligomerisation aiding the 
selective autophagy of dysfunctional proteins under oxidative stress conditions.  
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Chapter 1. Introduction 
1.1 Oxidative Stress and Redox Homeostasis 
The term “oxidative stress” relates to the imbalance between pro-oxidants and 
reducing agents (antioxidants) in a biological system. The mechanisms of oxygen 
toxicity began to be investigated over 70 years ago, when it was suggested that 
oxygen poisoning and ionising radiation (e.g. X-rays) both shared the formation of 
chemically-reactive free radicals (molecules containing at least one unpaired 
electron) (Gerschman et al., 1954). Soon after, endogenously-formed free radicals 
were proposed to be the cause of the ageing process in living organisms, leading to 
increased interest in the free radical area (Harman, 1956). The discovery of the 
superoxide dismutase (SOD) also suggested that the living systems had developed 
protective mechanisms against free radicals, such as the superoxide anion (McCord 
and Fridovich, 1969). 
The free radical theory of ageing was then modified by the same author, which 
proposed that mitochondria had a central role in ageing, where the genetically-
determined rate of oxygen consumption and formation of free radicals could have 
had a direct impact on the life span (Harman, 1972). The theory was then supported 
by further evidence that oxidative damage increases during the ageing process (Van 
Remmen and Richardson, 2001), although there is still a lack of direct evidence that 
oxidative stress might limit the life span of different organisms (Bokov et al., 2004; 
Muller et al., 2007). The term oxidative stress, however, does not solely refer to the 
cellular damage caused by free radicals, but also by non-free radical species 
(Hybertson et al., 2011).  
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1.1.1 Reactive oxygen species (ROS) 
Reactive oxygen species (ROS) are radical and non-radical molecules that arise from 
oxygen (O2) during normal metabolism reactions as well as following certain types of 
damage (e.g. irradiation) (Ray et al., 2012). Common examples of ROS are the 
superoxide anion radical (O2•-), hydrogen peroxide (H2O2) and the hydroxyl radical 
(•HO). Although commonly believed as highly reactive, some ROS can be less 
reactive than others (e.g. •HO is more reactive than O2•-), and their reactivity is also 
dependant on their local concentration (Sanz, 2016). An uncontrolled accumulation of 
ROS can determine oxidative stress towards a wide range of biological molecules, 
such as proteins, lipids and DNA (deoxyribonucleic acid), and has been connected to 
various diseases such as diabetes, cancer and neurodegeneration (Waris and 
Ahsan, 2006). However, there is growing evidence that ROS can serve as signalling 
mediators by interacting with a wide variety of proteins, thus regulating various 
signalling pathways among which are cellular growth, antioxidant defences and 
degradation pathways (Ray et al., 2012). Additionally, recent evidence suggests a 
possible role of mitochondrial ROS-mediated signalling in actually increasing the life 
span of lower organisms (e.g. Caenorhabditis elegans and Drosophila melanogaster) 
(Sanz, 2016). 
It is widely accepted that mitochondria are the principal source of ROS through the 
respiratory chain, which takes place in the mitochondrial inner membrane and matrix 
(Murphy, 2009). During oxidative phosphorylation, the oxygen (O2) is reduced into 
H2O (water) to produce ATP (adenosine triphosphate), the nucleotide used as the 
general energy currency as well as a coenzyme in every cell (Maruyama, 1991). 
However, the reduction of oxygen can be incomplete following the leak of electrons 
from mitochondrial complexes (complex I and III mainly), leading to the generation of 
the superoxide anion (Lenaz, 2001). The superoxide can be reduced to H2O2 by the 
action of SOD, which in turn can be further decomposed through the Fenton reaction 
(an iron- and copper-catalysed process) to form the highly reactive hydroxyl radical 
(Fridovich, 1995; Luehrs et al., 2007). Hence, the superoxide can be considered as 
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the “primary” ROS, from which the “secondary” ROS, such as H2O2 and the hydroxyl 
radical, can be generated (Valko et al., 2007). 
Although mitochondrial respiration (together with SOD) accounts for the majority of 
H2O2 production in the cell, other important sources are organelles (e.g. peroxisomes 
and endoplasmic reticulum) and enzymatic systems (e.g. nicotinamide adenine 
dinucleotide phosphate - NADPH - oxidase, xanthine oxidase) (Giorgio et al., 2007). 
Among the previously mentioned ROS, H2O2 is the less reactive, most stable and 
most concentrated ROS in the cell (10-7 M), it can be quickly produced intracellularly 
and degraded by the cellular antioxidant system (Giorgio et al., 2007). Due to its 
controlled turnover and unique chemical features, as well as its high propensity to 
diffuse, H2O2 appears to be suitable as a second messenger for signal transduction 
(Forman et al., 2010; Paulsen and Carroll, 2010). 
1.1.2 Redox signalling and regulation 
The term redox (contraction for reduction-oxidation) refers to chemical reactions 
where electrons and/or hydrogen atoms are gained (reduction) or lost (oxidation) by 
different species. Due to their chemical nature, ROS can efficiently function as redox 
signalling molecules. As mentioned earlier, ROS can interact with target proteins 
which can “sense” oxidation levels through reversible modification of their sulphur-
containing cysteine and methionine residues (Jones, 2008; Paulsen and Carroll, 
2010). The thiol (SH) side chain of the cysteine (Cys) residue is particularly sensitive 
towards oxidation, and at physiological pH, its thiolate ion (S-) acts as a nucleophile 
(a molecule that donates an electron pair) in reaction with H2O2 (Winterbourn and 
Metodiewa, 1999). The equilibrium between thiol and thiolate ion is determined by 
the acid dissociation constant (pKa), where a high pKa reflects an equilibrium shifted 
towards the protonated thiol at physiological pH (∼7), while a low pKa shifts the 
equilibrium towards the thiolate ion (Roos et al., 2013). Although free Cys residues 
have rather high pKa (8.6) and are protonated at physiological pH, such value can 
decrease to as low as 3.4 when Cys residues are incorporated into proteins 
(Grauschopf et al., 1995). Notably, Cys reactivity can be modulated by other polar 
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amino acids in their proximity that can stabilise the thiolate form (Salsbury et al., 
2008), as well as by other structural features like reactive sites related to the protein 
tertiary structure (Peskin et al., 2007). 
Upon reaction with H2O2, the Cys thiol group undergoes oxidation and produces its 
sulphenic acid (SOH), a reversible moiety involved in numerous biochemical 
reactions (Figure 1.1) (Paulsen and Carroll, 2010; Roos and Messens, 2011). This 
sulphenic derivative is fairly unstable, and usually tends to interact with a thiol group 
from another Cys to form a disulphide bond (S-S) (Poole et al., 2004). Disulphide 
bonds are much more stable than sulphenic acid derivatives, forming either intra- or 
inter-molecular bonds depending on whether the two Cys residues belong to the 
same or to another protein, respectively. Both the sulphenic acid and the disulphide 
bond are reversible modifications, and their reduction is tightly regulated by redox 
buffering systems, highlighting the importance of thiols dynamisms in redox 
signalling. Following extreme oxidative stress, the further oxidation of the Cys thiol 
group can also lead to the formation of additional derivatives such as sulphinic 
(SO2H) and sulphonic (SO3H) acids (Figure 1.1) (Roos and Messens, 2011). These 
oxidative states tend to alter the conformation and function of proteins, often leading 
to their inactivation or degradation (Reddie and Carroll, 2008). The sulphinic and 
sulphonic states are usually considered irreversible, although it has been discovered 
that the sulphinic acid can be reduced by the ATP-dependent enzyme sulphiredoxin 
(Srx) (Biteau et al., 2003).  
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Figure 1.1 | The thiol group of cysteine residues can sense intracellular oxidation 
levels. Following the reaction with H2O2, the thiolate ion (S-) of a cysteine residue (Cys) 
becomes oxidised and forms its sulphenic acid (SOH), which can be further oxidised to 
sulphinic (SO2H) and sulphonic (SO3H) acids, or react with another thiol group from a 
different Cys to form a disulphide bond (S-S). Adapted from (Paulsen and Carroll, 2010). 
 
The formation of disulphide bonds can lead to conformational changes in the proteins 
and thereby alter their function, interactions and localization (Paulsen and Carroll, 
2010; Holmstrom and Finkel, 2014). One example of ROS-mediated regulation is the 
increase of tyrosine (Tyr) phosphorylation following stimulation with growth factors 
(Bae et al., 1997). Such increase is mediated by ROS action on protein Tyr 
phosphatases (PTPs), where the oxidation of a conserved Cys residue in the active 
site of the PTPs causes their inactivation (Denu and Tanner, 1998; Holmstrom and 
Finkel, 2014). In a similar manner, deubiquitinating enzymes (DUBs) can be 
reversibly inactivated by ROS, which oxidise the catalytic Cys residue in the DUBs 
active site (Cotto-Rios et al., 2012; Lee et al., 2013). Another example of ROS 
regulation is the activation of autophagy during starvation. Here, starvation induces 
an increase in mitochondrial ROS production which, in turn, leads to the inactivation 
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of Atg4 (through Cys oxidation), a protease that regulates the formation of 
autophagosomes (Scherz-Shouval and Elazar, 2007; Scherz-Shouval et al., 2007). 
Furthermore, ROS play a pivotal role in cell proliferation by activating the MAPK 
(mitogen-activated protein kinase) pathway, specifically acting on p38 MAPK upon 
palmitic acid-mediated signalling (Wang et al., 2011). Importantly, ROS can also 
regulate the activity of specific transcription factors, such as AP-1 (activator protein 1) 
and FOXO (forkhead box protein O), by oxidation of specific Cys residues (Abate et 
al., 1990; Putker et al., 2013). For instance, the formation of a disulphide bond 
between FOXO4 and the nuclear import receptor transportin-1 determines the 
nuclear localisation and activation of the transcriptional factor, which leads to the 
expression of ROS-scavenging enzymes (Putker et al., 2013). In this way, ROS can 
directly influence the response of the cell to different stimuli and activate different 
pathways, such as growth, proliferation and survival (Trachootham et al., 2008). 
Considering how ROS appear to be important in regulating a vast array of cellular 
pathways, their production as well as their scavenging must be tightly regulated, and 
cells have developed several ways to protect their intracellular environment from 
harmful oxidative levels. 
 
1.1.3 Antioxidant responses 
Since high levels of ROS may produce irreversible modifications in protein thiols and 
affect their functions, it is fundamentally important for the cell to promptly activate 
effective antioxidant defences and alleviate the intracellular oxidising burden. In 
physiological conditions, the redox buffering is mainly mediated by glutathione 
(GSH), a highly abundant low-molecular-weight tripeptide (glutamate-cysteine-
glycine) containing a thiol group (Filomeni et al., 2002). Essentially, GSH provides a 
pool of thiols which buffers oxidation generated by ROS, thus providing a more 
reduced environment. Thus, GSH becomes oxidised and generates a disulphide 
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bond with another molecule of GSH, forming the glutathione disulphide GSSG 
(Meister and Anderson, 1983). The enzyme glutathione reductase (GR) then reduces 
GSSG back to GSH using the reducing equivalents (i.e. electrons) provided by 
NADPH, which in turn becomes oxidised (NADP+) (Deponte, 2013). This GSH-
GSSG-GSH cycle provides a balanced intracellular environment which protects 
proteins from harmful ROS levels. Additionally, the selenoprotein glutathione 
peroxidase (Gpx), which bears a selenocysteine (Sec) in its catalytic site, directly 
catalyses the reduction of H2O2 using GSH as a reductant (Brigelius-Flohe and 
Maiorino, 2013). 
Another important family of proteins involved in the endogenous antioxidant buffering 
is the thioredoxin (Trx) (Figure 1.2). The ubiquitous Trx family is composed of small 
12 kDa (kilo Dalton) dithiol protein reductases which, together with the homodimeric 
selenoprotein thioredoxin reductase (TrxR), reduce target proteins by thiol-disulphide 
exchange (Lu and Holmgren, 2014). TrxR is the only known enzyme that reduces Trx 
by using the reducing equivalents from NADPH (Argyrou and Blanchard, 2004). The 
TrxR homodimers are head-to-tail oriented, with the N-terminus of one molecule 
facing the C-terminus of the other molecule, forming a redox-active centre 
(Sandalova et al., 2001). The N-terminus bears a double Cys dithiol active site, while 
the C-terminal region contains a Cys-Sec pair (homologous to Gpx) (Zhong et al., 
1998). The disulphide bond in the N-terminus of TrxR becomes reduced by NADPH, 
then the N-terminal dithiol reduces the selenylsulphide bond in the C-terminus of the 
homodimeric subunit, which in turn reduces the disulphide bond in the active site of 
Trx (Lu and Holmgren, 2009). There seem to be clear redundancies between the 
GSH and Trx/TrxR systems, in order to maintain redox homeostasis when either of 
the systems is compromised (Schmidt, 2015; Tebay et al., 2015). 
The reducing power supplied by GSH and Trx/TrxR is promptly employed by a 
multitude of proteins, of which the peroxiredoxin (Prx) family of peroxidases is the 
most known example (Figure 1.2) (Hofmann et al., 2002). Prxs are a ubiquitous 
family of antioxidant proteins which reduce peroxides such as H2O2, thus having 
important implications in H2O2-mediated signalling (Wood et al., 2003a). Prxs were 
originally characterised into two categories, the 1-Cys and 2-Cys Prxs, based on the 
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number of Cys residues catalytically active, although subsequently the 2-Cys Prxs 
were further divided into two classes called the ‘typical’ and ‘atypical’ 2-Cys Prxs 
(Wood et al., 2003b). 
The largest class of Prxs are the typical 2-Cys Prxs, obligated homodimers, each 
containing a peroxidatic Cys (Cp) and a resolving Cys (Cr) (Hall et al., 2009). The Cp 
thiol of one subunit reduces the peroxide substrate and becomes oxidised by forming 
a sulphenic acid (SOH), then reacts with the Cr of the second subunit to form a 
disulphide bond which, in turn, is reduced by Trx or another reductase (Wood et al., 
2003b; Rhee et al., 2012). The atypical 2-Cys Prxs, instead, are functionally 
monomeric but share the same mechanism as the typical 2-Cys Prxs (Seo et al., 
2000). Here, both the Cp and its corresponding Cr are contained within the same 
subunit, thus forming an intramolecular disulphide bond (Rhee et al., 2012). The 1-
Cys Prxs, as the name suggests, only contain the Cp while missing the 
correspondent Cr (Choi et al., 1998). This last class of Prxs only forms the Cp 
sulphenic acid after reacting with the peroxide substrate (Rhee et al., 2012). 
Eukaryotic Prxs, compared to prokaryotic Prxs, are more susceptible to 
hyperoxidation due to their conformation, which restricts the access of the oxidised 
Cp to the Cr (Wood et al., 2003a). Thus, especially in the presence of higher levels of 
H2O2, the Cp thiol tends to form the sulphenic and sulphonic acids, losing its 
peroxidatic activity (Figure 1.2) (Yang et al., 2002; Hall et al., 2011). The “Floodgate” 
model proposes that such inactivation of Prxs might increase the signalling functions 
of H2O2 in eukaryotic cells (Wood et al., 2003a).  The only enzyme that can revert the 
sulphinic state of the Prxs Cp is the ATP-dependent Srx, thus reactivating the 
peroxidatic function and blocking H2O2 signalling (Hall et al., 2011; Jeong et al., 
2012). Interestingly, the hyperoxidation of Prxs can also facilitate the formation of 
higher molecular weight (MW) complexes with chaperone activity, important in 
protecting the cell from high levels of ROS (Jang et al., 2004; Lim et al., 2008).  
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Figure 1.2 | Schematic representation of H2O2 scavenging by the 
peroxiredoxin/thioredoxin system. The cysteine (Cys) residue of a peroxiredoxin (Prx) 
reacts with H2O2 to form a sulphenic acid derivative (SO-). This is followed by the formation of 
a disulphide bond between such Cys and the resolving Cys of a neighbouring Prx. The 
resulting Prx disulphides are reduced by thioredoxin family proteins (Trx) by thioredoxin 
reductase (TrxR) using electrons from NADPH. At high concentrations of H2O2, the Cys of 
Prx can become hyperoxidised to a sulphinic acid (SO2-), which can be reduced by 
sulphiredoxin (Srx) back to the SO- form. Adapted from (Latimer and Veal, 2016). 
 
During oxidative stress, very high levels of ROS can overwhelm the redox buffering 
system. Hence, the cell has developed mechanisms which can assist the antioxidant 
response and increase cell survival. The Nrf2 (nuclear factor erythroid 2-related 
factor 2) pathway controls the expression of a spectrum of genes involved in cellular 
defence against oxidative stress and toxic compounds (Vomhof-Dekrey and Picklo, 
2012). Nrf2 is the most studied stress-activated, cap’n’collar (CNC)-family basic 
leucine zipper (CNC-bZIP) transcription factor (Sykiotis and Bohmann, 2010). Nrf2 
contains six conserved Neh (Nrf2-ECH homology) domains in its sequence, allowing 
the binding with molecular partners and regulators, as well as with components of the 
transcriptional apparatus (Jaramillo and Zhang, 2013). The transcription of genes in 
mediated primarily by a dimer of Nrf2 (mediated by Neh1 domain) and a member of 
the small Maf (muscoloaponeuretic fibrosarcoma) oncogene family proteins (Itoh et 
al., 1997). An increase in cellular oxidative conditions leads to the translocation of the 
Nrf2-Maf dimer from the cytoplasm to the nucleus to bind the antioxidant response 
element (ARE) sequence in the promoter of different genes, leading to their 
transcription (Nioi et al., 2003). 
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The main regulator of the Nrf2 pathway is Keap1 (Kelch-like ECH-associated protein 
1), a Cullin3-based E3 ubiquitin ligase. In normal cellular conditions Keap1 
homodimerizes, acting as an adaptor for the Cullin3-dependent ubiquitination and 
subsequent proteasomal degradation of Nrf2 (Kobayashi et al., 2004). The 
dimerisation of Keap1 in mediated by the BTB (broad complex, tramtrack and bric-a-
brac) domain, while the Kelch repeats (which form a four-stranded β-sheet motif) 
ensure the interaction with the ETGE (glutamate-threonine-glycine-glutamate) and 
DLG (aspartate-leucine-glycine) motifs in the Nhe2 domain of Nrf2 (Itoh et al., 1999; 
Lo et al., 2006; Tong et al., 2006). An oxidative or chemical stimulus induces a 
conformational change in three reactive cysteines within the IVR (intervening region) 
domain of Keap1, which disrupts the interaction with the DLG motif of Nrf2 (Dinkova-
Kostova et al., 2002). The lost interaction with Keap1 disturbs the ubiquitination 
process and leads to the stabilization of Nrf2, its accumulation in the cytosol and 
translocation into the nucleus (Bryan et al., 2013). Target genes that respond to Nrf2 
include enzymes responsible for the biosynthesis of GSH and its utilisation, Trx 
production and regeneration, NAPDH generation and expression of various other 
cytoprotective proteins (Gorrini et al., 2013). 
Failure in keeping the intracellular environment in the correct redox state may cause 
irreversible changes in protein structure and function, lead to protein aggregation and 
inclusions formation and ultimately to cell death. Thus, cells have developed 
numerous molecular pathways to control the folding state of proteins, their function 
and degradation, in order to maintain a normal intracellular environment. 
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1.2 Control of Proteostasis 
The entirety of proteins within a cell, termed proteome, determines the cell functions 
and fate. Indeed, proteins are vital molecules that provide regulatory, structural and 
catalytic functions. It has been estimated that the proteins copy number in a single 
cell is of 2 to 4 million per cubic micron (Milo, 2013), a huge amount of molecules that 
needs to be monitored and coordinated in the different subcellular compartments. As 
the proteome faces countless changes during cellular development and ageing, cells 
must have developed highly responsive mechanisms in order to regulate the 
trafficking and folding state of the proteins. In fact, newly synthesised proteins need 
to be correctly folded to achieve their functional state. This is a remarkably dynamic 
process, by which the cell can change the folding state and therefore the function of 
selected proteins following environmental challenges to ensure cell survival 
(Gidalevitz et al., 2011). 
Through the proteostasis (i.e. protein homeostasis), cells can tightly regulate the 
production and degradation of the proteins as well as their correct folding, in order to 
maintain an appropriate intracellular environment. Hence, proteostasis is the key 
mechanism that cells adopt to face changes in their surroundings, maintain the 
proteome integrity and prevent the onset of different diseases (Balch et al., 2008). 
Loss of proteostasis often leads to the formation of misfolded and aggregated 
proteins, with catastrophic consequences for the cell (Hartl et al., 2011). 
The term proteostasis network (PN) has been given to the complex regulatory 
system that operates in order to control the proteome stability, avoiding the 
occurrence of protein misfolding and aggregation (Balch et al., 2008). The main 
function of the PN is to coordinate the synthesis, assembly, trafficking, disassembly 
and degradation of the proteins (Balch et al., 2008). The PN consists of: a 
translational machinery for the synthesis of proteins, molecular chaperones involved 
in the correct folding of proteins, degradative pathways like the proteasome and the 
autophagy pathway, plus essential PN modifiers such as cellular stress responses 
and post-translational modifications (Balch et al., 2008; Labbadia and Morimoto, 
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2015). Thus, it has been proposed that proteins have (beyond their primary, 
secondary, tertiary and quaternary structural states) a quinary physiological state 
given by the PN, which regulates their folding state and function in relation to the 
surrounding environment, enhancing the survival and the evolvability of the cell 
(Powers and Balch, 2013). 
Defects in any of the molecular machineries involved in the control of proteostasis 
may lead to the disruption of the PN functionality, leading to various diseases 
(Labbadia and Morimoto, 2015). This could lead to the conformational change of 
proteins towards misfolded states, leading to protein aggregation and/or degradation. 
Environmental stresses such as oxidation as well as ageing appear to be the major 
risk factors in the loss of PN functionality (Taylor and Dillin, 2011; Di Domenico et al., 
2014; Labbadia and Morimoto, 2014). 
1.2.1 The unfolded protein response (UPR) 
As protein misfolding and aggregation can represent a serious threat for the cytosolic 
environment, cells have developed several measures to counteract these menaces. 
An important reaction to the increase in the protein misfolding levels is through the 
activation of stress responses. Here, different transcription factors are activated in 
response to non-native protein conformations, ensuring the cellular adaptation to 
stress and survival (Labbadia and Morimoto, 2015). This is particularly important at 
the endoplasmic reticulum (ER) level, where the newly synthesised proteins must be 
correctly folded to be subsequently secreted. In fact, the ER is a highly dynamic 
organelle involved in the biosynthesis of lipid and proteins, particularly important in 
specialized secretory cells. Protein maturation and folding in the ER can be 
extremely demanding, surpassing the capacity of the folding machinery. This can 
generate a source of stress which is managed through the unfolded protein response 
(UPR) (Walter and Ron, 2011; Hetz, 2012). The UPR is an adaptive and complex 
mechanism that senses the misfolding in the ER, exerting its function through three 
different stress transducers to preserve the ER function (Ron and Walter, 2007). 
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The first branch of the UPR consists of the activation of IRE1 (inositol-requiring 
protein 1), an ER-transmembrane protein with serine/threonine kinase and 
endoribonuclease (RNase – ribonucleic acid hydrolase) activity that senses the 
unfolded proteins levels (Cox et al., 1993; Walter and Ron, 2011). The genes 
activated by IRE1 signalling are involved in the upregulation of the ER membrane 
biogenesis and folding machinery, as well as the ERAD (ER-associated 
degradation), a pathway which links the ER with the protein degradation machinery in 
the cytosol (Wang and Kaufman, 2012). The second branch of the UPR is mediated 
by PERK (protein kinase RNA-activated – PKR –like ER kinase), another 
transmembrane kinase (Ron and Walter, 2007). The PERK signalling can have a 
dual role: to protect the cell from protein accumulation or, in case of high levels of 
stress, to drive the cell to death. The third branch of the UPR is mediated by ATF6 
(activating transcription factor 6), which represents a group of transmembrane 
proteins involved in transducing the ER stress and in encoding transcription factors 
(Hetz, 2012). 
As it appears, different signalling pathways tightly control the misfolding in the ER. 
However, the cell has developed additional pathways to better regulate the stress 
associated with misfolded proteins, by allowing their correct folding or, when the 
folding capacity is exceeded, their degradation. 
1.2.2 Molecular chaperones 
During translation, proteins are synthesised as linear sequences of amino acids, 
however their functionality only arises from a correct folding process. Although a 
minor number of small proteins can fold autonomously, the majority of the bigger-
sized, multi-domain proteins need folding assistance. Molecular chaperones are a 
complex network of catalytic enzymes with the pivotal role of ensuring the correct 
folding of proteins (Kim et al., 2013). Chaperones are also known as heat shock 
proteins (Hsps), due to the fact that their expression is induced in conditions of stress 
such as heat shock or oxidation, which usually cause destabilisation of the native 
structure of proteins (Morano et al., 2012). Chaperones are classified according to 
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their MW, where Hsp70s and Hsp90s (Hsps of 70 and 90 kDa, respectively) are the 
most characterised as well as the most abundant families, constituting 1-2% of the 
total amount of proteins in many cells (Labbadia and Morimoto, 2015). The heat 
shock response (HSR) is a stress response which upregulates the chaperone activity 
following an increase in the misfolding and aggregation of proteins, usually in 
response to increased temperature as well as other sources of stress (Richter et al., 
2010). 
Activity of chaperones depends on their ability to bind and hydrolyse ATP. In fact, 
chaperones undergo an ATP/ADP (adenosine diphosphate) exchange cycle where 
the affinity for their substrates (known as clients) is highly influenced by the 
nucleotide binding (Kampinga and Craig, 2010). The hydrolysis of ATP to ADP leads 
to the conformational change of chaperones and increases their affinity for 
hydrophobic sequences of unfolded proteins, thus preventing protein aggregation 
(Hartl et al., 2011; Kim et al., 2013). The Hsp70s family of chaperones comprises the 
constitutively expressed Hsc70 (heat shock cognate of 70 kDa) and the stress-
inducible Hsp70 (Liu et al., 2012). The two chaperones share a high degree of 
homology, yet Hsp70 association with substrates and changes in the secondary 
structure upon oxidative stress are more pronounced than Hsc70 (Callahan et al., 
2002). Hsp90s are a highly conserved family of chaperones which, like Hsp70s, use 
ATP to exert their function in protein folding (Taipale et al., 2010). 
The activities of Hsp70s and Hsp90s are aided by the action of non-client binding 
partners known as co-chaperones, which assist the activity of chaperones (Caplan, 
2003; Hartl et al., 2011). The main functions of co-chaperones are the regulation of 
the ATPase cycle, the facilitation of client binding and the shuttling of chaperones to 
different subcellular locations. Thus, the complex made by chaperones/co-
chaperones forms the functional machinery that regulates the folding of proteins in 
the cell. Interestingly, the co-chaperone Hop (Hsp70-Hsp90 organising protein, also 
known as Sti1 - stress inducible protein 1), can bind both Hsp70s and Hsp90s, thus 
connecting the two chaperone systems and allowing the concerted folding of clients 
(Carrigan et al., 2006). Another co-chaperone, known as Hip (Hsc70-interacting 
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protein), binds instead to Hsc70 and activates its ATPase activity, stabilising the ADP 
state and enhancing the affinity for its clients (Hohfeld et al., 1995). 
Other co-chaperones are instead involved in the degradation of misfolded proteins 
that fail the refolding process and can lead to aggregation, as well as short-lived 
regulatory proteins that need to be degraded (Arndt et al., 2007). An important player 
in the chaperone-mediated protein degradation is the C-terminus of Hsp70-
interacting protein (CHIP), an E3 ubiquitin ligase and co-chaperone of both Hsp70s 
and Hsp90s which creates a bridge between the chaperones and the proteasome 
degradative machinery, facilitating the degradation of the protein substrates (Connell 
et al., 2001; Demand et al., 2001). Another co-chaperone important for chaperone-
mediated protein folding and degradation is BAG1 (B-cell lymphoma 2 – Bcl-2 –
associated athanogene 1), initially known as a biding partner of the apoptosis-
inhibiting regulator Bcl-2. BAG1 bears a BAG domain which binds to Hsp70s and 
connects the chaperone network to the proteasome (Luders et al., 2000; Arndt et al., 
2007). Furthermore, BAG1 can facilitate the CHIP-mediated degradation of 
chaperone substrates by facilitating their interactions with the proteasome (Demand 
et al., 2001). The BAG-family component BAG3, instead, mediates the recognition of 
misfolded proteins by binding to Hsp70s and drives their degradation through 
macroautophagy (Gamerdinger et al., 2009; Behl, 2011).  
Since molecular chaperones have an important role in promoting the correct folding 
of protein as well as targeting misfolded proteins for degradation, they are considered 
valuable therapeutic targets especially in neurons, where proteostasis is paramount 
for their survival (Smith et al., 2015). 
1.2.3 Protein misfolding and aggregation 
Protein misfolding can have deleterious effects for the cellular environment, since the 
exposure of otherwise hidden hydrophobic regions of the proteins could lead to their 
irreversible, non-native interaction and formation of insoluble aggregates (Figure 1.3) 
(Hartl et al., 2011; Kim et al., 2013). Therefore, it is fundamental for the cell to 
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implement several strategies to ensure the correct folding of proteins, especially 
under stress conditions. This is particularly important in neurons, since they are non-
dividing cells and therefore more susceptible to stresses, especially to proteotoxicity 
caused by misfolded proteins (Morimoto, 2008; Douglas and Dillin, 2010). In fact, 
many different neurodegenerative diseases are characterised by the accumulation of 
misfolded proteins in aggregates and ultimately in insoluble inclusions (see Chapter 
1.7) (Soto, 2003; Douglas and Dillin, 2010). 
The aggregation process can be either chaotic, led by hydrophobic forces to form 
amorphous aggregates, or ordered, following the development of proteins into β-
sheet conformation (Figure 1.3) (Moreno-Gonzalez and Soto, 2011). The β-sheet 
structure permits a more favourable interaction between proteins and leads to the 
formation of oligomers, proto-fibrils and fibrils, known to be toxic for the cell (Caughey 
and Lansbury, 2003; Moreno-Gonzalez and Soto, 2011). The toxicity elicited by 
soluble oligomers appears to be the highest, as they could induce apoptosis and 
impair the synaptic activity in neurons (Demuro et al., 2005; Shankar et al., 2008). 
The larger proto-fibrils may also contribute to apoptosis by creating pore-like 
structures in the plasma membrane and destabilising the intracellular environment 
(Lin et al., 2001). Fibrils are long and straight formations that are less toxic compared 
to oligomers and proto-fibrils, and tend to accumulate to form insoluble aggregates 
(Figure 1.3) (Caughey and Lansbury, 2003). Considering the high toxicity of soluble 
formation such as oligomers and proto-fibrils, it has been proposed that fibrils and 
ultimately insoluble inclusions could serve as a protective mechanism for the cell to 
sequester smaller, harmful species from causing damage, although this remains a 
controversial point (Ross and Poirier, 2005; Winklhofer et al., 2008; Treusch et al., 
2009). 
Aberrant conformation of proteins could arise from specific mutations (either sporadic 
or inherited) which destabilise the native state and alter the hydrophobicity, the 
charge and the secondary structure (Chiti et al., 2003). These aggregation-prone 
proteins tend to hinder the folding and degradation machineries and lead normal, 
unrelated proteins to misfolding and accumulation, thus exacerbating the toxicity in 
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the cell (Bates, 2006). The term “conformational diseases” has been given to those 
conditions where certain proteins undergo a toxic gain-of-function, becoming 
aggregate-prone and leading to cellular degeneration (Gidalevitz et al., 2010).  
 
 
Figure 1.3 | Protein aggregate formation following misfolding. The loss of correct protein 
conformation (unfolding) can lead to misfolding, where the protein abnormal structure can 
oligomerise and form either amorphous aggregates or ordinate fibrils. The latter can in turn 
lead to inclusion bodies and extracellular plaques formation, a prominent feature of most 
neurodegenerative diseases. Adapted from (Treusch et al., 2009). 
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1.3 Ubiquitin and Protein Degradation 
Degradation pathways have a fundamental role in the control of proteostasis, since 
many regulatory as well as damaged proteins need to be turned over in order to 
protect the cell from abnormal protein accumulation. Proteolysis is not only involved 
in the protein quality control but also important for a wide array of cellular processes 
like cell division, signal transduction and apoptosis. Intracellular proteolysis has been 
studied for more than 70 years, and the discovery of the lysosome as a proteases-
containing organelle led to the hypothesis that the degradation processes would have 
only been lysosome-mediated (Ciechanover, 2005). 
It later became clear that some non-lysosomal machinery was also involved in the 
degradation of the majority of the soluble, short-lived proteins, which was dependent 
on energy expenditure in form of ATP (Ciechanover, 2005). An essential component 
of this intracellular catalytic pathway was therefore called APF1 (ATP-dependent 
proteolysis factor 1), which was found to be covalently attached to the target 
substrates (Ciechanover et al., 1980; Hershko et al., 2000). It soon became clear that 
APF1 was in reality a ubiquitous protein known long before, yet without a 
recognisable function, called ubiquitin (Wilkinson et al., 1980). 
1.3.1 Ubiquitination process 
Ubiquitin is a small, heat-stable, highly conserved protein of 76 amino acids and 8.5 
kDa which was originally found ubiquitously (from here the given name) in every 
living organism, including prokaryotes (Goldstein et al., 1975). Subsequently, it 
became clear that ubiquitin was instead only present in eukaryotes, but its name has 
been kept for historical reasons (Ciechanover, 2005). Ubiquitin serves as a signalling 
molecule that tags damaged or unfolded proteins in a covalent way, leading to their 
degradation through cytosolic or lysosomal proteases (Glickman and Ciechanover, 
2002; Callis, 2014). Therefore, it is considered a post-translational modification 
similar to, yet more complex than, phosphorylation (Komander, 2009). Ubiquitination 
can also serve to regulate different important processes in the cell beyond protein 
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degradation, such as endocytosis, DNA repair, signal transduction and protein 
trafficking (Mukhopadhyay and Riezman, 2007). 
Three different enzymes enable the attachment of ubiquitin to a substrate in an ATP-
dependent manner, called E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating 
enzyme) and E3 (ubiquitin ligase) (Figure 1.4) (Hershko et al., 1983; Welchman et 
al., 2005). The reaction is initiated by the activation of ubiquitin through ATP 
expenditure, which leads to the formation of a reactive thioester bond between a 
cysteine (Cys) residue of E1 and the C-terminal glycine (Gly) of ubiquitin (Gly76) 
(Hershko and Ciechanover, 1998). In the second step, the ubiquitin C-terminus is 
transferred to a E2 Cys residue thus forming another thioester bond; then, ubiquitin is 
transferred onto the substrate by an E3 enzyme, which mediates the formation of an 
isopeptide bond between the Gly76 of ubiquitin and the ε-NH2 group of a Lys residue 
of the target protein (Figure 1.4) (Ciechanover, 1994; Pickart, 2001). Therefore, the 
enzymatic system for ubiquitin activation appears hierarchical: so far, two E1s have 
been identified to activate ubiquitin (Groettrup et al., 2008), which is transferred to 
several dozens of E2s and finally binds to its substrates through hundreds of E3s, the 
substrate-recognition modules (Pickart and Eddins, 2004). 
The E3s can be divided in two classes, depending on the type of domain present in 
their structure: HECT (homologous to E6-AP – E6-associated protein – carboxy-
terminus) domains and RING (really interesting new gene) finger domains (Metzger 
et al., 2012). The HECT domain E3s are large monomeric proteins that accept an 
ubiquitin moiety from E2s and form a thioester bond between their active-site 
cysteine and ubiquitin, prior to transferring it to their substrates (Rotin and Kumar, 
2009). There are ~30 HECT domain E3s in mammals, compared to the RING finger 
domain-containing enzymes which are more than 600 (Li et al., 2008). The RING 
finger domain E3s can be either monomeric or part of multimeric complexes, acting 
as scaffolds by facilitating the direct transfer of ubiquitin from the E2s to the 
substrates (Deshaies and Joazeiro, 2009). Ubiquitination is a reversible process, 
where DUB proteases cleave ubiquitin to either recycle it or reverse the modification 
of the target proteins (Reyes-Turcu et al., 2009). 
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Figure 1.4 | Ubiquitin process and different types of ubiquitination. Ubiquitin (Ub) is first 
activated in an ATP-dependent manner and forms a thioester bond with the cysteine of an 
ubiquitin-activating enzyme (E1). Then, Ub is transferred to an ubiquitin-conjugating enzyme 
(E2), forming a second thioester bond with an E2 cysteine. Lastly, an ubiquitin ligase (E3) 
mediates the transfer of Ub from the E2 to the substrate protein by forming an isopeptide 
bond. Multiple cycles of ubiquitination can determine the formation of mono-, multi-mono- 
and polyubiquitinated proteins. Lys48-linked chains present a closed conformation compared 
to the linear Lys-63-linked chains. PPi: pyrophosphate. Adapted from (Lipkowitz and 
Weissman, 2011). 
 
1.3.2 Types of ubiquitination 
A single ubiquitin modification is known as monoubiquitination, whereas multiple 
ubiquitin molecules could give rise to multi-monoubiquitination or polyubiquitination 
(Figure 1.4) (Komander, 2009). In fact, the presence of other Lys residues (positions 
6, 11, 27, 29, 33, 48 and 63) on itself allows ubiquitin to become an acceptor of other 
ubiquitin molecules, leading to the formation of different homotypic polyubiquitin 
chains (Komander, 2009; Behrends and Harper, 2011). In addition, the N-terminal 
methionine (Met1) can also contribute in the assembly of linear head-to-tail 
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polyubiquitin chains (Rieser et al., 2013). Notably, there is increasing evidence for 
mixed polyubiquitin chains where two or more different Lys residues of one ubiquitin 
moiety become available for attachment to other ubiquitin molecules, thus forming 
branched or “forked” chains (Kim et al., 2007; Komander, 2009). 
While mono-ubiquitination has been found to be important in regulating the 
endocytosis of cell-surface receptors and in the DNA-damage response (Sigismund 
et al., 2004), polyubiquitination appears fundamental in targeting damaged proteins 
for degradation and in regulating different signalling pathways, such as DNA repair 
and inflammation (Sun and Chen, 2004). Interestingly, the most abundant ubiquitin-
ubiquitin linkage occurs through Lys (K) in position 48 (K48), which adopts a more 
closed conformation compared to other linkages and represents the signal for 
proteasomal degradation (Komander, 2009; Fushman and Walker, 2010). By 
contrast, K63-linked polyubiquitin chains adopt a more linear conformation and are 
associated with signal transduction, although they can also signal the lysosomal 
degradation of substrates (Figure 1.4) (Tan et al., 2008; Behrends and Harper, 
2011). 
Ubiquitination is often regulated by numerous proteins containing at least 16 different 
ubiquitin-binding domains (UBDs), which recognise the ubiquitin moieties through 
non-covalent interactions and mediate most of their effects in the intracellular 
environment (Hurley et al., 2006). Besides ubiquitin, nearly 20 ubiquitin-like (UBL) 
protein modifiers have been discovered, which bear the β-grasp fold (known as the 
ubiquitin-fold) and can be attached by their C-terminus onto protein substrates to 
regulate different cellular processes (van der Veen and Ploegh, 2012). 
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1.4 The Ubiquitin-Proteasome System (UPS) 
Ubiquitinated proteins are often degraded through the proteasome, giving rise to the 
ubiquitin-proteasome system (UPS). The UPS is highly selective, degrading the 
majority of the soluble, short-lived proteins with regulatory functions as well as 
damaged proteins tagged for the degradation (Ciechanover, 2005). Proteasomes are 
enormous protein complexes that can be found in all eukaryotes and archaea as well 
as some bacteria, located both in the cytoplasm and in the nucleus (Peters et al., 
1994). 
The proteasome is a giant protease of 2.5 MDa (mega Dalton) composed of a core 
particle (CP) known as the 20S complex (S for Svedberg, coefficient of 
sedimentation) and one or two regulatory particles (RP) known as the 19S complex 
(Figure 1.5) (Finley, 2009). Cells contain two different forms of proteasome 
depending on the number of regulatory subunits attached to the CP, as one (RP1CP) 
or two (RP2CP) regulatory subunits constitute the 26S and 30S proteasomes, 
respectively (Tanaka et al., 2012). Because of some lack of accuracy, many refer to 
the proteasome as the 26S complex, although the physiological functioning unit in 
the cell seems to be the RP2CP (Tanaka et al., 2012). For simplicity, we will refer to 
the 26S proteasome as the main and active form. 
1.4.1 The 20S and 19S complexes 
The 20S (CP) complex of ∼730 kDa has a barrel-shaped structure composed by four 
rings of seven subunits each, up to a total of 28 subunits (Finley, 2009). The two 
outer α-rings are made up of α-subunits (α-α’1-7), which surround the two inner β-
rings of β-subunits (β-β’1-7) (Figure 1.5) (Lowe et al., 1995; Groll et al., 1997). The α-
rings structure is almost completely closed, thus preventing non-target proteins to 
enter inside the CP cavity formed by the β-rings, which contains the proteasome-
proteolytic sites. The subunits β1, β2 and β5 possess the catalytic sites exposed to the 
inner face of the chamber, bearing caspase-like, trypsin-like and chymotrypsin-like 
activities, respectively (Bochtler et al., 1999). These proteolytic subunits belong to the 
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N-terminal nucleophile (Ntn) hydrolase family, which share an active N-terminal 
threonine residue for peptide-bond cleavage (Brannigan et al., 1995). 
To gain access to the proteolytic sites, the substrates have to pass through the α-
rings located at the edges of the barrel. In the closed α-rings conformation, the N-
termini of the α-subunits assemble centrally, creating a network that topologically 
occludes the barrel pore (Groll et al., 2000). Importantly, at the interface between 
different α-subunits there are 7 α-pockets which face the external environment, 
permitting the interaction with the RP complex which, in turn, opens the channel, 
giving access to the proteolytic sites (Groll et al., 1997; Smith et al., 2007). 
 
 
Figure 1.5 | Structure of the 26S proteasome. The 26S proteasome is composed of one 
core particle (20S) and two regulatory particles (19S). The core particle consists of two outer 
α-rings and two inner β-rings, each of them composed of 7 subunits. The regulatory particles 
consist of 6 regulatory triple-A subunits (Rpt) and 9 regulatory non-ATPase subunits (Rpn), 
which constitute the base and lid subcomplexes. The Rpn10 (S5a) subunit interacts with both 
the base and the lid. Adapted from (Murata et al., 2009). 
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Two 19S (RP) complexes of ∼900 kDa bind at both ends of the 20S barrel, thus 
forming the complete proteasome of 26S (Figure 1.5) (Finley, 2009). Each RP 
comprises 19 subunits, which can be further classified into two groups: triple-A or 
AAA+ (ATPase associated with diverse cellular activities) subunits (also known as 
Rpt, regulatory particle triple-A protein) and non-ATPase (also known as Rpn, 
regulatory particle non-ATPase) subunits (Finley et al., 1998; Tanaka et al., 2012). 
These subsets of subunits are arranged to form two different subcomplexes: a base, 
which includes 6 ATPase (Rpt1-6) and 3 non-ATPase subunits (Rpn1, 2 and 13), and 
a lid, comprising the other 9 non-ATPase subunits (Rpn3, 5-9, 11, 12 and 15) 
(Glickman and Ciechanover, 2002; Murata et al., 2009). The ATPase subunits of the 
base bind to the α-subunits of the 20S barrel, while the lid can attach and detach 
from the base through the interaction with Rpn10 (known as S5a – subunit 5a – in 
mammals) (Glickman et al., 1998). The binding of the lid to the base is important for 
the recognition of the ubiquitinated substrates that need to be degraded. 
1.4.2 Substrate recognition and degradation 
The recognition of the substrates and their degradation is mediated by a multistep 
mechanism involving both the 19S and the 20S complexes (Pickart and Cohen, 
2004). The signal for degradation through the proteasome is the ubiquitination, where 
at least 4 ubiquitin moieties are attached to the substrate through K48 linkage 
(Thrower et al., 2000). The polyubiquitin chain is then recognised by the 19S 
subunits Rpn10/S5a and Rpt5 (an ATPase), driving the substrate towards the base 
subcomplex (Deveraux et al., 1994; Lam et al., 2002). The base of the 19S bears a 
chaperone-like activity, in fact the ATPase activity of the Rpt subunits determines the 
unfolding of the substrates (Braun et al., 1999). 
As only unfolded proteins can pass through the 19S complex and reach the 
proteolytic sites in the 20S complex (Glickman et al., 1998), the polyubiquitin chain of 
the substrates must be detached prior the entry into the proteasome. The Rpn11 
subunit is a zinc (Zn)-dependent DUB, which cleaves the polyubiquitin chain 
proximally to the substrate, and the released chain is further cleaved by additional 
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DUBs in order to recycle the ubiquitin moieties (Verma et al., 2002; Yao and Cohen, 
2002). Ubiquitin detachment is essential also because of its high stability, which 
would make its degradation too slow and therefore would reduce the flux of 
substrates through the proteasome (Pickart and Cohen, 2004). Once the substrate 
has been unfolded and its polyubiquitin chain detached, it can reach the proteolytic 
sites of the 20S complex and undergo degradation (Glickman and Ciechanover, 
2002). 
Due to the high selectivity in substrate recognition and elimination, the UPS cannot 
be employed in the degradation of insoluble protein aggregates, which instead can 
be efficiently degraded through autophagy. 
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1.5 The Autophagy Pathway 
Autophagy (from the Greek auto-phagein, “self-eating”) is an evolutionary conserved 
cellular catabolic process involving the lysosomal system, implicated in the regulation 
of long-lived proteins as well as in the degradation and recycling of whole 
cytoplasmic organelles (Klionsky and Emr, 2000). The autophagy pathway was 
described almost contemporary with the discovery of the lysosomes (De Duve et al., 
1955; De Duve and Wattiaux, 1966), and it has been linked to diverse physiological 
and pathophysiological roles such as development, apoptosis, immunity, cancer, 
ageing and age-related neurodegeneration (Mizushima et al., 2008). Initially thought 
to be a non-selective pathway for bulk degradation (in contrast with the UPS), it is 
now assured that autophagy is also involved in the selective elimination of specific 
targets, such as protein aggregates, lipid droplets, damaged organelles and invading 
pathogens (see Chapter 1.5.4) (Reggiori et al., 2012; Fimia et al., 2013). Before its 
selectivity was assessed, autophagy used to be distinguished into “baseline”, where 
cytosolic component are turned over for intracellular clearance, and “induced”, also 
known as non-selective or bulk autophagy, where the degradation is triggered by a 
lack of nutrients (Mizushima, 2005). During starvation, the cytoplasmic components 
are degraded through autophagy to produce free amino acids and fatty acids, which 
can be either used to synthesise new proteins or oxidised to produce ATP and 
ensure cell survival (Levine and Yuan, 2005). Signals including insulin, growth factors 
and amino acids converge and inhibit mTOR (mechanistic/mammalian target of 
rapamycin), an evolutionarily conserved serine/threonine, phosphatidylinositol (PI) 3-
kinase (PI3K)-related kinase (PIKK) considered the master regulator of cell growth 
and metabolism (Hay and Sonenberg, 2004; Laplante and Sabatini, 2009). 
The target of rapamycin TOR1 and TOR2 genes were first discovered in 
Saccharomyces cerevisiae after testing the inhibitory effects of the 
immunosuppressant, anti-fungal and anti-proliferative agent rapamycin (Heitman et 
al., 1991), a macrolide found in Streptomyces hygroscopicus from an Easter Island’s 
soil sample (Vezina et al., 1975). Rapamycin directly inhibits mTOR, thus leading to 
the cellular growth arrest and to the activation of the autophagy pathway (Dobashi et 
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al., 2011). Additionally, autophagy can also be stimulated in response to several 
stresses such as changes in the cellular volume, pathogen infection, oxidative stress 
and accumulation of damaged proteins (He and Klionsky, 2009). In fact, a key 
function of autophagy is to aid proteostasis by degrading misfolded and aggregate-
prone proteins, especially when the activity of the proteasome is compromised 
(Wong and Cuervo, 2010; Lilienbaum, 2013). An excessive induction, however, can 
lead to autophagic cell death, a type II programmed cell death (PCD) distinct from 
apoptosis (type I PCD) and necrosis (Levine and Yuan, 2005; Chen and Klionsky, 
2011). As mentioned above, it was in the late 1950s that autophagy was discovered 
and its associated vesicles described by electron microscopy (Eskelinen et al., 2011). 
The first to coin the term “autophagy” as a process of cellular self-catabolism has 
been De Duve, after identifying membrane-limited bodies containing cytoplasmic 
material which he called “autophagic vacuoles” (De Duve, 1963). The study of the 
autophagic pathway continued based on morphological analysis until the late 1990s, 
when by means of molecular biology approaches it became possible to identify and 
manipulate the genes involved in the process (Yang and Klionsky, 2010). 
Although it has been first described in mammals, most of the genetic characterisation 
of autophagy has arisen from studies on the yeast vacuolar system, similar to the 
mammalian lysosomal system (Takeshige et al., 1992; Huang and Klionsky, 2002). 
Furthermore, a biosynthetic pathway involving the vacuolar trafficking called the 
cytoplasm-to-vacuole-targeting (Cvt) pathway in yeasts shares analogous 
mechanisms with the autophagic pathway (Yorimitsu and Klionsky, 2005). Genetic 
screenings using Saccharomyces cerevisiae led to the identification of the first 
autophagy-defective mutants, named Apg (autophagy), which were unable to 
accumulate autophagic bodies inside the vacuoles (Tsukada and Ohsumi, 1993). 
The identification of autophagocytosis mutants Aut (autophagy) was also described 
following colony screening procedures (Thumm et al., 1994). Also, different mutants 
for the Cvt pathway were discovered (Harding et al., 1995), several of which were 
overlapping with the autophagy-deficient Aut and Apg mutants, showing a tight 
relationship between the two pathways (Harding et al., 1996; Scott et al., 1996). 
Therefore, it has been proposed a unified nomenclature for the identified mutants, 
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which have been called Atg (autophagy-related) (Klionsky et al., 2003). To date, 
more than 40 Atg proteins have been identified in yeast, many of them having their 
mammalian orthologues (Mochida et al., 2015; Wesselborg and Stork, 2015). 
Autophagy can be divided in three different sub-pathways with their distinct delivery 
modality, specificity and regulation: microautophagy, chaperone-mediated autophagy 
(CMA) and macroautophagy (Figure 1.6). The activation of one autophagic route 
instead of another plays an important role in the adaptation to environmental 
changes, guaranteeing a specific yet flexible substrate degradation through the 
lysosomal system (Cuervo, 2004). 
 
 
Figure 1.6 | The autophagy pathway. Autophagy is a catabolic pathway which can be 
distinguished into three different sub-pathways. Microautophagy is mediated by lysosomal 
engulfment of portions of the cytoplasm. Chaperone-mediated autophagy (CMA) consists in 
the recognition and unfolding of proteins bearing the KFERQ motif by the chaperone Hsc70, 
and the targeting to the lysosomal membrane receptor LAMP-2A. Macroautophagy is 
mediated by the formation of an isolation structure called the phagophore, which engulfs the 
cytoplasm and then expands to form the autophagosome, a double-membrane structure that 
fuses with lysosomes to form the autolysosome, where the cytoplasm is degraded. Adapted 
from (Mizushima et al., 2008). 
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1.5.1 Microautophagy 
Microautophagy consists in the engulfment of whole cytosolic regions directly by the 
lysosomal membrane, which are then subsequently degraded by the lysosomal 
hydrolases (Figure 1.6) (Li et al., 2012b). Microautophagy has been first described in 
mammalian cells subjected to long- and short-term starvation, where the lysosomes 
appeared to be able to internalise their membranes (Ahlberg et al., 1982; Mortimore 
et al., 1988). Its main functions are to maintain the homeostasis of organelles and 
membranes in the cell, especially under nitrogen starvation (Li et al., 2012b). 
Microautophagy can be either non-selective or selective, depending on whether 
random cytoplasmic components or specific organelles are degraded through the 
lysosomes. In the non-selective microautophagy (NSM, also known as “basal 
autophagy”), small cytoplasmic constituents are engulfed by the lysosome through 
the tubular invaginations of its membrane (Mijaljica et al., 2011). The process of 
tubular invagination requires the action of an ATPase to maintain the proton gradient 
and a GTPase (guanosine triphosphate hydrolase) to preserve the membrane 
potential (Sattler and Mayer, 2000). This “autophagic tube” presents a striking 
decrease in the density of transmembrane proteins at the top of the invagination, 
possibly through a lateral sorting mechanism of protein transportation (Muller et al., 
2000).  
Following the invagination, a vesicle starts to form due to the imbalance between 
lipids and proteins in a phase-separation process, which enzymatically expands until 
it completely separates from the lysosomal membrane and becomes internalised (Li 
et al., 2012b). To date, the degradation of mitochondria (micromitophagy), of the 
nucleus (micronucleophagy) and of the peroxisomes (micropexophagy) have been 
identified as selective processes of microautophagy. The selective microautophagy 
of these cellular components does not involve the formation of an autophagic tube, 
rather the lysosomal membrane protrudes to form arm-like structures that surrounds 
the organelles (Mijaljica et al., 2011). 
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Most of the mechanisms of microautophagy have been described in yeasts, with little 
understanding of the pathway in mammalian cells (Mijaljica et al., 2011). Further 
studies are needed to unveil the role of microautophagy in higher organisms and its 
possible connections with other degradative pathways. 
1.5.2 Chaperone-mediated autophagy (CMA) 
The main characteristic of CMA, compared to the micro- and macroautophagy, 
consists in the direct translocation of proteins through the lysosomal membrane, 
without the formation of intermediate vesicles (Figure 1.6) (Kaushik and Cuervo, 
2012). Differently from the other forms of autophagy, CMA is exclusively selective 
towards its substrates. CMA was first described in human fibroblasts cultured under 
acute depletion of serum growth factors (Neff et al., 1981; Backer and Dice, 1986), 
and further characterised as a selective degradation pathway involving the 
lysosomes by J. Fred Dice over 40 years of research (Dice, 2009; Cuervo, 2011). 
CMA is activated after more than 10 hours of starvation, reaching a plateau after ∼36 
hours and remaining active for up to 3 days, differently from other types of autophagy 
where the activation can start as early as 30 minutes after deprivation of nutrients 
(Cuervo et al., 1995; Kaushik et al., 2011). CMA can be also upregulated by oxidative 
stress, hypoxia or following protein denaturation and unfolding (Cuervo et al., 1999; 
Kiffin et al., 2004; Dohi et al., 2012). 
The signal for CMA degradation was found by comparing the half-life of RNase A and 
its related RNase S-protein (lacking the first 20 amino acids) (Cuervo, 2011). The 
turnover of the latter was not increased during serum withdrawal, yet it was restored 
upon reconstitution of the missing N-terminal sequence (S-peptide) (Backer et al., 
1983). The attachment of the S-peptide also enhanced the removal of other proteins 
upon to serum starvation (Backer and Dice, 1986). The sequence was subsequently 
narrowed down to the amino acids 7-11 of the S-peptide, the pentapeptide KFERQ 
(Lys-Phe-Glu-Arg-Gln) (Dice et al., 1986). It later became clear that approximately 
20-30% of the cytosolic soluble proteins possess a pentapeptide sequence related to 
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KFERQ, which are selectively degraded through CMA (Chiang and Dice, 1988; Dice, 
1990). 
The KFERQ sequence is recognised in the cytosol by the constitutively expressed 
Hsc70 (firstly characterised as Hsp73 or prp73 – peptide recognition protein of 73 
kDa) of the Hsp70s chaperone family in an ATP-dependent manner (Figure 1.6) 
(Chiang et al., 1989; Terlecky et al., 1992). Therefore, the name chaperone-mediated 
autophagy was given to this selective lysosomal degradation pathway (Cuervo and 
Dice, 2000a). The recognition motif may be hidden by the protein folding state, the 
attachment of other subunits, the sub-compartmentalisation or by post-translational 
modifications, which make the KFERQ sequence not accessible to Hsc70 and thus 
regulate protein degradation (Cuervo, 2010). After the Hsc70 binding to the 
recognition motif, the client proteins are translocated to the lysosome for degradation 
in a saturable and vesicle-free process (Cuervo et al., 1994). 
The search for a lysosomal receptor ended up with the identification of Lamp2a 
(lysosome-associated membrane protein type 2a), a single-span membrane protein 
that mediates the recognition of the Hsc70-substrate complex at the lysosomal 
membrane (Cuervo and Dice, 1996). This binding to Lamp2a promotes its 
multimerisation into a ∼700 kDa complex, a necessary step for the substrate 
unfolding and translocation inside the lysosome, while an Hsp90 in the lysosomal 
luminal side stabilises the complex (Bandyopadhyay et al., 2008). The complete 
substrate translocation, which requires the complete protein unfolding prior to 
lysosomal internalisation, takes place through the aiding action of a lysosomal Hsc70 
(ly-Hsc70) (Agarraberes et al., 1997; Salvador et al., 2000).  
The translocation machinery undergoes continuous cycles of assembly/disassembly, 
both mediated by Hsc70 (Bandyopadhyay et al., 2008). In fact, the expression levels 
of Lamp2a are tightly regulated, along with a controlled distribution of the receptor 
between the lysosomal membrane and matrix (Cuervo and Dice, 2000b). The 
presence of lipid micro-domains on the lysosomal membrane ensures the 
degradation of Lamp2a through the lysosomal protease cathepsin A, which mediates 
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the release of the receptor in the lysosomal matrix and its subsequent elimination by 
the resident hydrolases (Cuervo et al., 2003; Kaushik et al., 2006). 
1.5.3 Macroautophagy 
Macroautophagy (usually, and from here on, simply referred to as autophagy) is the 
principal and most characterised form of autophagy (Ravikumar et al., 2009). Here, 
the cytoplasmic components (known as cargo) are sequestered in a newly 
synthesised double membrane structure, the autophagosome; this cargo is then 
delivered to the lysosome to fuse and form an autolysosome, where the degradation 
of the enclosed material occurs by means of the lysosomal hydrolyses (Figure 1.6) 
(Eskelinen, 2005). The source of membranes for the formation of autophagic vesicles 
is still on debate (Lamb et al., 2013). It has been proposed that the membrane source 
can either derive from existing organelles (maturation model), or that different lipid 
molecules assemble de novo in a specific site (assembly model) (Juhasz and 
Neufeld, 2006; Tooze and Yoshimori, 2010). However, recent evidence have shown 
that the ER can work as a membrane platform, by interacting with other organelles 
such as mitochondria and Golgi apparatus, for the autophagosome formation 
(Shibutani and Yoshimori, 2014). 
In mammals, the first step in the formation of autophagosomes is the sequestration of 
cytoplasmic components from a unique membrane called phagophore that expands 
to enclose the substrate (Mizushima, 2007). This “Initiation” step is controlled by 
mTOR activity (Figure 1.7). As previously discussed, mTOR is mainly sensitive to 
nutrient levels within the cell (see Chapter 1.5). During nutrient-rich conditions, 
mTOR is active and inhibits autophagy, whereas during starvation mTOR is inhibited, 
activating autophagy (Dobashi et al., 2011). There are two different protein 
complexes formed by mTOR, known as mTOR complex 1 (mTORC1) and mTOR 
complex 2 (mTORC2), showing an opposite sensitivity to rapamycin (Loewith et al., 
2002). The two complexes are regulated by Raptor (regulatory-associated protein of 
mTOR) and Rictor (rapamycin-insensitive companion of mTOR), respectively (Hara 
et al., 2002; Sarbassov et al., 2004). The activity of mTORC1 is tightly regulated by 
Chapter 1. Introduction 
  
 
33 
 
the master sensor of energy status AMPK (adenosine monophosphate-activated 
protein kinase), the heterodimer TSC (tuberous sclerosis complex) composed by 
TSC1 (or hamartin) and TSC2 (or tuberin) which functions as a GTPase-activating 
protein (GAP), and the small GTPase Rheb (Ras – rat sarcoma – homolog enriched 
in brain) which directly interacts and activates mTORC1 (Laplante and Sabatini, 
2009). Following low energy levels, AMPK is activated and phosphorylates TSC2, 
which increases its GAP activity and converts Rheb into its inactive GDP-bound 
state, thus mediating the release and inactivation of mTORC1 (Inoki et al., 2003a; 
Inoki et al., 2003b). 
The inhibition of mTOR releases the activity of another serine/threonine kinase 
known as ULK1 (Unc-51-like kinases 1 – Unc-51 is the Caenorhabditis elegans 
homologous of the yeast Atg1), which forms a complex with mAtg13 (orthologue of 
yeast Atg13), FIP200 (focal adhesion kinase – FAK – family-interacting protein of 200 
kDa, a yeast Atg17 orthologous) and Atg101, a conserved eukaryotic protein not 
present in S. cerevisiae that has no homology with other Atg proteins and interacts 
directly with mAtg13 (Figure 1.7) (Hosokawa et al., 2009b; Jung et al., 2009; Mercer 
et al., 2009). The ULK1-mAtg13-FIP200-Atg101 complex is constitutively expressed 
in the cytosol, and in the presence of nutrients it is phosphorylated and inhibited by 
mTORC1 (Ganley et al., 2009). In the absence of nutrients, mTORC1 ceases to 
interact with ULK1, determining the dephosphorylation and the activation of ULK1, 
which then phosphorylates itself and its complex partners (except Atg101), leading to 
the initiation of autophagosome formation (Hosokawa et al., 2009a; Mizushima, 
2010; Wong et al., 2013). In yeast, autophagosomes generate from a site next to the 
vacuolar membrane called PAS (pre-autophagosomal structure), not found in 
mammals, where many of the Atg proteins gather and assemble (Suzuki et al., 
2001). Among these, the multispanning membrane protein Atg9, present on 
cytoplasmic mobile vesicles derived from the Golgi under the action of Atg23 and 
Atg27, assembles at the PAS and is required for autophagosomal membrane 
formation (Yamamoto et al., 2012). 
Subsequently, a “Nucleation” event is driven by Vps34 (vacuolar protein sorting 34), 
a specific class III PI3K (Figure 1.7). This kinase phosphorylates the PI generating 
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the phosphatidylinositol 3-phosphate (PI3P), a lipid that promotes the formation of 
the autophagosome membrane (Obara and Ohsumi, 2008). The Vps34 forms a 
complex with Vps15/p150, Atg14 and Beclin-1 (mammalian orthologous of 
Vps30/Atg6 in yeast and BEC-1 in C. elegans), which initiate the nucleation event 
(Mizushima, 2007; Kang et al., 2011). Beclin-1 is a key regulator of the autophagic 
pathway. It was originally identified as an interaction partner of Bcl-2, an anti-
apoptotic factor (Liang et al., 1998). The interaction between Beclin-1 and Bcl-2 is 
mediated by the BH3 (Bcl-2 homology 3) domain of Beclin-1 and exerts an inhibitory 
activity towards autophagy (Sinha and Levine, 2008). This interaction is reduced 
during nutrient deprivation, determining the release of Beclin-1 and the activation of 
autophagy (Pattingre et al., 2005). Another Beclin-1 partner is UVRAG (UV irradiation 
resistance-associated gene), an oncosuppressor gene that interacts with his CCD 
(coiled-coil domain) with Beclin-1, positively regulating autophagy by enhancing the 
activity of the PI3K complex (Liang et al., 2006). 
The “Elongation” of the membrane is regulated by two UBL conjugation systems 
(Figure 1.7) (Ohsumi, 2001; Shpilka et al., 2012). The first identified system is 
mediated by the UBL protein Atg12, which covalently attaches to Atg5 (Mizushima et 
al., 1998; Nakatogawa, 2013). The attachment between Atg12 and Atg5 is mediated 
by two E1- and E2-like enzymes, Atg7 and Atg10, respectively (Shintani et al., 1999; 
Tanida et al., 1999). In yeasts, the Atg12-Atg5 complex interacts non-covalently with 
Atg16, a self-oligomerising coiled-coil protein, forming a complex of ~350 kDa 
dependent on Atg16 oligomerisation (Mizushima et al., 1999; Kuma et al., 2002). In 
mammals, the Atg12-Atg5 complex interacts with the orthologue Atg16L (Atg16-like), 
which contains seven WD (also known as WD40, motif of ~40 amino acids 
terminating with a tryptophan-aspartate – WD – dipeptide) repeats important for 
protein-protein interactions, forming a bigger complex of ~800 kDa (Mizushima et al., 
2003). The Atg12-Atg5-Atg16 complex assists in the formation of the 
autophagosome membrane from the beginning of the elongation, and dissociates 
upon completion of the double membrane (Mizushima et al., 2001; Mizushima et al., 
2003). 
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Figure 1.7 | Molecular machinery of macroautophagy. Macroautophagy is initiated by the 
ULK1 complex, which is activated during starvation by inhibition of the mTORC1 complex. 
The nucleation of the autophagosome is mediated by the Vps34-Beclin1 complex, which 
promotes the formation of the autophagosomal membrane. The Atg12- and LC3-conjugation 
systems ensure the elongation of the membrane to form the mature autophagosome. ER: 
endoplasmic reticulum; Mito: mitochondria; PM: plasma membrane. Adapted from (Pyo et al., 
2012). 
 
The second conjugation system consists in the conjugation of a single lipid molecule, 
the phosphatidylethanolamine (PE), with the C-terminal Gly of LC3 (microtubule-
associated protein – MAP – light chain 3, mammalian orthologous of Atg8) (Ichimura 
et al., 2000; Shpilka et al., 2011). Together with the other two Atg8 mammalian 
homologues GABARAP (gamma-aminobutyric acid receptor-associated protein) and 
GATE-16 (Golgi-associated ATPase enhancer of 16 kDa), LC3 is an UBL protein 
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structurally similar to ubiquitin (Sugawara et al., 2004). The human LC3 family 
consists of four proteins, named LC3A (having two alternative splicing variants), 
LC3B, LC3B2 and LC3C, each being expressed in different tissues and having 
different roles during the autophagosome biogenesis (Shpilka et al., 2011; Klionsky 
et al., 2016). LC3 is synthesised as a precursor which is cleaved at its C-terminal by 
Atg4, a Cys protease that exposes the Gly residue involved in the lipidation process 
(Kabeya et al., 2000; Kirisako et al., 2000). The exposed Gly of the cleaved LC3 
(known as LC3-I) is activated by the E1-like enzyme Atg7 and then transferred onto 
the E2-like enzyme Atg3, leading to the formation of an amide bond between the PE 
and LC3 (known as LC3-II) (Ichimura et al., 2000). Differently from Atg12, LC3-II 
remains attached to both sides of the autophagosome membrane, and for this reason 
it is widely used as a marker for autophagosome formation (Rubinsztein et al., 2009; 
Mizushima et al., 2010). The LC3 molecules on the outer membrane can be cleaved 
off from PE by Atg4 (a process known as deconjugation) for recycle, while the 
molecules on the inner membrane are degraded together with the cargo after fusion 
with the lysosome (Mizushima et al., 2010; Yu et al., 2012). 
In the last steps of the autophagy process, the newly-synthesised autophagosome 
can either fuse with a lysosome and produce an autolysosome, where the 
cytoplasmic components are eventually degraded, or interact with the endosomal 
compartment forming an amphisome (Mizushima, 2007). The amphisome can 
eventually fuse to a lysosome following acidification by the membrane proton pumps, 
and mature into an autolysosome (Hansen and Johansen, 2011). 
1.5.4 Selective autophagy 
After being regarded as a non-selective degradation pathway for the bulk 
degradation of cytoplasm from its discovery until recently, new experimental 
evidence over the last decade has shown how autophagy can also be a selective 
process, where specific targets are exclusively degraded based on the necessity of 
the cell (van der Vaart et al., 2008; Reggiori et al., 2012). Since it has been proven 
difficult to exactly discern between starvation-induced autophagy and selective 
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autophagy, it has been recently proposed to classify the autophagic events in a more 
appropriate way, thus distinguishing between cargo-independent (i.e. non-selective) 
and cargo-induced (i.e. selective) autophagy (Zaffagnini and Martens, 2016). 
Therefore, it is possible to distinguish different types of selective autophagy 
depending on the type of cargo involved, such as mitochondria (mitophagy), ER 
(reticulophagy), ribosomes (ribophagy), peroxisomes (pexophagy), protein 
aggregates (aggrephagy) and invading pathogens (xenophagy) (Stolz et al., 2014). 
An example of selective autophagy is the Cvt pathway in Saccharomyces cerevisiae, 
a biosynthetic pathway involved in the delivery of cytoplasmic hydrolyses to the 
vacuole, which shares most of the molecular machinery of the autophagy pathway 
(Lynch-Day and Klionsky, 2010). Here, the cytoplasmic proenzyme prApe1 
(precursor of Ape1 – aminopeptidase 1) is the principal cargo, which first assembles 
into dodecamers and then forms higher order oligomers known as the Ape1 complex 
(Kim et al., 1997). The cargo is recognised by the protein receptor Atg19/Cvt19 which 
in turn binds to Ams1 (α-mannosidase), thus forming the Cvt complex (Morales 
Quinones et al., 2012). Finally, Atg19/Cvt19 interacts first with Atg11/Cvt9, mediating 
the recruitment of the Cvt complex to the PAS, and then with Atg8/Aut7/Cvt5, which 
determines the engulfment of the complex into the autophagosome-like Cvt vesicle 
(Scott et al., 2001; Shintani et al., 2002). The tight interaction between Atg19 and 
Atg8, mediated by the exposure of multiple Atg8-binding sites on Atg19 following 
cargo binding, determines the bending of the Cvt vesicle membrane, permitting the 
exclusion of non-specific cargo material (Sawa-Makarska et al., 2014). Once the Cvt 
vesicle is complete, its outer membrane fuses with the vacuole, thus releasing a 
single-membrane Cvt body into the vacuolar lumen (Umekawa and Klionsky, 2012). 
The Cvt body is then degraded by the lipase Atg15/Cvt17, releasing the prApe1 
whose N-terminal is cleaved off by the vacuolar enzyme Pep4 (proteinase 4), 
reaching the Ape1 mature and active form (Trumbly and Bradley, 1983; Teter et al., 
2001). 
Although the Cvt pathway does not involve the degradation of the cytoplasmic 
hydrolases (rather, their delivery to the vacuole and their activation), it shares the 
same criteria as for selective autophagy: recognition and engulfment of specific cargo 
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into nascent autophagosomal structures by means of a receptor protein, such as 
Atg19 (Zaffagnini and Martens, 2016). In fact, selective autophagy uses several 
receptor proteins to drive the degradation of its targets, while adaptor proteins (such 
as ULK1 and Atg12) are necessary for autophagosome formation but not for cargo 
recognition (Svenning and Johansen, 2013; Stolz et al., 2014). Receptor proteins are 
therefore degraded together with their cargo, while adaptor proteins are not. More 
than two dozen receptor proteins have been identified in mammals, although the best 
characterised are p62, NBR1 (neighbour of BRCA1 – breast cancer 1 – gene 1), NIX, 
NDP52 (nuclear domain 10 protein of 52 kDa) and OPTN (optineurin) (Stolz et al., 
2014). Interestingly, there seems to be a high degree of functional redundancy 
between these proteins, where different combinations of receptors are needed for the 
correct degradation of certain cargoes, such as protein aggregates, mitochondria and 
bacteria (Mancias and Kimmelman, 2016). 
For instance, p62 and NBR1 participate in the degradation of protein aggregates (see 
Chapter 1.6.3), while p62, NDP52 and OPTN cooperate for the removal of invading 
pathogens (Kirkin et al., 2009a; Wild et al., 2011). These autophagy receptors share 
some structural domains, and can interact with both LC3 and ubiquitin (Wild et al., 
2014). Indeed, ubiquitination is the most prevalent route for targeting cargoes 
towards selective disposal, as for the proteasome (Kirkin et al., 2009b). However, it is 
important to consider that a wider array of ubiquitin-independent mechanisms exists, 
such as direct interactions between receptors and cargoes (as for Atg19), recognition 
of lipids- and sugars-based signals, and UBL modifiers (Khaminets et al., 2016). 
Indeed, the receptor NIX is a mitochondrial outer-membrane protein that can link the 
mitochondria with the autophagosomal machinery without the need of ubiquitination 
(Novak et al., 2010). 
The most studied receptor protein in selective autophagy is certainly p62, which has 
an active and important role in the disposal of protein aggregates (van der Vaart et 
al., 2008). However, p62 is not only involved in protein degradation, but rather in a 
wide array of intracellular functions.  
Chapter 1. Introduction 
  
 
39 
 
1.6 Overview of SQSTM1/p62 
The roles of p62 in the cell are many and various. As a multi-domain protein, p62 
acts as a scaffold for many signalling pathways and takes part in various 
physiological and pathological processes like apoptosis, inflammation, cancer and 
ageing (Moscat and Diaz-Meco, 2009; Bitto et al., 2014). Its functions can vary from 
the degradation of polyubiquitinated cargoes to the activation of anti-stress 
responses. Furthermore, p62 mediates the interplay between the two major 
degradative routes in the cell, the UPS and the autophagy pathway (Lilienbaum, 
2013). The presence of p62 in virtually all protein inclusions found in 
neurodegenerative diseases suggests an active role of the protein in the formation of 
such aggregates, whose role still needs to be addressed (Zatloukal et al., 2002). 
1.6.1 Structure of p62 
SQSTM1/p62 (sequestosome 1, also known as A170 and ZIP) is a 440 amino acid, 
ubiquitously expressed multi-domain protein conserved in all metazoa, but not in 
plants and fungi (National Center for Biotechnology Information – NCBI – Entrez 
Gene ID for Homo sapiens: 8878). It was first discovered as a phosphotyrosine-
independent interacting partner of the p56lck (lymphocyte-specific protein tyrosine) 
kinase (Park et al., 1995). Soon after it was discovered that p62 could bind mono- 
and polyubiquitin moieties non-covalently through its C-terminal UBA (ubiquitin-
associated) domain (amino acids – a.a. – 393-438), mutations of which are 
commonly linked to Paget’s disease of bone (PDB), a condition characterized by 
increased osteoclastic activity and excessive bone resorption (Vadlamudi et al., 
1996; Layfield et al., 2004). For its ability to bind polyubiquitinated proteins, the name 
of “sequestosome” was given to the cytoplasmic compartment where p62 stores its 
targets (Shin, 1998). 
Other important protein-protein interacting domains are the N-terminal PB1 (Phox 
and Bem1p, a.a. 4-102), the ZZ-type zinc finger (a.a. 126-168), the TBS (an E3 
ubiquitin ligase, TNF – tumor necrosis factor – receptor-associated factor 6 – TRAF6 
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– binding site, a.a. 228-233), the LIR and KIR (LC3- and Keap1-interacting regions, 
a.a. 336-341 and 346-359, respectively) (Figure 1.8) (Salminen et al., 2012; Lin et 
al., 2013). In addition, there are two nuclear localisation signals (NLS1 and NLS2) 
and one nuclear export signal (NES), consistent with p62 shuttling between nucleus 
and cytoplasm, thus regulating the protein quality control in these two compartments 
(Pankiv et al., 2010). Two PEST sequences rich in proline (P), glutamate (E), serine 
(S) and threonine (T) are also present, acting as a signal for fast degradation, 
indicating that p62 should have a short intracellular half-life, a feature of many other 
regulatory proteins (Rechsteiner and Rogers, 1996). Indeed, it has been shown that 
p62 half-life is about 6 hours in HeLa cells (Bjorkoy et al., 2005). 
 
 
Figure 1.8 | Schematic representation of p62 functional domains. The multi-domain 
structure of p62 is represented. The explanation for each of the p62 domains is provided in 
the text. PB1: Phox and Bem1p; ZZ: zinc finger; TBS: TRAF6 binding site; NLS: nuclear 
localisation signal; NES: nuclear export signal; PEST: sequence rich in proline, glutamic acid, 
serine and threonine; LIR: LC3 interacting region; KIR: Keap1 interacting region; UBA: 
ubiquitin-associated. Adapted from (Salminen et al., 2012). 
 
1.6.2 Signalling functions of p62 
As mentioned earlier, p62 is a multi-domain protein which can interact with numerous 
binding partners, therefore acting as a signalling hub in a multitude of cellular 
responses (Katsuragi et al., 2015). The ZZ-type zinc finger domain, which binds two 
zinc ions, is responsible for the interaction between p62 and RIP1 (receptor-
interacting protein 1), a serine/threonine, TNFα-signalling adaptor kinase involved in 
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the induction of different signalling events that could lead to the death or the survival 
of the cell (Festjens et al., 2007). By the ZZ domain, p62 can also bind to AMPA (α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors, mediating their 
translocation to the plasma membrane as well as their atypical protein kinases C 
(aPKCs)-mediated phosphorylation, thus regulating the long term potentiation (LTP) 
response in neurons (Jiang et al., 2009). 
The N-terminal PB1 domain is a conserved scaffolding module with an UBL β-grasp 
fold topology, responsible for the oligomerisation of proteins (Moscat et al., 2006a; 
Sumimoto et al., 2007). PB1 domains are classified into type I (or A), containing an 
OPCA (OPR/PC/AID – octicosapeptide repeat/Phox and Cdc/aPKC-interacting 
domain) motif rich in acidic residues (Glu/Asp), type II (or B), possessing a basic 
cluster of Lys/Arg, and type I/II (or AB), which contains both (Seibenhener et al., 
2007). The PB1 domain of p62 is a type I/II, thus allowing p62 to self-oligomerise 
through a front-to-back interaction between the acidic OPCA motif (front) of one 
molecule with the basic cluster (back) of another one (Wilson et al., 2003). Artificial 
mutations in either the OPCA motif (D69A) or the basic cluster (K7A), or both 
(K7A,D69A), greatly impairs the ability of p62 to oligomerise (Lamark et al., 2003). It 
has been shown that oligomerisation of p62 is a necessary step for the selective 
degradation of ubiquitinated substrates, highlighting the importance of the PB1 
domain for the function of p62 as a receptor protein (Figure 1.9) (Ichimura et al., 
2008; Itakura and Mizushima, 2011). Additionally, the PB1 domain mediates the 
recognition and the degradation of p62 ubiquitinated cargoes through the UPS by 
interacting with the proteasomal subunits Rpn10/S5a and Rpt1 (Seibenhener et al., 
2004). Therefore, p62 may serve as a shuttle for the proteasomal degradation of 
polyubiquitinated proteins, since the depletion of p62 delays the turnover of several 
proteasomal substrates (Seibenhener et al., 2004). 
One important PB1-PB1 interaction is between p62 and the aPKCs, creating the 
scaffold for the NF-κB (nuclear factor-kappa B) stress response (Moscat et al., 
2006b). The atypical PKCs (such as aPKCζ and aPKCι/λ) are a subfamily of PKCs 
that are independent of both Ca2+ and diacylglycerol for their activation (Jaken, 
1996). The p62-aPKCs binding activates the NF-κB pathway downstream of TNF-α, 
Chapter 1. Introduction 
  
 
42 
 
interleukin 1 (IL1), RANK (receptor activator of NF-κB) ligand (RANKL) or NGF 
(nerve growth factor) cell stimulation (Moscat et al., 2007). Also, the interaction with 
TRAF6 by the TBS domain of p62 is important for NF-κB activation as well as for 
bone remodelling (Duran et al., 2004). Moreover, by interacting with TRAF6, p62 acts 
in the downstream events after the binding of neurotrophines such as NGF, brain-
derived neurotrophic factor (BDNF) and neurotrophin-3, inducing the activation of the 
ERK (extracellular signal-activated kinases)/MAPK signalling and playing a role in 
cell differentiation (Wooten et al., 2001; Geetha and Wooten, 2003). As mentioned 
above, the ZZ domain of p62 is also involved in the activation of NF-κB, following the 
interaction with RIP1 in response to TNF-α (Sanz et al., 1999). 
The NF-κB pathway is known to regulate a wide range of cellular functions, including 
immunity, inflammation and metabolism (Tornatore et al., 2012). NF-κB is usually 
found as a heterodimer formed by RelA/p65 and p50 proteins, which is sequestered 
in the cytoplasm by the inhibitory protein IκB (inhibitor of κB), thus preventing the NF-
κB nuclear translocation and the transcription of genes (Ghosh and Karin, 2002). The 
activation of NF-κB is controlled by the IKK (IκB kinase) complex, formed by two 
catalytic (IKKα and IKKβ) and one regulatory subunit (IKKγ, also known as NEMO – 
NF-κB essential modulator) (Karin and Ben-Neriah, 2000). In particular, the IKKβ 
appears to be important for the phosphorylation of IκB, its degradation by the UPS 
and the subsequent NF-κB nuclear translocation and activation (Ghosh and Karin, 
2002). The formation of p62-aPKCs complexes after cell stimulation leads to the 
recruitment and the oligomerisation of TRAF6, which has an E3 ubiquitin ligase 
activity and catalyses the K63-linked polyubiquitination of both itself and NEMO, 
inducing the phosphorylation and the activation of the IKK complex (Chen, 2005). 
Interestingly, mutations in the UBA domain (causing Paget’s disease) lead to an 
enhancement of NF-κB and osteoclasts activity (Chamoux et al., 2009). As the 
ubiquitination of proteins is important for their regulation and function, also 
deubiquitination has a considerable role. In the NF-κB pathway, the DUB CYLD 
(cylindromatosis tumor suppressor protein) appears to act as a negative regulator by 
inhibiting the IKK complex by cleaving off K63-linked polyubiquitin chains of TRAF6 
and NEMO (Kovalenko et al., 2003; Jin et al., 2008). Paradoxically, p62 interacts via 
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its C-terminus with CYLD facilitating its interaction with TRAF6, thus providing a 
negative contribution to the NF-κB signalling (Jin et al., 2008). The induction of NF-
κB signalling also seems to induce CYLD transcription, giving an autoregulatory 
feedback to the pathway (Jono et al., 2004).  
Additionally, p62 can interact with the Kelch domain of Keap1 through its KIR 
domain, likely competing for the binding with Nrf2 (Komatsu et al., 2010; Lau et al., 
2010). The Keap1-Cullin3-E3 ubiquitin ligase activity towards Nrf2 becomes impaired 
upon p62-Keap1 interaction, leading to Keap1 autoubiquitination instead (Lau et al., 
2010). Importantly, the ectopic expression of p62 leads to a decrease in Keap1 
levels, while the knock-down of p62 through siRNA (small interfering RNA) has 
shown an increase in the amount of Keap1 and a consequent diminution of Nrf2 
protein levels, suggesting that p62 is important in the degradation of Keap1 and in 
the activation of Nrf2 activity (Copple et al., 2010). The p62-Keap1 interaction 
enhances during autophagy-deficiency conditions, where the amount of p62 is 
increased due to the lack of its autophagic degradation (Komatsu et al., 2010; Lau et 
al., 2010). Thus, the hyperactivity of Nrf2 during autophagy inhibition could be due to 
the accumulation of p62, rather than the ROS-mediated modification on Keap1 (Lau 
et al., 2010). Furthermore, the p62 promoter is under the control of Nrf2, which 
generates a positive feedback for the expression of p62 and its role in upregulating 
the Nrf2 pathway (Jain et al., 2010). 
It has been proposed that p62 could be a point of cross-talk between Nrf2 and NF-κB 
pathways. In fact, as Keap1 is involved in the ubiquitination and degradation of IKKβ, 
its binding to p62 could rescue IKKβ from degradation, thus upregulating the NF-κB 
pathway in concert with Nrf2 (Stepkowski and Kruszewski, 2011). 
1.6.3 Selective autophagy and p62 
As previously mentioned, p62 participates in the selective degradation of autophagic 
substrates by acting as a receptor protein (see Chapter 1.5.4), linking the cargos to 
the autophagic machinery (Figure 1.9) (Johansen and Lamark, 2011). The 
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interaction between p62 and LC3 is mediated by the LIR domain, in which a 
sequence of 11 amino acids named LRS (LC3 recognition sequence) is sufficient for 
the effective binding to LC3 (Pankiv et al., 2007; Ichimura et al., 2008). The signalling 
molecule that leads to the autophagic degradation of substrates is ubiquitin, the 
hallmark of proteasomal degradation, which also has an important role in the 
disposal of both protein aggregates and organelles (Kirkin et al., 2009b). It has been 
reported that K63-linked polyubiquitin chains, which show a higher tendency in 
promoting protein aggregation, are mainly involved during autophagy (Tan et al., 
2008). Indeed, the lack of autophagy after genetic knock-out causes the formation of 
ubiquitin-positive inclusions in mice, which are suppressed upon p62 ablation 
(Komatsu et al., 2007a). 
The interaction between polyubiquitinated substrates and p62 is mediated by the 
UBA domain, which has a higher affinity for K63-linked polyubiquitin chains 
compared to K48-linked (Long et al., 2008). The ubiquitin binding causes a 
conformational switch in the UBA domain, determining a transition from a dimeric 
state (unbound) to a monomeric state (bound), possibly as an autoinhibitory 
mechanism (Isogai et al., 2011). The affinity between the UBA domain and 
polyubiquitin chains is increased by a phosphorylation event at the Ser403 of p62 
mediated by casein kinase 2 (CK2) when the proteasome is impaired, leading to the 
enhanced autophagic degradation of ubiquitinated substrates (Matsumoto et al., 
2011). More recently, it has been shown that TBK1 (TANK – TRAF family member-
associated NF-κB activator – binding kinase 1) can also phosphorylate p62 at 
Ser403, which leads to the efficient engulfment of depolarised mitochondria during 
Parkin-mediated mitophagy (Matsumoto et al., 2015). An additional phosphorylation 
site at Ser409 mediated by ULK1 has been shown to destabilise the UBA dimer 
interface of p62 and increase its affinity towards polyubiquitinated substrates (Lim et 
al., 2015).  
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Figure 1.9 | Representation of p62 function in selective autophagy. p62 binds to 
polyubiquitinated substrates through its UBA domain, while the LRS sequence recognises 
LC3 on the autophagosomal membrane. The PB1 domain is involved in the self-
oligomerisation of p62, an important step for its selective degradation. Impairment of 
autophagy can lead to the accumulation of p62 together with its cargo, leading to the 
formation of inclusion bodies. Adapted from (Tanaka and Matsuda, 2014). 
 
Both PB1 and UBA domains of p62 are required for the formation of ubiquitinated 
aggregates, also known as p62 bodies, which can be found as both membrane-free 
(sequestosomes) and membrane-enclosed (autophagosomes) structures ranging 
from 0.1 to 2 μm (Bjorkoy et al., 2005). The PB1 domain is responsible for the self-
oligomerisation of p62, a critical step for aggregate formation and their targeting to 
the autophagosome (Bjorkoy et al., 2005; Itakura and Mizushima, 2011). The 
oligomerisation of different p62 molecules by means of the PB1 domain determines a 
stronger interaction with ubiquitinated proteins, as well as a tighter binding with LC3 
clusters on the autophagosomal membrane, driving the bending of the latter around 
the cargo (Wurzer et al., 2015). It has been recently shown that the PB1 domain 
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assembles into a helical scaffold, creating long p62 filaments that can more efficiently 
bind to LC3 and determining the elongation of the autophagosomal membrane 
(Ciuffa et al., 2015; Johansen and Sachse, 2015). Interestingly, an electrostatic 
bridge (a.a. 100-122) rich in charged amino acids, located C-terminally to the PB1 
domain, has been shown to be crucial for stabilising the p62 filaments (Ciuffa et al., 
2015). It is important to notice that the binding with polyubiquitin chains leads to the 
shortening of such filaments which, together with the dimer-to-monomer 
destabilisation of the UBA domain upon ubiquitin binding, can be an inhibitory 
mechanism to avoid excessive aggregation (Isogai et al., 2011; Ciuffa et al., 2015). 
Notably, the targeting of p62 to the autophagosomal nucleation site requires its self-
oligomerisation through the PB1 domain but not LC3 binding, which is only needed 
during the actual enclosure of the cargo (Itakura and Mizushima, 2011). Following 
autophagy inhibition, p62 tends to accumulate together with ubiquitinated proteins, 
leading to the formation of insoluble inclusion bodies (Zatloukal et al., 2002; Komatsu 
et al., 2007b). 
Another selective autophagy receptor important in aggregate degradation is NBR1, a 
966 amino acids protein which has a domain organization similar to p62, containing 
an N-terminal PB1 domain, a ZZ-type zinc finger domain, a LIR and a C-terminal 
UBA domains (Kirkin et al., 2009a). Like p62, NBR1 binds to polyubiquitinated 
substrates through the UBA domain and links them to the autophagosomal 
membrane by binding to LC3 (Lamark et al., 2009). However, the interaction with 
LC3 is not the only way for proteins to interact with the autophagic machinery. An 
example is Alfy (autophagy-linked FYVE protein), a protein that contains the FYVE, a 
phospholipid-binding zinc finger domain which can interact with PI3P and therefore 
with the autophagosomal membrane, creating a scaffold for the degradation of 
ubiquitinated cargos (Simonsen et al., 2004; Filimonenko et al., 2010). The complex 
of p62, NBR1 and Alfy, together with ubiquitinated substrates, seems to be important 
for the formation of p62 bodies, as well as for their degradation through selective 
autophagy (Johansen and Lamark, 2011). 
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As already mentioned, the formation of ubiquitinated aggregates and insoluble 
inclusions could be an attempt of the cell to avoid the cytotoxicity of misfolded 
proteins (see Chapter 1.2.3). This is especially evident following proteasomal 
inhibition, where the main way for the cell to degrade such aggregates is through a 
subtype of selective autophagy called aggrephagy (Lamark and Johansen, 2012). It 
has been shown that protein aggregates can be targeted by microtubules to the 
MTOC (microtubule organising centre), located in perinuclear position, to form a 
membrane-free structure called aggresome (Johnston et al., 1998). Ubiquitinated 
particles reach the MTOC by a dynein/dynactin motor that brings them from the 
periphery to the perinuclear site (Garcia-Mata et al., 1999). Significant is the 
abundant presence of lysosomes at the MTOC, where they can fuse with 
autophagosomes which are also transported to the same location along microtubules 
(Fass et al., 2006). It has been shown that every aggresome particle has a fixed size 
of ∼50–90 nm, meaning that uniform number of proteins is needed to form a single 
particle (Garcia-Mata et al., 1999). Aggresome particles are then surrounded by a 
cage of intermediate filaments, such as vimentin, leading to the stability of the 
structure (Johnston et al., 1998). 
The transportation of aggresomes to the MTOC is regulated by the α-tubulin 
deacetylase HDAC6 (histone deacetylase 6). The role of HDAC6 in aggresome 
formation is essential, since it can bind ubiquitin through its BUZ (binding-of-ubiquitin 
zinc) finger domain, with a preference for K63-linked polyubiquitin chains, and also 
interacts with dynein motors, participating in the transport of ubiquitinated cargo 
towards the MTOC (Kawaguchi et al., 2003). However, unlike p62 and NBR1, 
HDAC6 cannot interact with LC3 due to the lack of the LIR domain. Thus, it is 
possible that HDAC6 and p62 may act sequentially, as p62 can mediate the 
aggregation of target proteins whereas HDAC6 can interact with dynein and carry 
aggregates to the MTOC (Yao, 2010). Moreover, it is known that HDAC6 controls the 
fusion between autophagosomes and lysosomes through actin remodelling, which is 
required after the recruitment of the autophagic machinery by p62 (Lee et al., 2010a). 
In this way, p62 and HDAC6 may act in concert to promote disposal of ubiquitinated 
protein aggregates. 
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Due to the importance of mitochondria in the development of various degenerative 
diseases, a lot of interest has been focussed on their selective degradation through 
mitophagy (Kubli and Gustafsson, 2012). Mitochondria generate ATP for the cells, 
but during this process they also produce ROS that could become harmful during 
pathological conditions. Increased ROS production in damaged mitochondria is an 
important reason for their fast elimination. It has been shown that p62, in concert with 
PINK1 (phosphatase and tensin homolog – PTEN – induced putative kinase 1) and 
Parkin, mediates the autophagic clearance of mitochondria (Geisler et al., 2010). 
Following mitochondrial depolarisation, the serine/threonine kinase PINK1 
accumulates onto the outer membrane of damaged mitochondria and recruits Parkin, 
an E3-ubiquitin ligase that labels mitochondrial proteins through ubiquitination 
(mainly by K27- and K63-linked polyubiquitin chains), leading to mitochondrial 
clearance (Geisler et al., 2010; Narendra et al., 2010b; Vives-Bauza et al., 2010). An 
important target of ubiquitination, preferentially by K27-linked polyubiquitin chains, is 
VDAC1 (voltage-dependent anion channel 1, also known as Porin), a protein 
involved in mitochondrial membrane permeabilisation and apoptosis (Kroemer et al., 
2007; Geisler et al., 2010). Thus, a Parkin-dependent degradation of damaged 
mitochondria could prevent leaking of pro-apoptotic factors and ultimately cell death 
(Geisler et al., 2010). 
Subsequently to Parkin-mediated ubiquitination, damaged mitochondria are targeted 
to the same perinuclear site where aggresomes accumulate through the concerted 
action of p62 and HDAC6, leading to their autophagic degradation, (Lee et al., 
2010b; Okatsu et al., 2010). Importantly, It has been reported that p62 can only 
induce mitochondrial clustering through its PB1 domain, but not the mitophagy 
process itself, suggesting a role for other receptor proteins in mitochondrial 
degradation (Narendra et al., 2010a). For instance, Parkin-mediated ubiquitination of 
two GTPases involved in mitochondrial fusion, mitofusins Mfn1 and Mfn2, leads to 
their degradation through the mediation of p97/VCP (valosin-containing protein) 
(Tanaka et al., 2010). More recently, it has been discovered that NDP52 and OPTN, 
known for their role in xenophagy, are principally involved in mitophagy in HeLa cells, 
while p62 is dispensable for this process (Lazarou et al., 2015).  
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1.7 Neurodegenerative Diseases (NDs) 
Neurodegenerative diseases (NDs) are devastating, chronic and terminal conditions, 
mostly age-related with a late-onset, characterised by the decline in cognitive 
functions due to neuronal vulnerability and death (Ross and Poirier, 2004). Many 
diseases fall under this category, such as Alzheimer’s disease (AD), Parkinson’s 
disease (PD), dementia with Lewy bodies (DLB), Huntington’s disease (HD), 
amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and many more. 
Despite the presence of some hereditary conditions, most of these diseases have a 
sporadic onset, whose causes are not yet established. A pathological feature that 
NDs share is the formation of cytoplasmic, nuclear and/or extracellular neuronal 
inclusion bodies (Figure 1.10) (Ross and Poirier, 2005). Different proteins are 
involved in the aggregation process in different NDs, becoming the hallmark for such 
diseases, e.g. β-amyloid (extracellular) and tau (intracellular) in AD, α-synuclein in 
PD and DLB, huntingtin in HD, SOD1 in ALS and TDP-43 (transactive response – 
TAR – DNA-binding protein of 43 kDa) in FTD and ALS (Ross and Poirier, 2004). 
These inclusions, which are used as a neuropathological marker for post-mortem 
diagnosis, are formed by the polymerisation of misfolded, fibril forming-prone proteins 
that tend to aggregate in one or more foci in the cell (Kopito, 2000; Douglas and 
Dillin, 2010). 
The first event that leads to aggregation is the loss of the three-dimensional native 
structure of proteins which results in an abnormal conformation (Stefani, 2004). As 
evidenced by extensive genetic studies, genetic mutations conferring a gain-of-
function are often the cause of protein misfolding and toxicity, a leading cause of NDs 
(Rubinsztein, 2006). Misfolded proteins could be toxic per se, or alternatively the loss 
of conformation can lead to the exposure of hydrophobic sites, or reactive NH and 
CO groups, which could interact with other cellular components and generate a toxic 
environment (Ross and Poirier, 2005). Also aggregates could have a role in inducing 
toxicity, or they might be a way for the cell to segregate toxic proteins and limit 
cellular damage (Kopito, 2000; Ross and Poirier, 2005). 
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Oxidative stress plays an important role in neurodegeneration, as certain neuron 
populations exhibit a higher susceptibility to ROS known as selective neuronal 
vulnerability (Wang and Michaelis, 2010). Such vulnerability relies upon the intrinsic 
characteristics of neuronal cells, such as higher dependence on oxidative 
phosphorylation, high oxygen consumption, enrichment in metal ions (which can 
catalyse ROS formation) and in polyunsaturated fats (prone to oxidation), and the 
relative low concentration of antioxidants compared to other organs (e.g. liver) (Chen 
et al., 2012). Thus, maintaining a balanced redox environment could be a hard task, 
especially during increased oxidative stress in the course of ageing (Finkel and 
Holbrook, 2000). High levels of ROS can cause irreversible oxidation of proteins, 
leading to protein misfolding and aggregation and ultimately to neurodegeneration, 
therefore reducing the oxidative burden could be a strategy for intervention in NDs 
(Melo et al., 2011). However, it is unclear whether oxidative stress is a cause or a 
consequence of neurodegeneration, although surely implicated in the propagation of 
cellular damage in NDs (Andersen, 2004). 
The protein quality control system in neurons has a principal role in the defence 
against the formation of aberrant proteins, and it relies on molecular chaperones, the 
UPS and the autophagic pathway (Chen et al., 2011; Takalo et al., 2013). Hence, 
impairment in proteostasis can lead to the formation of misfolded and aggregated 
proteins, causing the collapse of the PN and ultimately neurodegeneration (Labbadia 
and Morimoto, 2015). Experimental evidence indicates the autophagy pathway as a 
common theme for the clearance of aggregate-prone proteins associated with NDs 
(Garcia-Arencibia et al., 2010; Nah et al., 2015). Genetic studies have shown that the 
knock-out of autophagy-related genes Atg5 and Atg7 is sufficient to result in the 
formation of protein inclusions and neurodegeneration in mice (Hara et al., 2006; 
Komatsu et al., 2006). 
Indeed, impairment of autophagy has been observed in most NDs, where 
accumulation of autophagic vacuoles (AVs) were detected in neurons, particularly 
within dystrophic neurites (Nixon et al., 2005; Son et al., 2012). Although such 
accumulation of AVs was first interpreted as an activation of the autophagy pathway, 
it became clear that AVs clearance was instead reduced due to hindered fusion 
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between autophagosomes and lysosomes (Yu et al., 2005; Boland et al., 2008). On 
the other hand, the upregulation of the autophagic pathway could be a strategy of 
intervention, promoting the clearance of aggregates and the amelioration of NDs 
(Rubinsztein et al., 2007; Garcia-Arencibia et al., 2010). Interestingly, it has recently 
been proposed that autophagy could serve as an antioxidant protective pathway by 
removing damaged proteins and organelles, thus reducing the spreading of damage 
in neurons (Giordano et al., 2014). Hence, the upregulation of autophagy could be a 
better strategy in treating NDs rather than enhancing the antioxidant system directly, 
which could hinder the physiological cellular signalling (Giordano et al., 2014). 
Moreover, the clearance of mutated proteins associated with NDs is more dependent 
on autophagy than on the UPS, which is mainly implicated in the degradation of 
native/soluble form (Ravikumar et al., 2002; Webb et al., 2003). One explanation 
could be that the narrow size of the proteasome entrance is accessible for soluble 
proteins but not for aggregates, which must be degraded by autophagy (Yao, 2010). 
In fact, it has been shown that aggregated α-synuclein inhibits the 26S of the 
proteasome by interacting with the protein S6’/Rpt5, a subunit of the 19S cap particle 
(Snyder et al., 2003). Additionally, inhibition of autophagy impairs the UPS activity 
and leads to the accumulation of specific proteasome targets, while it has been 
shown that during UPS impairment the autophagic pathway is upregulated, but not 
vice versa (Pandey et al., 2007; Korolchuk et al., 2009; Korolchuk et al., 2010). Thus, 
upon UPS inhibition or under pathological conditions, the cell may not be able to 
eliminate soluble misfolded proteins, which may accumulate and become prone to 
form insoluble cytoplasmic inclusions. After this event, last chance for the cell to 
dispose of such inclusions is the autophagy pathway (Ravikumar et al., 2010). 
However, it remains to be clarified whether alterations in the UPS can be the cause 
of the development of NDs or the consequence of these pathologies (Ciechanover 
and Brundin, 2003; Layfield et al., 2005). 
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Figure 1.10 | Protein inclusions in neurodegenerative diseases. Representation of the 
diverse protein inclusions found in major neurodegenerative diseases: beta-amyloid in 
amyloid plaques (yellow arrows) and hyperphosphorylated tau in neurofibrillary tangles 
(white arrows) in Alzheimer’s disease, α-synuclein in Lewy bodies in Parkinson’s disease, 
huntingtin inclusions in Huntington’s disease and SOD1 aggregates in amyotrophic lateral 
sclerosis (white arrows). Adapted from (Soto, 2003). 
 
1.7.1 Role of p62 in NDs 
As a substrate and receptor of selective autophagy, together with its ability to self-
oligomerise, p62 has a crucial role in the development of inclusions in NDs. Indeed, 
the presence of p62 has been essentially detected in all NDs-related protein 
aggregates such as neurofibrillary tangles in AD (but absent in amyloid plaques), 
Lewy bodies in PD and DLB, inclusion bodies in HD as well as in ALS and FTD 
(Kuusisto et al., 2001; Zatloukal et al., 2002; Gal et al., 2007). For this reason, p62 
has become a “general inclusion stain” to facilitate the diagnosis of NDs (Kuusisto et 
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al., 2008). The ability to bind both ubiquitin and LC3 through its UBA and LIR 
domains, respectively, allows p62 to work as a bridge between the UPS and 
autophagy, thus becoming an important player in the quality control system of 
proteins (Kirkin et al., 2009b). 
Following autophagy inhibition, p62 tends to accumulate and aggregate through its 
PB1 domain together with polyubiquitinated proteins and can be found in cellular 
inclusions (Komatsu et al., 2007b). Importantly, genetic loss of p62 during autophagy 
inhibition strongly reduces the ubiquitin-positive aggregate formation, although the 
neurodegenerative process is not affected, suggesting the presence of additional 
factors mediating neurodegeneration in neurons (Komatsu et al., 2007b). On the 
other hand, the knock-out of p62 is also detrimental for neural physiology and 
enhances the accumulation of hyperphosphorylated tau protein in mice, where the 
inhibition of aPKCι, an interactor of p62, leads to the upregulation of protein kinases 
implicated in the hyperphosphorylation process (Ramesh Babu et al., 2008). The 
knock-out of TRAF6 also leads to the loss of tau K63-linked polyubiquitination, which 
normally drives tau for proteasomal degradation upon p62 interaction (Babu et al., 
2005). Therefore, either the abatement of p62 expression or the inhibition of 
proteasomal activity could enhance the formation of tau neurofibrillary tangles (Babu 
et al., 2005). 
It has been reported that p62 is involved in the polyubiquitination and aggregation of 
mutant huntingtin that drives its degradation by autophagy, thus reducing the toxicity 
correlated with the presence of the mutated protein (Bjorkoy et al., 2005). Cell death 
was enhanced by depletion of p62 or by expression of p62 lacking the UBA domain, 
whereas mutant huntingtin was still able to aggregate, highlighting the crucial role of 
p62 in driving such aggregates to the autophagic machinery (Nagaoka et al., 2004; 
Bjorkoy et al., 2005). 
Additionally, mutations of p62 have been connected to ALS as well as frontotemporal 
lobar degeneration (FTLD, a pathological process that occurs in FTD) (Fecto et al., 
2011; Rubino et al., 2012). Notably, several of these mutations are common to both 
ALS-FTLD and PDB, although the latter is likely to be often unrecognised in patients 
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due to its relative late onset (Teyssou et al., 2013; Rea et al., 2014). Differently from 
the PDB-associated mutations of p62 (usually affecting the UBA domain), ALS-FTLD 
mutations are present along the whole sequence of p62, often affecting its domains 
such as PB1, LIR, KIR and UBA (Rea et al., 2014). Recently, a LIR-associated 
L341V mutation of p62 has been shown to impair its binding to LC3, therefore 
altering the correct formation of phagophores (Goode et al., 2016). 
Although an impairment in autophagy has been associated with increased p62 levels 
due to a reduction of its selective degradation (Yue, 2007), it has been shown that 
the expression levels of p62 are down-regulated following oxidative stress conditions, 
which causes damage to the p62 gene promoter (Du et al., 2009a; Du et al., 2009b). 
The amount of damage in the p62 promoter sequence, revealed by the increased 
oxidation of guanine into its derivative 8-OHdG (8-hydroxy-2’-deoxyguanosine, used 
as a marker for DNA oxidation), is significantly increased in NDs, showing a 
reduction in the activation of the gene and in the expression of p62 (Kasai, 1997; Du 
et al., 2009b). 
The accumulation of p62 in cytoplasmic aggregates could be also a mechanism for 
modulating the signalling activity of p62 in the cell. For instance, NF-κB and Nrf2 
pathways, which are known to be involved in the response against oxidative stress 
during the development of NDs, could be modulated by p62 aggregation (Mattson et 
al., 2000; Calkins et al., 2009). Therefore, p62 has a complex role in NDs, where it 
can be involved in protein degradation for aggregates removal, but it can also play a 
detrimental role by driving aggregation especially when, as in many NDs, proteolytic 
degradation is impaired. 
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1.8 Objective and Aims 
Oxidative stress and autophagy inhibition have been shown to have an important role 
in the pathogenesis of NDs, in which protein aggregates accumulate. The selective 
autophagy receptor p62 drives the formation of protein aggregates for their 
degradation, however the mechanisms of p62 oligomerisation, especially during 
oxidative stress, are still incompletely understood. Preliminary data from our 
laboratory have shown that the electrophoretic mobility of p62 could be modified by 
different stressors, such as oxidation or DUBs inhibition, suggesting a new potential 
mechanism of p62 oligomerisation. This could lead to a better understanding on the 
role of p62 in forming protein aggregates during pathological conditions. The main 
objective of this thesis work is to investigate the molecular mechanism underlying the 
oligomerisation and the aggregation of p62, and finding potential molecular targets 
for the amelioration of human NDs. 
The first aim is to identify novel post-translational modifications of p62, together with 
the amino acids involved in intra- and inter-molecular interactions, in order to better 
characterise p62 oligomerisation and aggregate formation. The second aim is to 
understand whether such new mechanism of p62 oligomerisation could be relevant 
to human physiology, particularly in the pathogenesis of NDs.  
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Chapter 2. Materials and Methods 
2.1 Materials 
Table 2.1 | Consumables for cell culture used in this study. 
 
Cell Culture Consumables 
 
 
Reagent Manufacturer Product No. 
 CryoTube vials Thermo Fisher Scientific 377267 
Mr. FrostyTM freezing container Thermo Fisher Scientific 5100-0001 
0.6 ml 'Crystal Clear' microcentrifuge tube Starlab E1405-0600 
1.5 ml microcentrifuge tubes  Starlab S1615-5500 
6-well plates Fisher 11825275 
12-well plate Fisher 
TKB-100-
110R 
24-well plates Fisher 
TKB-100-
115H 
15 ml Centrifuge Tube, Conical (Sterile), 
Loose 
Star labs E1415-0200 
175 cm² TC treated flask with filter cap Greiner-Bio one 661175 
2 ml 'Crystal Clear' Microcentrifuge Tube Starlab E1420-2000 
50 ml Centrifuge Tube, Conical (Sterile), 
Loose 
Starlab E1450-0200 
75 cm2 TC treated flask with filter cap Greiner-Bio one 658175 
Acrodisc® Mini Spike syringe filters Sigma-Aldrich  
Z260444-
1PAK 
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Acryl Aquaclean 
WAK-Chemie Medical 
GmbH 
WAK-AQA-
250-50L 
Bijou sample container, plain label Sigma-Aldrich  
Z645346-
700EA 
Cell culture dish treated with vents sterile 
polystyrene non-pyrogenic 
Thermo Fisher Scientific 10075371 
Coverglass 13 mm/0.16 mm VWR 631-0150 
Glass Pasteur pipettes 230 mm VWR 612-1702 
Serological pipettes 10 ml Sarstedt 86.1254.001 
Serological pipettes 25 ml Sarstedt 86.1685.001 
Serological pipettes 5 ml Sarstedt 86.1253.001 
 
 
Table 2.2 | Reagents for cell culture used in this study. 
 
Cell Culture Reagents 
 
 
Reagent Manufacturer Product No. 
Trypsin-EDTA solution  Sigma-Aldrich  T3924 
Penicillin-Streptomycin Sigma-Aldrich  P4333 
Mycoalert Detection Kit Lonza LT07-218 
L-Glutamine solution  Sigma-Aldrich  G7513 
Lipofectamine® 2000 
Thermo Fisher 
Scientific 
11668019 
Dulbecco’s Modified Eagle’s Medium (DMEM), 
high glucose 
Sigma-Aldrich  D5796 
Opti-MEM® I Reduced-Serum Medium, no 
phenol red 
Thermo Fisher 
Scientific 
11058021 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich  D2650 
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20x PBS 
New England 
BioLabs Inc. 
9808 
Fetal Bovine Serum (FBS), heat inactivated BioSera FB1001H 
Isopropanol Sigma-Aldrich 278475 
 
 
Table 2.3 | Reagents for mutagenesis and cloning used in this study. 
 
Mutagenesis and Cloning Reagents 
 
 
Reagent Manufacturer Product No. 
QuikChange II XL Site-Directed 
Mutagenesis Kit 
Agilent Technologies 200521 
PfuUltra High-Fidelity DNA Polymerase Agilent Technologies 600380 
XL10-Gold® Ultracompetent Cells Agilent Technologies 200314 
Phusion High Fidelity PCR kit Thermo Fisher Scientific F553S 
QIAquick Gel Extraction Kit Quiagen 28704 
Calf Intestinal Alkaline Phosphatase Thermo Fisher Scientific 18009019 
T4 DNA Ligase 
New England BioLabs 
Inc. 
M0202S 
α-select Gold Efficiency Competent Cells Bioline BIO-85027 
Agarose Thermo Fisher Scientific BP1356-500 
Ampicillin Sigma-Aldrich  A5354 
Kanamycin  Sigma-Aldrich K0254 
Burner Bunsen Natural Gas 13mm SLS BUR3000 
Cell culture dish treated with vents sterile 
polystyrene non-pyrogenic 
Thermo Fisher Scientific 10075371 
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Glass spreaders Sigma-Aldrich S4522-6EA 
LB Agar Miller Thermo Fisher Scientific 10734724 
LB Broth Miller Powder Thermo Fisher Scientific 10638013 
Molecular Grade RNase-free water Thermo Fisher Scientific 
B-003000-
WB-100 
peqGREEN Peqlab 37-5000 
PureYield™ Plasmid Midiprep System Promega A2492 
S.O.C. Medium Thermo Fisher Scientific 15544-034 
QIAprep Spin Miniprep Kit Qiagen 27104 
 
 
Table 2.4 | Reagents for immunoblot used in this study. 
 
Immunoblot Reagents 
 
 
Reagent Manufacturer Product No. 
Ammonium persulphate (APS) Sigma-Aldrich A3678 
Bovine Serum Albumin (BSA) Sigma-Aldrich A2153 
Polyoxyethylene sorbitan (Tween-20) Sigma-Aldrich 93774 
N,N,N’,N’-Tetramethylethylenediamine 
(TEMED) 
Sigma-Aldrich T9281 
Clarity western ECL substrate Bio-Rad 170-5061 
2x Laemmli buffer Bio-Rad 1610737 
Precision Plus Protein™ Dual Color 
Standards 
Bio-Rad 610374 
DC Protein Assay Kit  Bio-Rad 500-0112 
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Marvel non-fat dry milk powder Asda N/A 
Immobilon-P polyvinylidene difluoride (PVDF) 
membrane 
Millipore IPVH00010 
Phosphatase inhibitor cocktail 100X  
Thermo Fisher 
Scientific 
1861280 
N-ethylmaleimide (NEM) Sigma-Aldrich E3876 
RestoreTM PLUS Western Blot Stripping Buffer 
Thermo Fisher 
Scientific 
46430 
GelCodeTM Blue stain reagent 
Thermo Fisher 
Scientific 
10608494 
Acrylamide/Bis-acrylamide Severn Biotech 20-2100-10  
Sodium chloride (NaCl) Sigma-Aldrich  S7653 
Sodium deoxycholate (NaDoC) Sigma-Aldrich D6750 
IGEPAL® CA-630 (NP-40) Sigma-Aldrich  I3021 
Methanol Sigma-Aldrich 32213 
Thick blotting paper VWR 732-0594 
Gel loading tips Starlab 1022 0600 
20x PBS New England Bio 9808 
Glycine Sigma-Aldrich G8898 
Trizma® base (Tris) Sigma-Aldrich T1503 
β-mercaptoethanol (β-ME) Sigma-Aldrich  M3148 
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Table 2.5 | Reagents for immunofluorescence used in this study. 
 
Immunofluorescence Reagents 
 
 
Reagent Manufacturer Product No. 
20x PBS New England Bio 9808 
Bovine Serum Albumin (BSA) Sigma-Aldrich  5482 
Triton X-100 Sigma-Aldrich X100 
Polyoxyethylene sorbitan (Tween-20) Sigma-Aldrich 93774 
Microscope slide ground edges, twin frosted 
Thermo Fisher 
Scientific 
FB58628 
ProLong® Gold Antifade Mountant with DAPI 
Thermo Fisher 
Scientific 
P36935 
TO-PRO-3 iodide 
Thermo Fisher 
Scientific 
T3605 
37% Formaldehyde Sigma-Aldrich 252549 
Normal Goat Serum Vector Laboratories S-1000 
Normal Rabbit Serum Vector Laboratories S-5000 
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Table 2.6 | Reagents for immunohistochemistry used in this study. 
 
Immunohistochemistry Reagents 
 
 
Reagent Manufacturer Product No. 
Microscope slide ground edges, twin frosted 
Thermo Fisher 
Scientific 
FB58628 
Histoclear National Diagnostics HS-200 
Ethanol 
Thermo Fisher 
Scientific 
 E/0650DF/17 
Normal Goat Serum Vector Laboratories S-1000 
VECTASTAIN ABC kit Vector Laboratories PK-4000 
NovaRED Vector Laboratories SK-4800 
haematoxylin Vector Laboratories H-3401 
DPX mounting medium  
Thermo Fisher 
Scientific 
12658646 
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2.3 Cell Culture 
2.3.1 Cell Lines 
HeLa cells were obtained from ECACC (European Collection of Cell Cultures). p62 
knock-out (p62-/-) mouse embryonic fibroblasts (MEFs) (Komatsu et al., 2007b) were 
kindly provided by Eiji Warabi (University of Tsukuba, Japan). The p62/A170 mouse 
gene of the p62-/- MEFs was isolated by designing a targeting vector against the 
exons 1-4 of the gene. HEK293FT (human embryonic fibroblasts) lentivirus 
packaging cells were from Invitrogen. Stable p62-/- cell lines expressing FLAG-p62 
transgenes either wild-type or C105,113A double mutant of p62 were produced in 
this study by lentiviral transduction. Cells were grown in DMEM (Dulbecco’s modified 
eagle’s medium, Sigma-Aldrich) supplemented with 10% heat-inactivated FBS (fetal 
bovine serum, Biosera), 1% penicillin/streptomycin (Invitrogen) and 2 mM L-
glutamine (Sigma-Aldrich) in a humidified atmosphere containing 5% CO2 at 37°C 
(Table 2.1, 2.2). Cells at ∼80% confluency were treated with the compounds listed in 
Table 2.7. Cell medium was switched to serum-free DMEM for the duration of the 
treatments. 
2.3.2 Cryogenic storage 
Exponentially growing adherent cells were trypsinised (when at ∼80% confluence) 
with trypsin-EDTA (ethylene-diamine-tetraacetic acid, Sigma-Aldrich). Trypsin was 
neutralized with the addition of pre-warmed media and cells centrifuged at 900 rpm 
for 3 min at room temperature. The supernatant was removed and cells were 
resuspended in FBS containing 10% (v/v) dimethyl sulfoxide (DMSO) at a density of 
1x106 cells/ml. The cell suspension was immediately transferred to cryovials in 1 ml 
aliquots (containing 1x106 cells) and placed in a Mr. FrostyTM freezing container 
(Thermo Fisher Scientific) filled with isopropanol (Sigma-Aldrich). Cells were placed 
at -80°C for 24 hours to allow slow freezing, before being transferred to liquid 
nitrogen for long term storage. 
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2.3.3 Resuscitation of frozen cells 
Cryovials containing the cell suspension were removed from liquid nitrogen and 
placed in a water bath at 37°C to thaw for 5 min. The thawed cell suspension was 
immediately added to pre-warmed media and seeded in cell flask. Cell culture media 
was replaced after 24 hours to remove the DMSO and cell debris. 
2.3.4 Cell density calculation 
Cell density was calculated using a 0.1 mm Improved Neubauer haemocytometer 
(Hawksley, #AC1000), where 10 µL of trypsinised cells suspension were analysed 
using an inverted microscope (DM IL LED, Leica Microsystems). Cells were counted 
from two different corner squares of the haemocytometer, and their average was 
equivalent to the number of cells x104/ml. This allowed for the calculation of the total 
number of cells by multiplying the volume of the cell suspension to the cells 
concentration (cells/ml). For seeding purposes, the C1*V1=C2*V2 formula was used, 
where: 
C1= Starting cells concentration (cells/ml) 
V1= Cells volume needed for seeding (ml) 
C2= Desired cells concentration (cells/ml) 
V2= Desired cells volume (ml) 
The desired amount of cells (C2) was multiplied to the desired volume of media (V2), 
then divided to the starting concentration of cells (C1) by using the formula:  
V1= (C2*V2)/C1. Cells were tracked by recording the dilution factor and the number 
of passages. 
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Table 2.7 | Compounds for cell culture treatments used in this study. 
 
Cell Culture Treatments 
 
 
Reagent Manufacturer Product No. 
Bafilomycin A1 (Baf) Enzo Life Sciences BML-CM110-0100 
Chloroquine (CQ) Sigma-Aldrich C6628 
H2O2 Sigma-Aldrich 323381 
PR-619 LifeSensors SI9619 
N-acetylcysteine (NAC) Sigma-Aldrich A7250 
Paraquat (PQ) Sigma-Aldrich 36541 
Puromycin Santa Cruz Biotechnology sc-108071 
Staurosporine Sigma-Aldrich S4400 
Z-VAD-FMK Calbiochem 219007 
N-ethylmaleimide (NEM) Sigma-Aldrich E3876 
Curcumin Sigma-Aldrich C1386 
Auranofin Sigma-Aldrich A6733 
Cycloheximide (CHX) Sigma-Aldrich C7698 
MG132 Sigma-Aldrich C2211 
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2.4 Transfection 
HeLa cells and MEFs were seeded in either 6- or 12-well plates, cultured for 24 
(HeLa) or 48 (MEFs) hours and transfected with Lipofectamine® 2000 (Thermo 
Fisher Scientific) according to the manufacturer’s instructions for 24 hours prior to 
lysis. For each transfection, 1 μg DNA, 3 μl of transfection reagent and 100 μl Opti-
MEM® I Reduced-Serum Medium (Thermo Fisher Scientific) per well were used. 
Plasmids used in this study: pEGFP-p62, pEGFP-ΔUBAp62 and pDEST-GST-p62 
were kindly provided by Terje Johansen (University of Tromsø, Norway) (Lamark et 
al., 2003), His-FLAG-p62 was kindly provided by Robert Layfield (University of 
Nottingham, UK) (Najat et al., 2009), pEGFP-C2 (Clontech, #632481), pLENTI6/V5-
DEST (Invitrogen, #V496-10), and all the p62 mutants and deletion constructs 
generated in this study. 
2.5 Mutagenesis 
Point mutagenesis of the p62 gene was carried out using the QuikChange II XL Site-
Directed Mutagenesis Kit (Agilent Technologies) (Table 2.3) following the provided 
protocol. Mutagenesis primers were designed using the QuikChange Primer Design 
program available online on the Agilent website (http://www.genomics.agilent.com/) 
(Table 2.8). The pEGFP-p62 and FLAG-p62 wild-type plasmids were used as a 
template. Every PCR mixture was prepared according to the provided protocol: 1x 
reaction buffer, 10 ng dsDNA template, 125 ng oligonucleotide primers (both forward 
and reverse), 200 μM dNTP, 3 μl QuikSolution reagent, PfuUltra High-Fidelity DNA 
polymerase (Agilent Technologies, 2.5 U/μl) and ddH2O up to final volume 50 μl. 
PCR reactions were placed on a Veriti 96-Well Thermal Cycler (Applied Biosystems) 
using the provided program: 1 cycle at 95°C for 1 min, 18 cycles (Denaturation 95°C 
for 50 sec, Annealing 60°C for 50 sec, Extension 68°C for 7 min) and 1 cycle at 68°C 
for 6 min. PCR samples were then kept at 4°C until digestion with 10 U/μl of DpnI 
(1 hour at 37°C), which digests parental methylated and hemimethylated DNA and 
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selects the mutagenised DNA. Bacteria transformation was then carried out using 45 
μl of XL10-Gold® Ultracompetent Cells (Agilent Technologies) and 2 μl of β-ME mix 
provided with the kit, together with 2 μl of the DpnI-treated DNA per each reaction. 
Transformation mixtures were incubated on ice for 30 min, heat-pulsed in a 42°C 
water bath for 30 sec, incubated on ice for 2 min, followed by the addition of 500 μl of 
S.O.C. medium (Thermo Fisher Scientific). After 1 hour incubation at 37°C with 
shaking at 220 rpm, 250 μl of each transformation reaction were plated on LB agar 
(Thermo Fisher Scientific) plates containing 100 ng/μl of ampicillin (Sigma-Aldrich) 
and incubated overnight at 37°C. Then, colonies were picked up and grown in 5 ml of 
LB broth (Thermo Fisher Scientific) overnight at 37°C with shaking at 220 rpm. 
Bacterial DNA was extracted using the QIAprep Spin Miniprep Kit (Qiagen) to a final 
volume of 50 μl and sent for sequencing (Genevision, Newcastle University). 
Sequenced DNA was aligned with the wild-type sequence of p62 to confirm the 
presence of mutations using the BLAST software available online (NCBI). 
2.6 Cloning 
Deletions of p62 were produced through PCR (Table 2.3, see Appendix A, B, C), 
using the pEGFP-p62 wild-type as a template and specific primers generated by 
SnapGene software (GSL Biotech) (Table 2.8). The generated fragments were then 
ligated into the pEGFP-C2 vector. Forward primers included a BglII (sticky end, New 
England BioLabs Inc.) restriction site. PCRs were performed using the Phusion High-
Fidelity PCR kit (Thermo Fisher Scientific) and every PCR mixture was prepared 
according to the provided protocol: 1x Phusion High-Fidelity buffer, 10 ng DNA 
template, 125 ng oligonucleotide primers (both forward and reverse), 200 μM dNTP, 
Phusion High-Fidelity DNA polymerase (2 U/μl) and ddH2O up to final volume of 50 
μl. PCR reactions were placed on a Veriti 96-Well Thermal Cycler (Applied 
Biosystems) using the provided program: 1 cycle at 98°C for 30 sec, 25 cycles 
(Denaturation 98°C for 10 sec, Annealing 57°C for 30 sec, Extension 72°C for 1 min) 
and 1 cycle at 72°C for 5 min. The p62 fragments were then digested with BglII for 3 
hours at 37°C and run on 0.8% agarose gel which was then purified. The pEGFP-C2 
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vector was digested with SmaI (blunt end, New England BioLabs Inc.) and run on 
0.8% agarose gel followed by purification with QIAquick Gel Extraction Kit (Quiagen). 
The pEGFP-C2 vector was then digested with BglII, followed by gel purification. After 
the double digestion, the pEGFP-C2 vector was dephosphorylated by calf intestinal 
alkaline phosphatase (Thermo Fisher Scientific) for 50 min at 37°C. The digested p62 
fragments were ligated into the double digested pEGFP-C2 vector (sticky-end/blunt-
end ligation) using the T4 DNA Ligase (New England BioLabs Inc.) at 16°C 
overnight. Bacterial transformation was performed using α-select GOLD Efficiency 
chemically competent cells (Bioline) adding 2 μl of ligation mixture to 45 μl of cells. 
Cells were plated on LB agar plates containing 50 ng/ml of kanamycin (Sigma-
Aldrich). FLAG-p62 and FLAG-C105,113Ap62 for lentiviral expression were 
subcloned into the pLENTI6/V5-DEST vector using EcoRI and XhoI (New England 
BioLabs Inc.) as described above. 
 
Table 2.8 | Primers for mutagenesis and cloning used in this study. Fw: forward; Rev: 
reverse. 
 
Primers for Mutagenesis and Cloning 
 
 
Name/direction Sequence 
K7A_Fw 5'-CGTCGCTCACCGTGGCGGCCTACCTTCTGG-3' 
K7A_Rev 5'-CCAGAAGGTAGGCCGCCACGGTGAGCGACG-3' 
C26A_Fw 5'-CCGCTTCAGCTTCGCCTGCAGCCCCGAG-3' 
C26A_Rev 5'-CTCGGGGCTGCAGGCGAAGCTGAAGCGG-3' 
C27A_Fw 5'-GCTTCAGCTTCTGCGCCAGCCCCGAGCCTG-3' 
C27A_Rev 5'-CAGGCTCGGGGCTGGCGCAGAAGCTGAAGC-3' 
C44A_Fw 5'-GGTCCGGGACCCGCCGAGCGGCTGCT-3' 
C44A_Rev 5'-AGCAGCCGCTCGGCGGGTCCCGGACC-3' 
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D69A_Fw 5'-CGCACTACCGCGCTGAGGACGGGGA-3' 
D69A_Rev 5'-TCCCCGTCCTCAGCGCGGTAGTGCG-3' 
C105A_Fw 5'-ACATTAAAGAGAAAAAAGAGGCCCGGCGGGACCACCG-3' 
C105A_Rev 5'-CGGTGGTCCCGCCGGGCCTCTTTTTTCTCTTTAATGT-3' 
C113A_Fw 5'-CCACCGCCCACCGGCTGCTCAGGAGGCG-3' 
C113A_Rev 5'-CGCCTCCTGAGCAGCCGGTGGGCGGTGG-3' 
C128A_Fw 5'-GCACCCCAATGTGATCGCCGATGGCTGCAATGGG-3' 
C128A_Rev 5'-CCCATTGCAGCCATCGGCGATCACATTGGGGTGC-3' 
C131A_Fw 5'-GTGATCTGCGATGGCGCCAATGGGCCTGTGGT-3' 
C131A_Rev 5'-ACCACAGGCCCATTGGCGCCATCGCAGATCAC-3' 
C142A_Fw 5'-GAACCCGCTACAAGGCCAGCGTCTGCCCAG-3' 
C142A_Rev 5'-CTGGGCAGACGCTGGCCTTGTAGCGGGTTC-3' 
C145A_Fw 5'-CTACAAGTGCAGCGTCGCCCCAGACTACGACTTG-3' 
C145A_Rev 5'-CAAGTCGTAGTCTGGGGCGACGCTGCACTTGTAG-3' 
C151A_Fw 5'-CCAGACTACGACTTGGCTAGCGTCTGCGAGGG-3' 
C151A_Rev 5'-CCCTCGCAGACGCTAGCCAAGTCGTAGTCTGG-3' 
C154A_Fw 5'-CAAGCCCTTTCCCTCGGCGACGCTACACAAGTCG-3' 
C154A_Rev 5'-CGACTTGTGTAGCGTCGCCGAGGGAAAGGGCTTG-3' 
C289A/C290A_Fw 5'-GCTTGCTGGGGTCAGAGGCGGCGCTGCTTGGCTGTGAGC-3' 
C289A/C290A_Rev 5'-GCTCACAGCCAAGCAGCGCCGCCTCTGACCCCAGCAAGC-3' 
C331A_Fw 5'-GTCATCATCTCCTCCTGAAGCGTTATCCGACTCCATCTGT-3' 
C331A_Rev 5'-ACAGATGGAGTCGGATAACGCTTCAGGAGGAGATGATGAC-3' 
p62_1BglII_Fw 5'-CTCAGATCTCGATGGCGTCGCTCACCG-3' 
p62_114BglII_Fw 5'-CTCAGATCTCGGCTCAGGAGGCGCCC-3' 
p62_122SalI_Rev 5'-ACCGTCGACTCTACACCATGTTGCGGGGC-3' 
p62_200SalI_Rev 5'-ACCGTCGACTCTAACCCATTTCCCATCCTGGC-3' 
p62_440_Rev 5'-TCACAACGGCGGGGG-3' 
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2.7 Lentiviral Transduction 
Stable expression of FLAG-p62 and FLAG-C105A-C113Ap62 in p62-/- MEFs was 
achieved through lentiviral transduction. FLAG-p62 (see Appendix D) and FLAG-
C105A-C113Ap62 transgenes were cloned into the pLenti6/V5-DEST expression 
vector containing the blasticidin resistance gene (see Appendix E). HEK293FT cells 
were seeded in antibiotic-free medium supplemented with 0.1 mM MEM non-
essential amino acids (Gibco, #11140050) and then cotransfected with either empty 
or p62 lentiviral expression vectors and 3rd generation packaging system plasmids 
(Thermo Fisher Scientific, #K497500). After 24 hours, media was replaced with fresh 
media without antibiotics. 48 hours after transfection, viral transduction was 
performed by transferring media from HEK293FT cells 70% confluent p62 knock-out 
(p62-/-) MEFs in the presence of 6 μg/ml Polybrene (Sigma-Aldrich, #H9268). Media 
containing virus was replaced after 24 hours with fresh media containing 8 μg/ml of 
blasticidin (Thermo Fisher Scientific, #R21001) for selection of transduced cells. 
Media was replaced every 2-3 days for 10-12 days by keeping the antibiotic 
selection. Transduced MEFs were then maintained in lower levels of blasticidin (4 
μg/ml) until seeding for experimental purposes. 
2.8 GST-p62 Purification 
GST-p62 fusion protein was produced in E. cloni EXPRESS BL21 (DE3) Chemically 
Competent Cells (Lucigen, #60401) using the pDEST-GST-p62 plasmid as 
previously described (Lamark et al., 2003). Fusion protein expression was induced 
by adding 0.2 mM IPTG (isopropyl β-D-1-thiogalactopyranoside, Sigma-Aldrich, 
#I5502) for 2 hours. Bacterial pellets were lysed by sonication in buffer (50 mM Tris 
pH 7.4, 150 mM NaCl) and GST-fusion protein purified using Glutathione-Sepharose 
4B beads (GE Healthcare, #17075601). Purified GST-p62 fusion protein was then 
treated with H2O2 and PR-619 as indicated and subjected to immunoblot analysis. 
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2.9 Immunoblot Analysis 
2.9.1 Protein extraction 
HeLa, MEFs or HEK293E cells were seeded in 6- or 12-well plates 24 (HeLa and 
HEK293E) or 48 (MEFs) hours prior treatments (Table 2.4). After treatments, cells 
were washed in ice-cold 1x PBS then lysed in RIPA (radioimmunoprecipitation assay) 
buffer (150 mM NaCl, 1% NP-40, 0.5% NaDoC, 0.1% SDS, 50 mM Tris pH 7.4, 
supplemented with 1X Halt protease & phosphatase inhibitor cocktail (Thermo Fisher 
Scientific) in ddH2O) plus 50 mM N-ethylmaleimide (NEM, Sigma-Aldrich), which 
determines alkylation of reduced cysteine residues and protects them from being 
oxidised during sample preparation (Gregory, 1955; Paulech et al., 2013). Cells were 
scraped with rubber scrapers on ice and lysates were centrifuged at 4°C at 13,000 
rpm for 10 min to remove insoluble cellular components. Supernatants containing 
proteins were then quantified. 
2.9.2 Protein quantification 
Protein concentration was measured by Bradford assay using the DC Protein Assay 
Kit I (Bio-Rad), a detergent-compatible colorimetric assay. Four different dilutions of 
protein standards (0, 0.25, 0.75 and 1.5 μg of BSA) in duplicate were used to 
generate a calibration curve. After adding the standards (5 μl) and the unknown 
protein samples (2 μl) in a 96-well plate, 25 μl of Reagent A’ (an alkaline copper 
tartrate solution) were added to each well, followed by 200 μl of Reagent B (Folin 
reagent). The colorimetric reaction is mediated by a reaction between proteins and 
copper in an alkaline medium, and a subsequent reduction of Folin reagent by the 
copper-treated proteins. Absorbance was then measured with a FLUOstar Omega 
plate reader (BMG Labtech) at 750 nm, and the colorimetric values were analysed on 
Excel (Microsoft). Samples were prepared at the same concentration by mixing the 
appropriate volume of protein lysate and 2x Laemmli buffer (Bio-Rad) and boiled at 
100°C for 5 min in the presence or absence of 2.5% β-ME (β-mercaptoethanol, 
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Sigma-Aldrich). Samples were either stored at -20°C or immediately used for 
immunoblot analysis. 
2.9.3 Acrylamide gel preparation 
Gels for electrophoresis were assembled by pouring a mix solution for the resolving 
gel (10-15% acrylamide, 1.5 M Tris pH 8.8, 10% SDS, 10% ammonium persulphate 
and 0.05% TEMED in ddH2O), pouring it into 1.5 mm empty gel cassette (Thermo 
Fisher Scientific) leaving 1 inch empty and overlaying with 1 ml of water to ensure a 
straight edge. After the polymerisation of the resolving edge, a mix solution for the 
stacking gel (5% acrylamide, 1 M Tris pH 6.8, 10% SDS, 10% ammonium 
persulphate and 0.1% TEMED in ddH2O) was then poured into the cassette on top of 
the resolving gel, and a gel comb (10-15 wells, Thermo Fisher Scientific) was 
inserted. 
2.9.4 Electrophoresis and transfer 
The cassettes with the polymerised gel were placed in an XCell SureLockTM Mini-Cell 
electrophoresis system (Invitrogen) which was filled with Tris-Glycine running buffer 
(250 μM Tris, 1.92 mM glycine and 0.1% w/v SDS). Samples (20-40 μg of proteins) 
were loaded into the wells of the gel along with the Precision Plus ProteinTM Dual 
Color Standards (Bio-Rad) and electrophoresis was performed at 120 volts, 35 mA 
and 5 watts for 90 min. Following electrophoresis, gels were removed from the 
cassettes and proteins were transferred to Immobilon-P PVDF membranes (0.45 μm, 
Millipore) using a Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad) at 17 volts for 1 
hour. Thick blotting paper pads (VWR International) soaked in transfer buffer (250 
μM Tris, 1.92 mM glycine) were used above and under the gels. Alternatively, gels 
were stained with GelCodeTM Blue stain reagent (Thermo Fisher Scientific), based on 
colloidal Coomassie dye G-250 for nanogram-level detection of proteins, for 1 hour at 
room temperature. 
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After the transfer, membranes were stained with Ponceau S solution (0.5% Ponceau 
and 5% acetic acid in ddH2O) for band detection, to assess efficiency of the transfer 
and to trim membranes as required. 
2.9.5 Membranes staining and evaluation 
Membranes were washed in PBS and incubated with a blocking solution (PBS 
containing 5% fat-free dry milk, 0.1% Tween-20) for 1 hour. After washing with PBS, 
membranes were incubated with primary antibody (Table 2.9) diluted in blocking 
solution at 4˚C overnight with gentle shaking. The day after, membranes were 
washed three times, 5 min each: one time with PBS, once in PBS with 0.1% Tween-
20 and one more time in PBS. Then, membranes were incubated with HRP 
(horseradish peroxidase)-conjugated secondary antibody diluted in blocking solution 
for 1 hour at room temperature with gentle shacking. The secondary antibodies were: 
α-mouse (Sigma-Aldrich, #A2554, 1:5000), α-rabbit (Sigma-Aldrich, #A0545, 1:5000) 
and α-guinea pig (Dako, #P0141, 1:1000). Membranes were washed three times as 
above, then incubated for 5 min with ClarityTM Western ECL Substrate (Bio-Rad), 
which is prepared by mixing equal amounts of peroxide reagent and 
luminol/enhancer reagent. Membranes were visualised by chemiluminescence using 
a LAS-4000 CCD camera system (Fujifilm). 
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Table 2.9 | Primary antibodies for immunoblot used in this study. 
 
Primary antibodies for immunoblot 
 
 
Protein Host Dilution 
Manufacturer/ 
Product No. 
p62 Guinea pig 1:2000 GP62-C 
Ubiquitin Mouse 1:1000 
LifeSensors 
#VU101 
LC3 Mouse 1:1000 
Enzo Life Sciences 
#ALX-803-081-C100 
Mfn2 Mouse 1:1000 
Sigma-Aldrich 
#WH0009927M3 
rpL10 (QM) Rabbit 1:200 
Santa Cruz Biotechnology 
#sc-798 
Prx-3 Rabbit 1:2000 (Olahova et al., 2008) 
Prx-SO3 Rabbit 1:2000 
Abcam 
#ab16830 
GFP Mouse 1:1000 
Santa Cruz Biotechnology 
#sc-9996 
GAPDH Rabbit 1:10,000 
Cell Signaling 
#5174 
Actin Rabbit 1:2000 
Abcam  
#ab8227 
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2.10 Ultracentrifugation 
Lysates from HeLa cells and MEFs were spun first at 4°C at 13,000 rpm for 10 min, 
and samples of whole-cell lysates were prepared by boiling in 2x Laemmli buffer 
(Bio-Rad) at 100°C for 5 min. Supernatants where loaded into 1 ml thickwall 
polycarbonate cuvettes (Beckman Coulter, #343778) and centrifuged using an 
OptimaTM TLX Ultracentrifuge (Beckman Coulter) at 100,000 rpm at 4°C for 1 hour. 
Soluble and insoluble fraction samples were prepared by boiling supernatants and 
pellets in 2x Laemmli buffer (Bio-Rad) at 100°C for 5 min. 
2.11 Immunoprecipitation (IP) 
HeLa cells were seeded in 100 mm dishes and subjected to transfection after 24 
hours. The following day, cells were lysed in IP buffer (20 mM Tris pH 7.4, 150 mM 
NaCl, 0.5% NP-40, 2 mM MgCl2, 50 mM NEM supplemented with 1X Halt protease & 
phosphatase inhibitor cocktail (Thermo Fisher Scientific) in ddH2O) on ice and 
centrifuged at 13,000 rpm for 10 min at 4°C. After centrifugation, the supernatants 
were collected (5%) for subsequent analysis of protein expression levels. 
Supernatants were then incubated with 20 μl of α-FLAG M2 magnetic beads (Sigma-
Aldrich, #M8823) for 1 hour at 4°C with constant rotation. Beads were then washed 
three times in IP buffer and eluted by adding 0.2 M glycine-HCl pH 2.5 and boiling 
the elution in 2x Laemmli buffer (Bio-Rad) for 5 min at 100°C. Alternatively, the beads 
were boiled in 2x Laemmli buffer (Bio-Rad) at 100°C for 5 min in the presence or 
absence of 2.5% β-ME.  
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2.12 6xHis Pull-Down Assay 
The 6xHis pull-down assay was carried out using TALON magnetic beads (Clontech, 
#635636) as per company instructions. Briefly, HeLa cells were seeded in 100 mm 
dishes and transfected after 24 hours. The following day, cells were lysed on ice in 
1x Equilibration buffer in the presence of 8 M urea, 50 mM NEM and 1X Halt 
protease & phosphatase inhibitor cocktail (Thermo Fisher Scientific). Lysates were 
centrifuged at 13,000 rpm for 10 min at 4°C. After centrifugation, the supernatants 
were collected (5%) for subsequent analysis of protein expression levels. 
Supernatants were then incubated with 100 μl of TALON magnetic beads (Clontech) 
for 1 hour at 4°C with constant rotation. Beads were then washed three times in 1x 
Equilibration buffer and eluted by adding 1x Elution buffer and boiling the elution in 
2x Laemmli buffer (Bio-Rad) for 5 min at 100°C. Alternatively, the beads were boiled 
in 2x Laemmli buffer (Bio-Rad) for 5 min at 100°C. 
2.13 Click-iT AHA Assay 
Cells were seeded into 10 mm dishes and grown until 70-80% confluency. For 
labelling of newly synthesised proteins, cells were washed once with PBS and 
incubated overnight with 4 µM Click-iT AHA (L-azidohomoalanine) (Thermo Fisher 
Scientific, #C10102) in DMEM without cysteine and methionine (Thermo Fisher 
Scientific, #21013024).  The following day, AHA was removed and cells were washed 
with PBS and incubated in serum-free DMEM for the required chase time (0-6 hours). 
Cells were harvested into 400 µl p62 IP buffer (20 mM Tris pH 7.4, 150 mM NaCl, 
0.5% NP-40, 2 mM MgCl2 and protease inhibitor cocktail (Roche)) and incubated on 
ice for 10 min. Lysates were centrifuged for 10 min at 13,000 rpm, the supernatant 
was incubated with 20 µl of prewashed EZview M2 agarose beads (Sigma-Aldrich, 
#F2426) for 2 hours at 4°C with constant rotation. Beads were then washed 3 times 
in p62 IP buffer. The AHA containing proteins were then labelled with biotin (biotin 
alkyne, Thermo Fisher Scientific, #B10185) on the beads via Click-iT Cell Reaction 
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Buffer Kit (Thermo Fisher Scientific, #C10269) and following the manufacturer’s 
protocol. Finally, beads were washed 3 times in p62 IP buffer before protein was 
eluted by boiling in 2x Laemmli sample buffer (Bio-Rad). Eluted samples were run on 
10% SDS-PAGE gels and transferred to low fluorescence PVDF membrane 
(Millipore). Western blots were probed with streptavidin conjugated to IRdye Infrared 
Dyes (LiCor Biosciences, #800CW) and visualised using an Odyssey Scanner (LiCor 
Biosciences). Band intensity was quantified using Image Studio software (LiCor 
Biosciences). 
2.14 Immunofluorescence 
For immunofluorescence (Table 2.5), HeLa cells and MEFs were seeded on 
coverslips in 12-well plates. After treatments, cells were fixed in 3.7% formaldehyde 
in PBS for 10 minutes at room temperature. Formaldehyde was removed and cells 
were washed three times with PBS. Cells were permeabilised with 0.5% Triton X-100 
for 5 minutes at room temperature. Following permeabilisation, cells were washed 
three times in PBS and incubated in blocking solution (5% normal goat or rabbit 
serum in PBS, 0.1% Tween-20) for 1 hour at room temperature in constant agitation. 
Cells were incubated with primary antibodies diluted in blocking solution overnight at 
4°C. Primary antibodies used in this study include guinea pig α-p62 (Progen, #GP62-
C 1:200), goat α-Ubiquitin (Santa Cruz Biotechnology #sc-34870, 1:200) and mouse 
α-LC3 (Enzo Life Sciences, #ALX-803-081-C100, 1:200). Cells were washed three 
times and incubated with the appropriate secondary antibodies (Life Technologies, 
1:5000) for one hour at room temperature. Cells were washed three times in PBS, 
nuclear DNA was stained by incubation with TO-PRO-3 iodide (Life Technologies, 
1:3000) for 10 minutes at room temperature. Coverslips were mounted on slides with 
ProLong® Gold Antifade Mountant with DAPI (Thermo Fisher Scientific) and imaged 
with an LSM 510 META Confocal Microscope (Zeiss) using a 63X Plan-Apo/1.4 NA 
Oil objective. 
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2.15 Cell Death Assay 
MEFs were seeded 24 hours prior to treatments in 12-well plate. After treatments, 
cells viability was assessed using Ready Probes Cell Viability Imaging kit (Thermo 
Fisher Scientific, #R37609) as per company instructions. Briefly, NucBlue Live 
reagent (Hoechst 33342) and NucGreen Dead reagent (FITC/GFP) were added to 
the media for 30 min after treatments to determine cell viability by counting total vs. 
dead cells. NucBlue Live reagent stains all cell nuclei, while NucGreen Dead reagent 
stains only the nuclei of cells with compromised plasma membrane. Cells were 
imaged on inverted DM IL LED Leica microscope equipped with an Invenio 3SII 
digital camera (3.1 Mpix Colour CMOS; DeltaPix). Images were analysed using 
ImageJ and the percentage of cell death was quantified. 
2.16 ROS Measurement 
Hydrogen peroxide formation was detected using non-fluorescent dihydrorhodamine 
123 (DHR, Thermo Fisher Scientific, #D23806), which after its oxidation by H2O2 is 
converted to fluorescent rhodamine. MEFs were seeded in a 12-well plate, the next 
day they were treated with the different ROS inducing agents. Cells were then 
washed with PBS, followed by trypsinisation. Cells were transferred to a 15 ml tube, 
centrifuged for 3 min at 1,600 rpm. The pellet was resuspended in 500 μl DMEM 
containing the DHR dye (5 μM). Following 30 minutes incubation at 37˚C, cells were 
centrifuged again for 3 min at 1,600 rpm and the pellet was resuspended in 2 ml 
DMEM. Cells were immediately analysed by fluorescence-activated cell sorting 
(FACS, Partec PAS). 
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2.17 Human Brain and Spinal Cord Tissue 
Frozen brain and spinal cord tissue were obtained from the Newcastle Brain Tissue 
Resource bank. Frozen tissue from Alzheimer’s disease (AD, temporal cortex), 
frontotemporal dementia (FTD, temporal cortex), dementia with Lewy bodies (DLB, 
cingulate cortex), Parkinson’s disease (PD, substantia nigra), amyotrophic lateral 
sclerosis (ALS), and matched controls (Table 2.10, 2.11) were homogenised using a 
Ultra-Turrax T10 (IKA) in homogenisation buffer (0.1 M Tris pH 7.4, 0.5% Triton X-
100, 50 mM NEM supplemented with 1X Halt protease & phosphatase inhibitor 
cocktail (Thermo Fisher Scientific) in ddH2O) in a 1:10 ratio (e.g. 50 mg of tissue in 
500 μl of buffer). Homogenised samples were centrifuged (13,000 rpm for 10 min at 
4°C), protein concentration in supernatants was measured as described previously 
and samples were made by adding 2x Laemmli sample buffer to supernatants in the 
presence or absence of 2.5% β-ME. Samples were then analysed by immunoblot 
analysis. 
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Table 2.10 | Human brain tissue used in this study. PM: post-mortem 
 
Human Brain Tissue 
 
 
Case ID Diagnosis Area (Cortex) Hemisphere Age Sex 
PM 
delay (h) 
0205 AD Temporal Left 86 F 5 
0026 AD Temporal Left 83 M 12 
0083 AD Temporal Left 63 F 11 
0378 FTD Temporal Left 88 M 42 
0051 FTD Temporal Left 73 F 47 
0085 FTD Temporal Left 83 F 39 
0932 DLB Cingulate Left 78 M 8 
0310 DLB Cingulate Left 91 F 10 
0017 DLB Cingulate Left 77 M 8 
0115 Control Cingulate/Temporal Left 82 F 12 
1035 Control Cingulate/Temporal Right 66 M 9 
0102 Control Cingulate/Temporal Left 72 M 17 
0038 PD Substantia Nigra Left 76 M 49 
0827 PD Substantia Nigra Left 83 M 105 
1912 PD Substantia Nigra Left 70 M 48 
0400 Control Substantia Nigra Left 65 F 47 
0411 Control Substantia Nigra Left 88 M 28 
1903 Control Substantia Nigra Left 52 M 102 
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Table 2.11 | Spinal cord tissue used in this study. PM: post-mortem 
 
Spinal Cord Tissue 
 
 
Case ID Diagnosis 
Area of 
Onset 
Age Sex PM delay (h) 
0768 ALS Limbs 75 F 26 
0219 ALS Limbs 72 F 52 
1913 ALS Limbs 80 F 26 
0496 Control N/A 80 F 31 
1016 Control N/A 74 F 49 
0891 Control N/A 73 M 25 
 
2.18 Mouse Brain Tissue and Immunohistochemistry 
Young (3 months) and old (24 months) mice were housed in same-sex cages in 
groups of 4 to 6 (56×38×18 cm; North Kent Plastics, Kent, UK) and individually 
identified by an ear notch. Mice were housed at 20 ± 2°C under a 12 hours light/12 
hours dark photoperiod with lights on at 7.00 am. The diet used was standard rodent 
pelleted chow (CRM (P); Special Diets Services, Witham, UK). For immunoblot, 
samples were prepared as for human tissue. For immunohistochemistry (Table 2.6), 
paraffin sections were deparaffinised with Histo-Clear (National Diagnostics) and 
ethanol, antigen was retrieved by incubation in 0.01 M pH 6.0 citrate buffer at 95°C 
for 20 min. Slides were incubated in 0.9% H2O2 for 30 min and afterwards placed in 
blocking buffer (5% normal goat serum, Vector Laboratories) for 30 min at room 
temperature. Primary antibody (guinea pig α-p62) was applied overnight at 4°C. 
Slides were washed three times with PBS and incubated for 30 min with secondary 
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antibody (Vector Laboratories). Antibodies were detected using peroxidase 
VECTASTAIN ABC kit (Vector Laboratories) according to the manufacturer’s 
instructions. Substrate was developed using NovaRED (Vector Laboratories). 
Sections were counterstained with haematoxylin (Vector Laboratories) and mounted 
with DPX (Thermo Fisher Scientific). 
2.19 p62 Alignment and in Silico Calculations 
The sequences of p62 protein in 30 organisms (Table 2.12) were identified by 
searching UniProt for the gene name SQSTM, then removing sequence fragments 
and choosing the longest isoform from each organism. Multiple sequence alignment 
was carried out using the Muscle server at the EBI (European Bioinformatic Institute) 
website (http://www.ebi.ac.uk/Tools/msa/muscle/) with default parameters. The 
resulting alignment was visualised using ALINE software (Bond and Schuttelkopf, 
2009). Conservation is indicated by depth of colour from light to dark red, with 
conservation below 40% indicated in white. All 30 sequences were used to generate 
the alignment and calculate conservation, but only 14 were included in the graphical 
output. Secondary structure in the PB1 domain was indicated by using the X-ray 
crystal structure (PDB entry 4MJS chain B), and in the ZZ zinc-finger domain using 
homology to CBP (PDB entry 1TOT). 
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Table 2.12 | List of organisms used for multiple alignment of p62 protein sequences. 
Organisms included in Figure 4.3 are marked with an asterisk. 
 
Organisms for Multiple Alignment 
 
 
Genus/Species/Common name 
Homo sapiens (Human)* 
Pongo abelii (Sumatran orang-utan)* 
Gorilla gorilla gorilla (Western Lowland gorilla) 
Pan troglodytes (Chimpanzee) 
Macaca mulatta (Macaque)* 
Papio anubis (Olive baboon) 
Callithrix jacchus (Common marmoset) 
Nomascus leucogenys (White-cheeked gibbon) 
Otolemur garnettii (Small-eared galago) 
Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) 
Drosophila melanogaster (Common fruit fly)* 
Caenorhabditis elegans (Roundworm/nematode)* 
Ovis aries (Sheep) 
Bos taurus (Cow)* 
Sus scrofa (Pig) 
Oryctolagus cuniculus (Rabbit) 
Rattus norvegicus (Rat) 
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Mus musculus (Mouse)* 
Canis familiaris (Dog)* 
Felis catus (Cat) 
Cavia porcellus (Guinea pig)* 
Loxodonta africana (African elephant) 
Sarcophilus harrisii (Tasmanian devil)* 
Gallus gallus (Chicken)* 
Ficedula albicollis (Collared flycatcher) 
Xenopus laevis (African clawed frog)* 
Xenopus tropicalis (Western clawed frog) 
Anolis carolinensis (Carolina anole)* 
Danio rerio (Zebrafish) 
Latimeria Chalumnae (African coelacanth)* 
 
2.20 Quantifications and Statistical Analysis 
Quantification of cells was performed by blind scoring of slides as described 
previously (Korolchuk et al., 2011). More than 200 cells were counted per slide and 
quantification was based on at least three independent experiments. Quantification of 
immunoblots was carried out using ImageJ software (National Institutes of Health) by 
measuring the integrated density from each band after background subtraction. Two-
tailed, unpaired Student’s t-tests were carried out on experimental data from at least 
three individual experiments. 
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Chapter 3. p62 Senses Oxidation by Forming Disulphide-Linked 
Conjugates (DLC) 
3.1 Introduction 
Autophagy is a catabolic pathway important for protein homeostasis involved in the 
degradation of damaged proteins and organelles. Autophagy employs double-
membrane vesicles called autophagosomes to engulf ubiquitinated substrates 
recognised by receptor proteins, and delivers them to lysosomes (Stolz et al., 2014). 
Impairment of autophagy has been linked to many pathophysiological processes 
such as ageing and neurodegeneration, and modulation of autophagy activity 
appeared to be an effective approach to ameliorate such conditions in different 
animal models (Rubinsztein et al., 2011; Rubinsztein et al., 2012; Carroll et al., 
2013). Oxidative stress, which represents the imbalance between reactive oxygen 
species (ROS) formation and their neutralisation by the antioxidant defences, has 
also been connected to ageing and age-related diseases (Finkel and Holbrook, 2000; 
Chen et al., 2012). Although ROS have important regulatory functions in the cell, 
their excessive production can lead to damage of a vast array of molecules. The thiol 
group of cysteine (Cys) residues are particularly susceptible to ROS action, and tend 
to form disulphide bonds when oxidised (Cremers and Jakob, 2013). SQSTM1/p62 is 
a selective autophagy receptor involved in the accumulation and degradation of 
polyubiquitinated substrates by targeting them to autophagosomes (Pankiv et al., 
2007). Importantly, p62 tends to form aggregates and inclusions during autophagy 
deficiency (Bjorkoy et al., 2005; Komatsu et al., 2007b).  Indeed, p62 has been found 
in virtually all protein aggregates related to neurodegenerative diseases (NDs), which 
are a hallmark of neurodegeneration (Zatloukal et al., 2002). 
Although p62 has been extensively studied in relation to its receptor function in 
selective autophagy, its role during conditions of oxidative stress is unknown. In this 
chapter, we sought to examine the role and the function of p62 during oxidation. 
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3.2 Results 
3.2.1 p62 forms disulphide-linked conjugates (DCL) and aggregates in old 
mouse brain tissue 
In order to investigate age-related changes in proteostasis, we homogenised brain 
tissue from young (3 months) and old (24 months) mice and analysed them by 
immunoblot (Figure 3.1A, B). In agreement with (Ohtsuka et al., 1995), the old brain 
tissue contained a higher amount of ubiquitinated proteins which could indicate an 
imbalance in the degradation processes (Figure 3.1A). Additionally, it was possible 
to detect an increased amount of hyperoxidised Prx (Prx-SO3), a marker of oxidative 
stress (Wagner et al., 2002), in the old brain tissue. Since the imbalance in 
proteostasis could have been a direct consequence of the increased oxidation, also 
regulatory proteins such as p62 could have been affected by the oxidative 
environment. 
Thus, an immunoblot analysis of the young and old brain tissue was performed in the 
presence (reducing) or absence (non-reducing) of β-mercaptoethanol (β-ME), a 
reducing agent that breaks disulphide bonds between Cys residues (Figure 3.1B). In 
the absence of β-ME it was possible to detect an accumulation of p62 at higher MW 
in the old brain tissue, which was not observed after addition of β-ME. Hence, these 
structures were named disulphide-linked conjugates (DLC) of p62 since they were 
observed only in non-reducing conditions and were likely to be dependent on 
different Cys through covalent interactions. Considering that p62 DLC were 
exclusively present in the old mouse brain tissue together with increased oxidative 
stress, we hypothesised that p62 DLC formation could have been oxidation-
dependent. 
On the other hand, levels of autophagy markers such as LC3-II and p62 itself were 
comparable in both young and old tissue, suggesting no significant difference in the 
autophagy function between them (Figure 3.1A, B). This finding was in conflict with 
the general idea of impaired autophagy during ageing, a concept that has become 
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more prominent after multiple studies reporting the inhibition of autophagic 
degradation during ageing and neurodegenerative diseases (Rubinsztein et al., 
2011). On the contrary, evidence has been given for an increase in autophagy levels 
during ageing in mouse brain (Gamerdinger et al., 2009; Narita, 2010). These 
discrepancies indicate that autophagy is a dynamic and complex process which 
could be difficult to examine, especially in vivo. In our hands, we could not find 
differences in autophagy between young and old mouse brain tissue. 
Additionally, we investigated whether p62 formed aggregates in the old brain tissue. 
In fact, accumulation and aggregation of p62 has been previously reported following 
autophagy inhibition (Komatsu et al., 2007b; Korolchuk et al., 2009), a common 
feature during ageing. Since we did not find any impairment in the autophagy 
function, we questioned whether increased oxidation could also induce p62 inclusion 
bodies formation. Thus, cerebellum tissue form young and old mice was 
immunostained for p62 and analysed by light microscopy, and the percentage of 
Purkinje cells with aggregates was then quantified (Figure 3.1C) The formation of 
p62 aggregates was enhanced in the old mouse tissue, although the overall levels of 
p62 protein were not different between young and old (cf. Figure 3.1B). This 
suggested that oxidation and the formation of DLC of p62 could have been important 
for its aggregation. Thus, it could be hypothesised that disulphide bond formation 
could promote an initial oligomerisation of p62 and facilitate the formation of 
aggregates. 
In summary, p62 showed to sense oxidation potentially through formation of 
disulphide bonds in an age-dependent manner, which would lead to its increased 
aggregation. 
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Figure 3.1 | Oxidative stress and ageing determine p62 aggregation and DLC formation 
in old mouse brain tissue. (A and B) Young (3 months) and old (24 months) mouse brain 
tissues (n=3) were homogenised and subjected to immunoblot analysis for ubiquitin, Prx-SO3 
and LC3 in reducing conditions (2.5% β-ME) (A), and for p62 in either reducing or non-
reducing conditions (B). Actin was used as a loading control. Arrows represent monomers 
and DLC of p62. (C) Young and old mouse cerebellum sections were immunostained for p62 
and analysed by light microscopy; the percentage of Purkinje cells positive for p62 
aggregates was quantified. Error bars represent s.e.m., n=3, ***p<0.005. Data are 
representative of at least two independent experiments. The work in (A, B) was done in 
collaboration with Elsje G. Otten, while the work in (C) was carried out by Dr Diana Jurk at 
Newcastle University. 
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3.2.2 Oxidative stress induces formation of p62 DLC in cell culture 
To model the behaviour of p62 seen in old mouse brain tissue, we used mammalian 
cells in tissue culture and tested whether oxidation could induce the formation of DLC 
of p62. HeLa (named after the donor Henrietta Lacks) cells, an immortalised cervical 
cancer cell line (Landry et al., 2013), were used throughout the experiments as they 
were easy to grow and transfect. Since autophagy was not perturbed in the old 
mouse brain tissue (cf. Figure 3.1A), we compared the effects of autophagy 
inhibitors and oxidative stress inductors on the ability of p62 to form DLC. Our 
expectations were that inhibition of autophagy would only lead to the accumulation of 
p62 as shown by previous studies (Bjorkoy et al., 2005; Komatsu et al., 2007b; 
Korolchuk et al., 2009), while oxidation would induce the formation of disulphide bond 
of p62 and slow down its electrophoretic mobility. 
To inhibit autophagy, we used bafilomycin A1 (Baf) and chloroquine (CQ), two late 
phase inhibitors of autophagy. Bafilomycin A1, a macrolide antibiotic derived from 
Streptomyces griseus, is an inhibitor of vacuolar H+-ATPase (V-ATPase) which 
prevents the acidification of lysosomes and the fusion between autophagosomes and 
lysosomes (Yoshimori et al., 1991; Yamamoto et al., 1998). Chloroquine is a 
lysosomotropic agent which tends to accumulate in lysosomes and reduce their 
acidity, therefore inhibiting the formation of autolysosomes (Shintani and Klionsky, 
2004). The induction of oxidation was carried out using hydrogen peroxide (H2O2), 
added as a bolus to the cell medium. H2O2 is a strong oxidiser due to its unstable 
peroxide bond, and is the most abundant ROS produced in the cells (cf. Chapter 1.1) 
(Giorgio et al., 2007). Additionally, we tested whether ubiquitination of p62 could 
have also been implicated in DLC formation. We employed a non-specific and 
reversible inhibitor of DUB enzymes known as PR-619 (2,6-diaminopyridine-3,5-
bis(thiocyanate)), in order to induce accumulation of polyubiquitinated proteins (Altun 
et al., 2011; Seiberlich et al., 2012). 
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Immunoblot analyses on HeLa cell lysates showed that inhibition of autophagy by Baf 
and CQ led primarily to the accumulation of p62 at its expected MW (62 kDa) (Figure 
3.2A). This was in agreement with previous observations, where aggregation of p62 
consequent to autophagy inhibition has been shown to be mediated by non-covalent 
PB1 domain-dependent interactions (Lamark et al., 2003). In contrast, H2O2 was able 
to induce a decrease in the electrophoretic mobility of p62 in non-reducing 
conditions, leading to the formation of p62 DLC similarly to what was seen in old 
mouse brain tissue (cf. Figure 3.1B).  
Interestingly, PR-619 also increased the formation of p62 DLC in HeLa cells, exerting 
an even stronger effect than H2O2 (Figure 3.2A). Thus, we questioned how PR-619 
could induce p62 modification. Since oxidation was the main candidate in DLC 
formation, we performed FACS analysis on HeLa cells treated with PR-619 in the 
presence or absence of N-acetylcysteine (NAC), an N-acetyl derivative of L-cysteine 
which replenishes GSH levels thus acting as an antioxidant (Atkuri et al., 2007), and 
compared them to H2O2-treated cells (Figure 3.2B). Surprisingly, we found that PR-
619 was a strong oxidising agent, producing high levels of ROS in the cells. To 
further confirm the ability of PR-619 to oxidise, we treated HeLa cells with PR-619 in 
the presence or absence of NAC and subjected the protein lysates to immunoblot 
analysis (Figure 3.2C). As expected, both ROS production and p62 DLC formation 
were strongly inhibited after addition of NAC. Thus, we confirmed that PR-619 
induced oxidative stress which in turn led to the formation of p62 DLC.  
DLC were completely abolished in the presence of β-ME, again suggesting the 
important role of covalent interactions between Cys in the formation of these high 
MW structures (Figure 3.2A). Importantly, the amount of p62 visible at 62 kDa was 
also diminished compared to the control, indicating an actual shift of the protein 
towards higher MW. This shift was ranging from 180 kDa to 250 kDa and above in 
the stacking gel, suggesting formation of inter-molecular bonds between different p62 
molecules (trimers and tetramers) or other interactors, or both. 
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Figure 3.2 | Oxidative stress induced by H2O2 and PR-619 determines p62 DLC 
formation. (A) HeLa cells were treated with autophagy inhibitors bafilomycin A1 (Baf, 400 
nM, 4 hours) and chloroquine (CQ, 50 μM, 4 hours), with the oxidative stressor H2O2 (5 mM, 
10 min) and the DUB-inhibitor PR-619 (50 μM, 30 min). Lysates were analysed by 
immunoblotting for endogenous p62 in either non-reducing or reducing (2.5% β-ME) 
conditions. GAPDH was used as a loading control. Asterisk indicates an unspecific band. (B) 
HeLa cells were treated with H2O2 (1 mM, 10 min) or PR-619 (10 μM, 10 min) in the 
presence or absence of the antioxidant N-acetylcysteine (NAC, 5 mM), then oxidation levels 
were assessed by staining cells with dihydrorhodamine 123 (DHR) and analysing by 
fluorescence-activated cell sorting (FACS). Data were normalised, error bars represent 
standard deviation, n=2. (C) HeLa cells were treated with PR-619 as in (B) in the presence of 
absence of 5 mM NAC, then lysed and subjected to immunoblot analysis for endogenous 
p62. GAPDH was used as a loading control. (D) GST-p62 was purified from E. coli, treated 
with H2O2 and PR-619 as in (A) and immunoblotted for p62. Arrows represent monomers and 
DLC of p62. Data are representative of at least two independent experiments. 
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Thus, to assess whether other proteins besides p62 (e.g. ubiquitin) were required for 
DLC formation, we expressed a recombinant GST-p62 in E. coli and purified it with 
glutathione-sepharose beads, and then tested p62 electrophoretic mobility in vitro 
(Figure 3.2D). Treatments with H2O2 and PR-619 were sufficient to induce p62 DLC 
in the absence of other proteins, suggesting that formation of DLC could occur 
between different p62 molecules.   However, the participation of other partners to the 
process in vivo was not excluded, which could explain the different pattern of DLC 
bands compared to HeLa cells (cf. Figure 3.2A). 
In brief, oxidative stress appeared to be the stimulus leading to p62 DLC formation, 
while autophagy inhibition only led to the accumulation of p62 at its expected MW. 
The sole presence of p62 in vitro was sufficient to produce DLC formation upon 
oxidation, without excluding that hetero-oligomerisation with other proteins could 
possibly take place in vivo. 
3.2.3 Oxidative stress and DLC formation enhance p62 aggregation and 
insolubility 
Next, we wanted to test whether the oligomerisation of p62 through DLC formation 
could be involved in the development of p62 aggregates. This would have been in 
agreement with the previous findings of enhanced oxidation and p62 aggregation in 
the old mouse brain tissue (cf. Figure 3.1). Since autophagy inhibition is known to 
increase formation of p62 aggregates (Bjorkoy et al., 2005; Komatsu et al., 2007b; 
Korolchuk et al., 2009), we tested whether also oxidation would induce a similar 
effect in p62 aggregation. To induce oxidation, we used paraquat (PQ) along with 
H2O2 and PR-619. Paraquat is an herbicide belonging to a family of redox-active 
heterocycles, which catalyses the formation of ROS and depletes the reducing 
equivalents in the cell (Bus and Gibson, 1984). 
HeLa cells were treated with the autophagy inhibitors Baf and CQ and the oxidation 
inducers PQ, H2O2 and PR-619, stained for the endogenous p62 and analysed by 
confocal microscopy (Figure 3.3A). Both Baf and CQ increased the formation of p62 
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aggregates as expected. Similarly to autophagy inhibition, the formation of p62 
inclusions was also induced under conditions of oxidative stress. This suggested that 
the formation of p62 aggregates could be mediated by different mechanisms, where 
increased levels of p62 due to its impaired degradation as well as direct disulphide 
bond formation would lead to its aggregation. 
Additionally, we sought to investigate whether oxidation, and in turn DLC formation, 
could affect p62 solubility. To do so, we implemented the use of ultracentrifugation on 
HeLa cell lysates to separate the soluble fraction from the insoluble one (RIPA buffer 
insoluble), after treating the cells with H2O2 and PR-619 to induce oxidation (Figure 
3.3B). During control conditions, monomeric p62 was distributed between the soluble 
and insoluble fractions, although more concentrated in the latter (lanes 2 and 3). 
After treatments, the amount of monomeric p62 in the soluble fraction was reduced, 
while it accumulated in the insoluble fraction. Strikingly, p62 DLC were only evident in 
the insoluble fraction (lanes 6 and 9), but absent from the soluble one (lanes 5 and 
8), suggesting that DLC formation causes p62 to aggregate and form insoluble 
inclusions. Such effect of DLC on p62 aggregation might be important for its function 
as a receptor for selective autophagy, since oligomerisation of p62 and aggregate 
formation is known to be required for the efficient degradation of substrates (Itakura 
and Mizushima, 2011). 
In summary, different types of stress like autophagy inhibition and oxidation could 
induce accumulation and aggregation of p62 in tissue culture, similarly to what has 
been found in old mouse brain tissue. Also, the solubility of p62 seemed dependent 
on oxidation and DLC formation, which drive the shift of p62 from the soluble to the 
insoluble fraction. 
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Figure 3.3 | Oxidative stress induces p62 aggregation and insolubility. (A) HeLa cells 
were treated with autophagy inhibitors bafilomycin A1 (Baf, 400 nM, 4 hours) and 
chloroquine (CQ, 50 μM, 4 hours), and with oxidative stressors Paraquat (PQ, 1 mM, 30 
min), H2O2 (5 mM, 10 min) and PR-619 (50 μM, 30 min). Cells were immunostained for p62 
and analysed by confocal microscopy. (B) HeLa cells were treated with H2O2 (5 mM, 1 min) 
and PR-619 (10 μM, 10 min), lysed and subjected to ultracentrifugation to separate the 
soluble and insoluble fractions. Whole cell, soluble and insoluble fractions were then 
immunoblotted for endogenous p62. GAPDH was used as a loading control. Arrows 
represent monomeric and DLC p62. Data are representative of at least two independent 
experiments. 
Chapter 3. p62 Senses Oxidation by Forming Disulphide-Linked Conjugates (DLC) 
  
 
95 
 
3.2.4 p62 is a specific sensor of oxidative stress 
To understand whether p62 was a specific sensor of oxidation, we evaluated whether 
other proteins unrelated to p62 could be able to sense oxidation and produce DLC. 
We tested the mitochondrial outer membrane protein mitofusin 2 (Mfn2), a known 
selective autophagic substrate and Parkin receptor (Chen and Dorn, 2013) with 13 
Cys residues in its sequence, and the ribosomal protein L10 (rpL10, also known as 
QM), involved in the regulation of transcription (Inada et al., 1997) with 8 Cys 
residues in its sequence. 
In addition to oxidation, we tested further treatments known to induce oligomerisation 
and aggregation of p62, such as inhibition of protein synthesis by puromycin (Pankiv 
et al., 2007) and apoptosis induction (Jin et al., 2009) by staurosporine. Puromycin is 
an aminonucleoside antibiotic derived from Streptomyces alboniger which, due to its 
structural analogy to aminoacyl-tRNA, prevents the formation of full-length protein by 
hindering the ribosomes (Azzam and Algranati, 1973). It has been shown that 
puromycin induces the formation of ALIS (aggresome-like induced structures) 
containing p62 and ubiquitin (Szeto et al., 2006; Pankiv et al., 2007). Staurosporine is 
an alkaloid derived from Streptomyces staurosporeus, a strong inhibitor of protein 
kinases and an inducer of apoptosis by both caspase-dependent and –independent 
pathways (Zhang et al., 2004). The treatment with staurosporine was combined with 
the caspase inhibitor Z-VAD-FMK, in order to inhibit the actual cell death. 
HeLa cells were subjected to the above compounds as well as H2O2 and PR-619, 
and protein lysates were analysed by immunoblot (Figure 3.4). Neither puromycin 
nor staurosporine induced formation of p62 DLC in comparison to H2O2 and PR-619, 
further confirming the role of oxidation in DLC formation while also showing that p62 
oligomerisation and DLC formation might be driven by different mechanisms (Figure 
3.4A). Both Mfn2 and rpL10 proteins did not produce DLC following treatments with 
puromycin, staurosporine as well as H2O2 and PR-619, supporting the idea that p62 
would act as a specific sensor of oxidation. In summary, p62 formed DLC specifically 
upon oxidation, while other structurally-unrelated proteins did not share the same 
behaviour. 
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Figure 3.4 | p62, but not other structurally-unrelated proteins, forms DLC uniquely in 
response to oxidation. (A, B) HeLa cells were treated with H2O2 (5 mM, 1 min), puromycin 
(10 μg/ml, 3 hours), staurosporine (0.5 μM and Z-VAD-FMK 6.6 μM, 3 hours) and PR-619 
(20 μM, 10 min), lysed and subjected to immunoblot analysis for p62 (A), Mfn2 and rpL10 
(B). GAPDH (A) and Actin (B) were used as loading controls. Arrows in (A) represent 
monomeric and DLC p62. Data are representative of at least two independent experiments. 
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3.2.5 H2O2 and PR-619 induce p62 DLC with different kinetics 
Since H2O2 and PR-619 showed a different degree of efficacy towards p62 shifting to 
higher MW (cf. Figure 3.2A), we sought to determine whether these two treatments 
could induce p62 DLC in a different manner. Thus, we analysed the kinetics of DLC 
formation upon H2O2 and PR-619 treatments. HeLa cells were treated with increasing 
concentrations and time points (1, 10 and 30 min) of H2O2 and PR-619, then lysed 
and analysed by immunoblot (Figure 3.5). 
Interestingly, H2O2 induced a rapid formation of DLC after 1 min of exposure (lanes 2, 
5 and 8, Figure 3.5A), although its effect appeared transient already after 5 min, and 
almost disappeared after 30 min at lower concentrations (100 μM and 500 μM, lanes 
3 and 6). This transient formation of p62 DLC might depend on H2O2 quick decay 
after bolus addition to the media (Gulden et al., 2010), and their subsequent break 
down by the cellular antioxidant systems. In contrast, PR-619 produced a more 
sustained oxidative stress reflected by progressive accumulation of DLC following 
longer treatments (10 and 30 min, Figure 3.5B). Notably, the shift of p62 towards 
higher MW was more prominent at the highest dose (50 μM), accompanied by a 
decrease in the amount of monomeric p62. Such loss of monomeric p62 was also 
visible in previous data (cf. Figure 3.2A, C and Figure 3.4A), and might reflect an 
increase in the protein insolubility that leads to lower amounts of the monomeric 
protein (cf. Figure 3.3B). As mentioned previously, PR-619 is a non-selective and 
reversible DUB inhibitor, thus we wanted to rule out any involvement of ubiquitin 
during DLC formation. To do so, we treated cells with N-ethylmaleimide (NEM), a Cys 
protease inhibitor that irreversibly blocks DUB enzymes (Liu et al., 2003; Paulech et 
al., 2013), and we checked for p62 DLC formation by immunoblot analysis (Figure 
3.4C). Treatments with NEM at different time points did not produce any DLC of p62, 
suggesting that increased levels of ubiquitination driven by DUBs inhibition were not 
involved in p62 DLC formation, while PR-619 was used as a positive control (once 
again showing reduced levels of monomeric p62). 
These results further showed that ubiquitination was not involved during DLC 
formation, and that oxidation was responsible for p62 modification. In order to 
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understand whether additional oxidative stressors could also cause p62 to form DLC, 
we tested other ROS-inducing compounds such as rotenone and paraquat, but 
neither of them gave consistent results (data not shown). Therefore, we continued 
using H2O2 and PR-619 as bona fide inducers of p62 DLC throughout the successive 
experiments. 
 
 
Figure 3.5 | H2O2 or PR-619 induce oxidation of p62 with different kinetics. (A, B) HeLa 
cells were treated with increasing concentration of H2O2 (A) or PR-619 (B) at different time 
points as indicated, lysed and subjected to immunoblot analysis for p62. (C) HeLa cells were 
treated with NEM (50 mM) at different time points as indicated, lysed and subjected to 
immunoblot analysis for p62. GAPDH (A, C) and Actin (B) were used as loading controls. 
Arrows represent monomeric and DLC p62. Data are representative of at least two 
independent experiments. 
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3.2.6 Inhibition of the peroxiredoxin/thioredoxin (Prx/Trx) antioxidant system 
enhances p62 DLC formation 
Since oxidation was clearly involved in the formation of p62 DLC, we tested whether 
the antioxidant system, specifically the peroxiredoxin/thioredoxin (Prx/Trx) system 
(Chapter 1.1.2) could be involved in the reduction of DLC as for NAC (cf. Figure 
3.1C). Thus, we employed immunoblot analysis to visualise Prx-SO3 and Prx-3 (a 
mitochondrial Prx) as additional readouts for oxidation and for their role in regulating 
the redox state of the cell. At the same time, we employed HEK293E (human 
embryonic fibroblasts), to assess whether p62 would form DLC also in a different cell 
model. 
Hence, HEK293E cells were treated with increasing concentrations of H2O2 (starting 
from 10 μM up to 500 μM) and different time points (20 sec, 1 and 10 min), then 
lysed and analysed by immunoblotting for p62, Prx-3 and Prx-SO3 (Figure 3.6A). 
Interestingly, p62 reacted only slightly to the lower concentrations of H2O2 (10 and 50 
μM) by appearing at about 250 kDa. The formation of more prominent amounts of 
p62 DLC was only achievable with higher doses of H2O2 (100 and 500 μM) and in a 
transient manner (DLC were reduced after 10 min), in agreement with the result of 
the previous time course (cf. Figure 3.5A). Treatments with H2O2 up to 100 μM 
increased the dimerisation of Prx-3, indicating its activation upon low-to-medium 
doses of H2O2. Such dimerisation appeared reduced upon high levels of H2O2 (100-
500 μM, last four lanes) while levels of hyperoxidised Prx-SO3 were increased, 
suggesting the inability of Prx in buffering high levels of oxidation as shown 
previously (Cox et al., 2010).  
Thus, it is possible that p62 forms DLC when the H2O2-buffering capacity of the cells 
is saturated (i.e. when Prx-3 is hyperoxidised), while during low levels of H2O2 the 
oxidising burden can be handled by the cellular antioxidant defence (i.e. Prx 
dimerisation). This would explain the need of high doses of H2O2, as well as high 
levels of oxidation mediated by PR-619, in order to produce DLC of p62. 
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Since Prx-3 appeared to be more sensitive to ROS than p62, we examined whether 
by blocking the Prx/Trx antioxidant system we could accelerate the formation of p62 
DLC upon oxidation. To do this, we employed two compounds, curcumin and 
auranofin, both known to block the activity of thioredoxin reductase (TrxR). Curcumin 
is the main polyphenol of the plant Curcuma longa (widely known as turmeric) known 
for its antitumor properties, which irreversibly modifies the catalytic site of TrxR 
causing inhibition of its reductase activity and production of ROS (Fang et al., 2005). 
Auranofin is a gold-containing compound used as an antirheumatic agent, which 
reacts with the selenocysteine residue of TrxR thus blocking its activity (Gromer et 
al., 1998). 
HeLa cells were pre-treated with either curcumin or auranofin for 30 min in order to 
block the activity of TrxR, then treated with H2O2 at different time points (1, 10 and 30 
min) (Figure 3.6B). In the absence of pre-treatments, H2O2 did not induce a 
significant amount of p62 DLC, although the concentration used was rather high (3 
mM). Nevertheless, in the presence of both curcumin and auranofin, it was possible 
to identify DLC of p62 already in the absence of H2O2 (lanes 5 and 9), especially 
following auranofin pre-treatment. Upon addition of H2O2, the production of p62 DLC 
was greatly intensified, showing enhanced accumulation of p62 in the stacking gel 
together with the reduction of the monomeric form (once again, auranofin had the 
biggest effect). This would suggest that p62 DLC are normally reduced by the Prx/Trx 
system. Notably, the dimerisation of Prx-3 was also increased during oxidation 
following curcumin and auranofin treatments, as found in previous studies (Cox et al., 
2010). The amounts of Prx-SO3 were instead decreased, since Prx-3 dimerises but 
cannot cycle back to monomer due to the absence of reducing equivalents following 
TrxR inhibition. Both increased dimerisation of Prx-3 and loss of Prx-SO3 were more 
evident following auranofin treatment, further confirming the higher efficacy of the 
compound over curcumin. 
In summary, p62 DLC seemed to be reduced by the Prx/Trx antioxidant system. 
While low levels of oxidation were not sufficient to induce DLC formation, higher 
levels of H2O2 were sufficient to deplete the redox buffering capacity of the cells and 
induce p62 DLC. 
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Figure 3.6 | The peroxiredoxin/thioredoxin (Prx/Trx) antioxidant system is involved in 
the reduction of p62 DLC. (A) HEK293E cells were treated with increasing concentrations 
of H2O2 at different time points as indicated, then lysed and immunoblotted for p62, Prx-3 and 
Prx-SO3. (B) HeLa cells were pre-treated with either curcumin (50 μM) or auranofin (5 μM) 
for 30 min, then treated with H2O2 (3 mM) at different time points as shown. Cell were then 
lysed and immunoblotted for p62, Prx-3 and Prx-SO3. GAPDH was used as a loading control. 
Arrows indicate monomeric and DLC p62, as well as monomeric and dimeric Prx-3. Asterisk 
indicates an unspecific band. Data are representative of at least two independent 
experiments. 
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3.2.7 p62 DLC are “sticky” and cannot be purified by immunoprecipitation 
To better understand the composition of p62 DLC, we sought to purify these high 
MW species by immunoprecipitation (IP) followed by mass spectrometry, in order to 
analyse both the type of interactions involved in DLC formation and the presence of 
possible p62 interactors. 
HeLa cells were transfected with FLAG-p62 (in order to overexpress p62 and 
increase DLC amount) for 24 hours and treated with PR-619 to induce formation of 
DLC; then, an IP was performed on cell lysates using α-FLAG magnetic beads and 
samples were analysed by immunoblot (Figure 3.7A). Any aspecific binding of p62 to 
the beads was ruled out by the absence of detectable p62 in untransfected cells 
(lane 4). Although p62 DLC were easily detectable in the Input following PR-619 
treatment (lane 3), these were not eluted by acid buffer (which is commonly used to 
disrupt the interaction between the antibody and the antigen) (lane 6). Notably, 
monomeric levels of p62 were decreased both in the Input and after elution (lanes 3 
and 6), indicating that p62 was oxidised but somehow lost during the elution process. 
The unbound fraction, which did not bind to the beads, showed lower levels of p62 
both monomeric and DLC compared to the Input, suggesting that p62 overexpression 
worked beyond the binding capacity of the magnetic beads. 
Interestingly, once the beads were boiled directly in the SDS-loading buffer in 
reducing conditions (β-ME), the amount of monomeric p62 after PR-619 treatment 
was increased. This would suggest that p62 DLC might be “sticking” to the beads, for 
example through hydrophobic interactions, and that a reducing environment would 
release them from binding to the beads. Indeed, manipulating proteins outside from 
their intracellular environment or overexpressing them as  tagged proteins may result 
in a change in their conformation, determining increased aggregation and “stickiness” 
(Feller and Lewitzky, 2012). The absence of p62 DLC after IP was also confirmed by 
boiling the samples in non-reducing SDS-loading buffer followed by Blue Coomassie 
staining (Figure 3.7B). Although monomeric p62 was visibly reduced after PR-619 
treatment, there was no presence of p62 DLC, in a similar way to what we found after 
eluting the proteins (cf. with Eluted in Figure 3.7A). 
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Since p62 “stickiness” could have been dependent on the protein ternary structure, 
we employed a different construct, a 6xHistidine-tagged p62 (His-p62), in order to 
pull-down the protein in denaturing conditions (8 M urea) and reduce the occurrence 
of hydrophobic interactions. In fact, the binding of His-tag to the purification beads 
(which commonly employ bivalent ions) is not dependent on the protein tertiary 
structure, thus allowing the addition of denaturing agents to the IP buffer without 
affecting the purification process (Bornhorst and Falke, 2000). 
Thus, we transfected HeLa cells with His-p62 for 24 hours and treated them with 
H2O2; cell lysates were then subjected to pull-down using TALON magnetic beads 
(employing cobalt ions, Co2+, to bind the His-tag) and samples were analysed by 
immunoblot (Figure 3.7C). Although monomeric p62 was visible also in 
untransfected samples due to unspecific binding, the amount of proteins bound to the 
beads was higher in the transfected samples. The presence of p62 DLC was evident 
in the Input, although completely lost in the eluted fraction as well as after boiling in 
non-reducing SDS-loading buffer. To further assess the potential presence of DLC, 
we performed a Blue Coomassie staining on eluted and boiled samples (Figure 
3.7D). We could not find any difference in either monomeric p62 levels or DLC 
formation between untransfected and transfected cells, once again confirming the 
impossibility of isolating such formations. 
In short, by performing IP and pull-down with different p62-tagged constructs we 
could not isolate and purify p62 DLC, possibly due to hydrophobic interactions that 
would lead to the “stickiness” of the protein to the isolation beads. 
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Figure 3.7 | p62 DLC are lost during immunoprecipitation. (A, B) HeLa cells were 
transfected with FLAG-p62 for 24 hours, treated with PR-619 (20 μM, 10 min) and lysed. 
Lysates were subjected to immunoprecipitation using α-FLAG magnetic beads which were 
either eluted with glycine-HCl buffer pH 2.5 or boiled in reducing SDS-loading buffer (+β-ME) 
as indicated. Input indicates whole cell lysates. Samples were then subjected to immunoblot 
analysis for p62 (A) or stained with Blue Coomassie (B). (C, D) HeLa cells were transfected 
with His-p62 for 24 hours, treated with H2O2 (5 mM, 1 min) and lysed. Lysates were 
subjected to pull-down using TALON Co2+ magnetic beads in denaturing conditions (8 M 
urea) which were either eluted with elution buffer or boiled in non-reducing SDS-loading 
buffer as indicated. Input indicates whole cell lysates. Samples were then subjected to 
immunoblot analysis for p62 (C) or stained with Blue Coomassie (D). Arrows represent 
monomeric and DLC p62. Data are representative of at least two independent experiments. 
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3.2.8 p62 accumulates and forms DLC in human brain tissue 
After confirming the formation of p62 DLC both in old mouse brain tissue and in 
mammalian cell culture upon oxidative stress, we sought to investigate whether the 
DLC were also relevant to human age-related diseases. Since oxidative stress and 
impairment of autophagy are known to be associated with neurodegenerative 
diseases (NDs) (Melo et al., 2011; Vidal et al., 2014), we also examined the 
relevance of these processes to the NDs aetiology. To do so, we analysed human 
brain tissue provided by the Newcastle Brain Tissue Resource bank. 
Human brain tissue from Alzheimer’s disease (AD, temporal cortex), dementia with 
Lewy bodies (DLB, cingulate cortex) and frontotemporal dementia (FTD, temporal 
cortex) samples, plus age-matched controls, were homogenised and subjected to 
immunoblot analysis for p62, LC3 and the oxidation marker Prx-SO3 (Figure 3.8A). 
Regarding LC3, we could only detect LC3-I (higher MW) but not LC3-II (lower MW). 
This was in agreement with previous studies, which have shown greater 
accumulation of LC3-I over LC3-II in crude brain homogenates, causing difficulties in 
detecting the latter (Yang et al., 2011; Klionsky et al., 2016). Thus, it was not possible 
to assess the actual levels of autophagic activity in these samples. 
The ratio between monomeric and DLC p62 to the loading control was quantified and 
normalised to the healthy controls (Figure 3.8B). Strikingly, we could detect 
accumulation of monomeric p62 as well as p62 DLC in the disease samples, showing 
that DLC of p62 were also pertinent to human brain tissue. The DLC were 
accumulating at ∼250 kDa, in accordance with our previous findings. The monomeric 
p62 was ranging between 37 and 60 kDa, possibly due to degradation processes 
occurring during the post-mortem (PM) delay. Such accumulation of p62 might 
suggest either impairment in autophagy, since p62 could not be degraded efficiently, 
or upregulation of p62 (and p62 DLC) expression levels in order to sequester toxic 
proteins into aggregates. Additionally, Prx-SO3 seemed to accumulate in the 
diseased tissue, suggesting higher oxidation levels compared to the control tissue. 
This could explain the accumulation of p62 DLC in the NDs samples, in accordance 
with our finding that oxidation would be the stimulus leading to p62 modification. The 
Chapter 3. p62 Senses Oxidation by Forming Disulphide-Linked Conjugates (DLC) 
 
 
106 
 
DLC were completely abolished after addition of β-ME to the sample buffer, thus 
showing that the cysteine residues of p62 were mediating DLC formation by covalent 
interactions. This was in agreement with our previous findings in both mouse brain 
tissue and mammalian cells (cf. Figure 3.1B, 3.2A). 
To further investigate whether oxidation of p62 was also detectable in a wider context 
of neurodegeneration, we homogenised Parkinson’s disease (PD, substantia nigra) 
brain tissue and amyotrophic lateral sclerosis (ALS, lumbar transverse section) spinal 
cord samples, plus age-matched controls, and analysed them by immunoblot 
analysis for p62 (Figure 3.8C, E). The ratio between monomeric p62 and p62 DLC to 
the loading control was quantified and normalised to the healthy control (Figure 
3.8D, F). As for the other diseased tissue, also PD and ALS samples showed 
accumulation of monomeric p62 at lower MW, ranging from 37 kDa to 45 kDa, 
possibly due to PM delay. The DLC were also accumulating at ∼250 kDa as for the 
other NDs. 
In summary, p62 appeared to accumulate and form DLC in brain tissue affected by 
NDs, together with the presence of enhanced oxidation. This was in agreement with 
our previous findings that p62 would form DLC upon oxidative stress and induce 
protein aggregation, possibly leading to aggregates degradation through autophagy. 
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Figure 3.8 | Monomeric and DLC p62 accumulate in diseased human brain tissue.  
(A, C, E) Human brain tissue from patients with Alzheimer’s disease (AD), frontotemporal 
dementia (FTD), dementia with Lewy bodies (DLB) (A), Parkinson’s disease (PD) (C), 
amyotrophic lateral sclerosis (ALS) (E) and matching controls (n=3) were subjected to 
immunoblot analysis for p62, LC3 (A) and Prx-SO3 (A) in either non-reducing or reducing 
(2.5% β-ME) conditions. GAPDH was used as a loading control. Arrows represent 
monomeric and DLC p62. (B, D, F) Levels of monomeric and DLC p62, as well as Prx-SO3 
(B), were quantified and normalised to the control. Error bars represent s.e.m., n=3, *p<0.05. 
Data are representative of at least two independent experiments. 
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3.3 Discussion 
The cross-talk between autophagy and oxidative stress has been extensively studied 
in regards to nutrient deprivation, as ROS have been shown to induce the autophagy 
process while antioxidants can partially or completely halt it (Filomeni et al., 2010). 
Nevertheless, little is still known regarding how the autophagic machinery is activated 
by oxidative stress, with only few evidences suggesting how the process is regulated. 
For instance, the Cys protease Atg4, important in the elongation of the 
autophagosomal membrane, has been shown to be modified by mitochondrial H2O2 
on a Cys residue in its catalytic site, leading to Atg4 inactivation and subsequent 
lipidation of LC3 (Scherz-Shouval et al., 2007). It has also been suggested that 
AMPK, which senses energy levels in the cells and induces autophagy by inhibiting 
mTOR, can be regulated by H2O2 exposure on one reactive Cys (Zmijewski et al., 
2010). Interestingly, oxidation of GSH has been shown to induce autophagy in the 
absence of other stimuli (Desideri et al., 2012), thus indicating that Cys thiol oxidation 
could have an important function in regulating the autophagy process. Other proteins 
involved in autophagy activation have been suggested to be regulated by ROS, such 
as the ubiquitin-like Atg3, Atg7 and Atg10 (Filomeni et al., 2010). Among these, also 
the selective autophagy receptor p62 has been noted since its ZZ-type zinc finger 
domain, containing several Cys residues, could provide redox sensitivity like other 
zinc finger-containing proteins (Giles et al., 2003; Filomeni et al., 2015). 
In this chapter, we have for the first time shown that p62 can sense oxidation and can 
be covalently modified, most likely by cysteine oxidation and disulphide bond 
formation. Indeed, p62 formed HM weight species in non-reducing immunoblot 
analysis which were completely abolished by addition of a reducing agent such as β-
ME (β-mercaptoethanol, which breaks disulphide bonds between the proteins), thus 
we have named these formations disulphide-linked conjugates (DLC) (Figure 3.1B, 
3.2A). Importantly, no other selective autophagy receptors have been so far 
described to sense oxidation levels, a feature which could have an important role for 
p62 function in degrading autophagic cargoes. We have found that formation of p62 
DLC is evident in aged mouse brain tissue, as well as in mammalian cell culture and 
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diseased human brain tissue, demonstrating the relevance of p62 modification both 
in vivo and in vitro (Figure 3.1B, 3.2A, 3.8). 
Comparing young and old mouse brain tissue, we could not find differences in 
autophagy levels, nevertheless both oxidation stress (increased levels of Prx-SO3) 
and proteostasis imbalance (increase in polyubiquitination) was evident in the old 
mice (Figure 3.1A). It has been shown previously that aged mouse brain tissue 
accumulates ubiquitinated proteins compared to young mice, especially in the 
cerebellum, which was not due to the elevation of the free ubiquitin pool (Ohtsuka et 
al., 1995). In our case, we can assume that increased levels of oxidation would 
cause damage to proteins and drive their ubiquitination in aged brain tissue. Such 
mice also exhibited formation of p62 DLC sensitive to β-ME reduction (Figure 3.1B), 
suggesting that oxidation would be the signal involved in the process. Since p62 
showed to accumulate in old mouse brain cerebellum (Figure 3.1C), we have 
hypothesised that DLC formation could lead to increased p62 aggregate formation, a 
feature that has only been associated with p62 self-oligomerisation mediated by its 
PB1 domain (Lamark et al., 2003). The importance of p62 aggregation for its function 
in degrading ubiquitinated substrates is well established (Ichimura et al., 2008; 
Itakura and Mizushima, 2011), thus our hypothesis would mean a stronger response 
of p62 during oxidative stress conditions, in order to accumulate toxic proteins and 
dispose them through autophagy. 
We confirmed that p62 DLC were induced by oxidation by employing H2O2 and PR-
619 (which showed to be a strong oxidiser) in mammalian cell culture, specifically in 
HeLa cells and HEK293E (Figure 3.2A, 3.6A). Both treatments showed to induce 
p62 shift towards HM weights, while autophagy inhibition predominantly increased 
monomeric p62 levels. H2O2 induced p62 DLC transiently (Figure 3.5A), while PR-
619 produced a much stable response over time (Figure 3.5B). Additionally, 
oxidative stress and DLC formation increased p62 insolubility and induced aggregate 
formation, again suggesting that both oxidation and p62 aggregation could be 
interconnected (Figure 3.3). 
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Regarding the size of p62 DLC, they appeared at ∼180-250 kDa, potentially 
resembling a trimer and a tetramer of p62 proteins. At the same time, other proteins 
that could covalently bind p62 could not be excluded, which would explain why 
oxidation of purified GST-p62 led to different DLC size (Figure 3.2D). Unfortunately, 
we were unable to purify p62 DLC to assess whether other proteins would be 
involved in the process, as the DLC appeared to “stick” to the purification beads 
(Figure 3.7). Especially following PR-619 treatment, the DLC were often 
accumulating at much higher MW, up in the stacking gel. It is therefore possible that 
DLC could drive p62 oligomerisation through Cys residues, a first step in allowing 
p62 aggregate formation during oxidative stress conditions. Additionally, the shift 
from the soluble to the insoluble fraction following oxidation suggests that p62 DLC 
may lead to the formation of insoluble protein aggregates (Figure 3.3B). It is also 
important to notice that monomeric p62 tended to disappear following high levels of 
oxidative stress (i.e. using high amounts of H2O2 and PR-619), as if the majority of 
the protein would react to the oxidising environment and produce DLC (cf. Figure 
3.2A, 3.5B, 3.6B). Such reduction in p62 monomeric levels have been previously 
described following incubation of purified GST-p62, together with the concomitant 
accumulation of p62 high MW and intracellular aggregates (Paine et al., 2005). 
These spontaneous aggregates were in fact p62 β-sheet fibrils resembling those of 
α-synuclein and β-amyloid, demonstrating that p62 has aggregation-prone properties 
which are important for substrates sequestration and cell survival (Paine et al., 2005). 
In a similar manner, p62 DLC could be important for aggregate formation under 
conditions of oxidative stress, leading to the degradation of damaged substrates. 
Additionally, high MW species of p62 have been previously shown during cellular 
ageing, where the levels of monomeric p62 seemed to decrease while SDS-resistant 
polymers would accumulate (Gamerdinger et al., 2009). The authors hypothesised 
that these polymers of p62 could represent inclusion bodies of aggregated proteins, 
which were enhanced due to the increased activity of autophagic degradation to 
maintain the protein quality control (Gamerdinger et al., 2009). Instead, we argue that 
p62 DLC are solely dependent on oxidative stress. More recently, covalently-
crosslinked oligomers of p62 have been shown to be induced by singlet oxygen, a 
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type of ROS where electrons have been rearranged in the oxygen atom (Donohue et 
al., 2014). The authors also showed that such high MW species of p62 were present 
in aged cells and could be produced by purified GST-p62, similarly to what we have 
shown in our lab (Donohue et al., 2014). Nevertheless, the authors concluded that 
crosslinked p62 would lead to the impairment of autophagy and autophagosome 
formation, while we suggest that p62 DLC would be important for aggregate 
formation and subsequent autophagic degradation of substrates. 
In order to further confirm the role of oxidation in p62 DLC formation, we blocked the 
peroxiredoxin/thioredoxin (Prx/Trx) antioxidant system by using two inhibitors of Trx 
reductase (TrxR), curcumin and auranofin (Figure 3.6B). Both compounds showed to 
increase p62 DLC formation, suggesting that p62 is constantly reduced by TrxR and 
starts producing DLC once the redox buffering system is saturated (e.g. during high 
levels of oxidation). Inactivation of Prx by high levels of oxidative stress has been 
previously shown to be important for Trx to act on other oxidised substrates (Day et 
al., 2012). Thus, increased in Prx-SO3 and decreased Prx-3 dimers following high 
levels of H2O2 (Figure 3.6) could indicate a similar scenario, where p62 DLC would 
become targets of TrxR action. This result further supports our hypothesis that p62 
senses oxidation and forms DLC during oxidative stress conditions. 
Finally, we looked into human diseases to investigate whether p62 DLC were also 
relevant in a wider context of neurodegeneration. Thus, we analysed human brain 
tissue affected by several NDs, such as Alzheimer’s disease (AD), frontotemporal 
dementia (FTD), dementia with Lewy bodies (DLB), Parkinson’s disease (PD) and 
amyotrophic lateral sclerosis (ALS), comparing them to healthy age-matching 
controls (Figure 3.8). In all NDs cases we could find accumulation of monomeric p62, 
suggestive of autophagic impairment. As mentioned earlier, autophagy dysfunction 
has been connected to ageing and neurodegeneration, although there has been also 
evidence of enhanced autophagy during ageing (Wohlgemuth et al., 2010; 
Rubinsztein et al., 2011). Such discrepancy might be due to difficulties in addressing 
a dynamic process like autophagy with simple “snapshots” of activity (Narita, 2010). 
Unfortunately, we were not able to detect LC3-II in our samples (Figure 3.8A), a 
difficulty that has been previously reported (Yang et al., 2011; Klionsky et al., 2016). 
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Nevertheless, we were able to detect higher levels of Prx-SO3 in the diseased 
samples, indicating the presence of oxidative stress in the analysed NDs (Figure 
3.8A). Strikingly, the tissue affected by NDs showed accumulation of p62 DLC 
compared to the healthy controls, which could be therefore correlated with the higher 
levels of oxidation (Figure 3.8). However, p62 DLC presence could also be 
dependent on the accumulation of monomeric p62, which might depend on 
autophagy impairment. We propose that both autophagy impairment and oxidative 
stress in NDs cause accumulation of p62 and formation of DLC, enhancing the 
aggregation of misfolded ubiquitinated proteins and their sequestration into less 
harmful inclusions. In such a scenario, the therapeutic induction of autophagy and 
subsequent degradation of protein aggregates could have positive effects and slow 
the progression of NDs as previously hypothesised (Rubinsztein et al., 2012). 
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Chapter 4. Two Cysteine Residues of p62 are Critical for DLC 
Formation 
4.1 Introduction 
In Chapter 3, we have identified a new mechanism of oligomerisation of p62 through 
disulphide-linked conjugates (DLC) triggered by oxidative stress. DLC of p62 were 
detected in old mouse brain tissue which appeared to have increased levels of 
oxidation. Additionally, the possibility of inducing the formation of p62 DLC in 
mammalian cells by means of hydrogen peroxide (H2O2) and PR-619 (having proved 
to be a strong oxidiser) also accredited the oxidation-sensing rationale. The main 
hypothesis for the formation of DLC was that cysteine (Cys) residues in the p62 
molecule were involved in this process. In fact, Cys residues can sense oxidation by 
modifications of their thiol (SH) group, which becomes oxidised forming a sulphenic 
acid (SOH) leading to disulphide bonds formation (Poole et al., 2004). Since DLC 
were disrupted in the presence of a reducing agent like β-mercaptoethanol (β-ME), 
we have hypothesized that the DLC could be dependent on oxidation of specific 
redox-sensitive Cys residues in p62 protein, which could subsequently form 
disulphide bonds through their thiol groups. In this chapter, we sought to identify 
which region of p62 was involved in DLC formation, in order to identify the Cys 
residues involved in the process.  
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4.2 Results 
4.2.1 Production of p62 deletion constructs  
In order to understand which particular region of p62 was implicated in the formation 
of DLC, we performed molecular cloning of different p62 fragments in a pEGFP-C2 
vector to produce deletion constructs of p62 (Figure 4.1) (see Section 2.6, 
Appendix A, B, C). Therefore, the encoded fusion proteins contained the GFP 
protein (27 kDa) attached to the N-terminal of p62. The rationale of using a GFP-
tagged p62 was to investigate the effects of the expression of deletion constructs 
also by live cell imaging, although we later dismissed it. The GFP-p62 constructs 
were designed to include different domains of the p62 protein: full-length GFP-p62 
(a.a. 1-440, 89 kDa), ΔUBAp62 (a.a. 1-385, lacking the C-terminal UBA domain, 69 
kDa), 1-200p62 (including the PB1 and ZZ-zinc finger domains, 50 kDa), 1-122p62 
(including the PB1 domain plus a neighbouring unstructured region, 41 kDa) and 
114-440p62 (excluding the PB1 domain, 75 kDa). 
 
 
Figure 4.1 | Schematic representation of p62 deletion constructs produced in this 
study. Deletion constructs of p62 were produced by performing PCR using the GFP-p62 
construct as a template. The different p62 constructs were then ligated into a previously 
digested pEGFP-C2 plasmid. The different domains of p62 are represented in different 
colours. 
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4.2.2 The N-terminal fragment of p62 is necessary for DLC formation 
Once the p62 deletion constructs were cloned, we used them to overexpressed GFP-
p62 fusion proteins, focusing on the N-terminal fragment as it comprised the PB1 and 
the ZZ-zinc finger domains incorporating the majority of the Cys residues in p62 
sequence (11 out of 14). Moreover, it has been already postulated that the ZZ-zinc 
finger domain of p62, rich in Cys residues involved in metal binding that may be 
redox regulated, could be important for sensing oxidation levels (Filomeni et al., 
2015). 
HeLa cells were transfected with different GFP-p62 constructs showed in Figure 4.1, 
and treated with H2O2 and PR-619 to induce DLC formation (Figure 4.2). 
Interestingly, all the constructs were able to form DLC upon oxidation except for the 
114-440p62 fragment (blot n. 5) which did not contain the PB1 domain (amino acids 
4-102) and its flanking region (amino acids 103-114). The 1-122p62 fragment, 
comprising the PB1 domain and the flanking unstructured region, was essential for 
p62 redox-sensitivity, as it was required and sufficient for both the formation of DLC 
and the preservation of monomeric p62 (blot n. 4). On the contrary, the ZZ-zinc finger 
domain appeared not to be involved in p62 DLC formation although it contained 
several Cys residues (6 out of 14), since DLC were visible both in the presence and 
absence of this domain (cf. blot 3 and 4). Also the UBA domain, lacking in Cys 
residues, did not seem to participate in the production of DLC (blot n. 2), suggesting 
that the binding to ubiquitin was not important in the process. 
These results suggested that the N-terminus of p62 alone, containing the PB1 
domain and the unstructured neighbouring region, was likely to be involved in DLC 
formation upon oxidation, while other fragments of the protein were not essential for 
the process. 
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Figure 4.2 | The N-terminal fragment of p62 
is required for DLC formation. HeLa cells 
were transfected with different GFP-tagged 
p62 constructs, treated with H2O2 (1 mM, 1 
min) or PR-619 (20 μM, 10 min) and subjected 
to immunoblot analysis for GFP-tagged p62. 
Actin and GAPDH were used as loading 
controls. Arrows represent monomeric and 
DLC p62. Data are representative of at least 
two independent experiments. 
  
Chapter 4. Two Cysteine Residues of p62 are Critical for DLC Formation 
  
 
117 
 
4.2.3 Two cysteine residues in the p62 N-terminus are conserved in 
vertebrates 
Since the N-terminal fragment of p62 appeared to be essential for DLC production, 
we hypothesised that the Cys residues contained in the 1-122 fragment would be 
involved in sensing oxidative stress. Unexpectedly, the Cys residues in the ZZ-zinc 
finger domain, which are conserved throughout the metazoa, seemed not to be 
participating in DLC formation (cf. Figure 4.2), although their potential sensitivity to 
ROS has been postulated (Filomeni et al., 2015). 
Hence, we performed a multiple alignment of p62 sequences (a.a. 1-175) from 30 
different species (cf. Table 2.12) using the software ALINE (Bond and Schuttelkopf, 
2009), in order to compare the levels of conservation of the Cys residues between 
the p62 N-terminus fragment (1-122) and the ZZ domain (Figure 4.3). The analysis 
showed that the three Cys in the PB1 domain (positions 26, 27 and 44) did not show 
a high degree of conservation among the chosen species. Interestingly, two Cys 
residues (positions 105 and 113, green boxes) in the unstructured region (a.a. 103-
125) flanking the PB1 domain, unexpectedly showed a higher degree of conservation 
among species. Notably, these two Cys residues were surrounded by a considerable 
amount of amino acids with charged side chains, such as Lys (+), Arg (+), His (+), 
Asp (-) and Glu (-), hence they could have been sensitive to the charged 
environment. However, both C105 and C113 were missing in invertebrates (D. 
melanogaster and C. elegans) but present only in vertebrates, suggesting that C105 
and C113 appeared later in evolution. As expected, all six Cys residues lying in the 
ZZ domain (positions 128, 131, 142, 145, 151 and 154) were all conserved in both 
vertebrates and invertebrates. Since C105 and C113 were the only conserved Cys 
residues lying in the N-terminal of p62 which was essential to produce DLC, we 
hypothesised that they could be redox-regulated. 
In summary, our analysis showed that two Cys residue, C105 and C113, lying in an 
unstructured region between PB1 and ZZ domains, exhibited a high degree of 
conservation among vertebrates but were missing in invertebrates.  
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Figure 4.3 | Multiple 
alignment of p62 
sequences shows a 
high degree of 
conservation of 
C105 and C113 in 
vertebrates. A 
multiple alignment of 
p62 N-terminus (a.a. 
1-175) was 
performed in 30 
different species 
(showing only 14) 
using the protein-
sequence alignment 
editor ALINE. 
Increasing 
conservation of 
amino acid residues 
is shown by light-to-
dark red. Cysteine 
residues are 
indicated by stars; 
C105 and C113 are 
highlighted by green 
boxes. Predicted 
ordered regions are 
indicated by lines 
above the sequence 
alignment with β-
sheets and α-helixes 
shown as blue 
arrows and red 
cylinders, 
respectively. PB1 
domain: a.a. 4-102; 
ZZ domain: a.a. 126-
168. The work was 
carried out by Dr 
Graham Smith at 
Newcastle University. 
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4.2.4 Cysteine residues C105 and C113 are important for p62 DLC formation 
To test our hypothesis whether the Cys residues in the N-terminus of p62 (PB1 
domain and the flanking unstructured region) were effectively sensing ROS and 
playing a role in DLC formation, we performed single Cys-to-Ala site-directed 
mutagenesis on the full-length GFP-tagged p62, specifically on positions 26, 27, 44, 
105, and 113. 
Each single mutant was then expressed in HeLa cells, following treatments with H2O2 
and PR-619 to induce p62 oxidation and immunoblot analysis (Figure 4.4A). The 
ratio between DLC and monomeric p62 was quantified and normalised to the wild-
type GFP-p62 (Figure 4.4B). Although it was possible to detect some differences in 
the amount of p62 protein that was shifting toward higher MW, none of the p62 single 
mutants were able to prevent the formation of DLC. However, C105A and C113A 
mutants seemed to develop slightly lower levels of DLC, as well as preserving the 
monomeric form of p62 from shifting to higher MW. Notably, the C113A mutant 
produced less DLC compared to the C105A mutant. This result showed that Cys 
residues in p62 sequence were indeed involved in sensing oxidative stress, 
specifically the C105 and C113 that appeared to be conserved in our alignment 
analysis (cf. Figure 4.3). 
In short, Cys-to-Ala single mutagenesis in the p62 N-terminus showed that C105 and 
C113, located in the unstructured region ahead of the PB1 domain, were involved in 
DLC formation upon oxidation. 
 
Chapter 4. Two Cysteine Residues of p62 are Critical for DLC Formation 
 
 
120 
 
 
Figure 4.4 | Single mutagenesis of C105 and C113 of p62 reduces DLC formation. (A) 
HeLa cells were transfected with GFP-tagged wild-type or different p62 mutants as shown, 
treated with H2O2 (1 mM, 1 min) or PR-619 (10 μM, 10 min) and subjected to immunoblot 
analysis for GFP-tagged p62. GAPDH was used as a loading control. Arrows represent 
monomeric and DLC p62. (B) The ratio between DLC and monomeric p62 was quantified 
and normalised to the wild-type GFP-p62. Data are representative of at least two 
independent experiments, while quantification represents n=1.  
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4.2.5 Double mutation of C105A and C113A dramatically reduces p62 DLC 
formation 
Since the C113A mutant of p62 seemed to produce less DLC among the other p62 
N-terminal mutants (cf. Figure 4.4), we selected it as a template for a second round 
of Cys-to-Ala site-directed mutagenesis. In our prediction, the double mutation of the 
two conserved Cys residues C105 and C113 would have led to the loss of p62 redox 
sensitivity. We also employed the well-characterised K7A,D69A double mutant of 
p62, known to disrupt the ability of the PB1 domain to self-oligomerise (Lamark et al., 
2003), in order to understand whether PB1-mediated aggregation was important 
during oxidation and DLC formation. 
The double mutants of p62 were then expressed in HeLa cells, treated with H2O2 and 
PR-619 to induce oxidation and analysed by immunoblot (Figure 4.5A). The ratio 
between DLC and monomeric p62 was quantified and normalised to the wild-type 
GFP-p62 (Figure 4.5B). All Cys double mutants of p62 showed a reduction of DLC 
formation or a preservation of the monomeric form of p62 since they all contained the 
C113A mutation affecting DLC formation (cf. Figure 4.4A). Strikingly, the C105A-
113A double mutant dramatically reduced the levels of DLC formation, although 
without abolishing them completely. This result was in accordance with our 
hypothesis that the two conserved Cys residues C105 and C113 would have a 
primary role in DLC formation. However, residual presence of p62 DLC was still 
evident after substitution of the two Cys residues, suggestive of redundancy between 
the Cys residues along p62 sequence. Interestingly, the K7A,D69A double mutant of 
p62 did not show any changes in the formation of DLC compared to the wild-type, 
demonstrating that the self-oligomerisation of p62 mediated by non-covalent 
interactions was not important in the formation of DLC during oxidative stress. 
In summary, the Cys residues C105 and C113 in the N-terminal of p62 were crucial 
in DLC formation but not indispensable for the process. Instead, the PB1-mediated 
oligomerisation of p26 was not contributing to DLC production during oxidative 
stress. 
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Figure 4.5 | Cysteine residues C105 and C113 of p62 are crucial for DLC formation. (A) 
HeLa cells were transfected with GFP-tagged wild-type or different p62 mutants as shown, 
treated with H2O2 (1 mM, 1 min) or PR-619 (10 μM, 10 min) and subjected to immunoblot 
analysis for GFP-tagged p62. GAPDH was used as a loading control. The C105,113A p62 
double mutant is highlighted by red boxes. Arrows represent monomeric and DLC p62. (B) 
The ratio between DLC and monomeric p62 was quantified and normalised to the wild-type 
GFP-p62. Error bars represent s.e.m., n=3, **p<0.01. Data are representative of at least 
three independent experiments.  
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4.2.6 Additional mutations in the PB1 domain of p62 do not further decrease 
DLC formation 
Since the substitution of C105 and C113 did not lead to a complete loss of p62 DLC 
(cf. Figure 4.5), we sought to investigate whether other Cys residues in the N-
terminus of p62 were implicated in DLC formation. As already mentioned, low 
remaining levels of DLC after C105 and C113 mutation could have been caused by 
neighbouring redundant Cys residues, hence additional mutation of Cys residues 
could have been needed to completely abolish p62 DLC. 
To do so, we used the C105,113A p62 double mutant to perform a further round of 
Cys-to-Ala site-directed mutagenesis, specifically on positions 26, 27 and 44. The 
triple mutants of p62 were then expressed in HeLa cells, treated with H2O2 and PR-
619 to induce oxidation and analysed by immunoblot (Figure 4.6A). The ratio 
between DLC and monomeric p62 was quantified and normalised to the wild-type 
GFP-p62 (Figure 4.6B). Although the reduction of DLC was evident in all triple 
mutants, none of them completely suppressed p62 DLC formation. Since the Cys 
residues in the PB1 domain did not appear to be conserved in our multiple-sequence 
alignment (cf. Figure 4.3), we hypothesised that more conserved Cys residues in p62 
sequence would instead have been implicated in DLC formation, such as those 
present in the ZZ domain. 
In summary, further mutations of Cys residues in the PB1 domain of p62 did not 
show a complete abolishment of DLC, suggesting that other Cys residues along p62 
sequence could provide redundancy during oxidation.  
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Figure 4.6 | Additional mutations in the N-terminus of p62 do not show reduction of 
DLC. (A) HeLa cells were transfected with GFP-tagged wild-type or different p62 mutants as 
shown, treated with H2O2 (1 mM, 1 min) or PR-619 (10 μM, 10 min) and subjected to 
immunoblot analysis for GFP-tagged p62. GAPDH was used as a loading control. Arrows 
represent monomeric and DLC p62. (B) The ratio between DLC and monomeric p62 was 
quantified and normalised to the wild-type GFP-p62. Error bars represent standard deviation, 
n=2. Data are representative of at least two independent experiments.  
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4.2.7 Additional mutations along p62 sequence lead to variability in DLC 
formation 
Since the additional mutation of Cys residues in the PB1 domain did not completely 
suppress p62 DLC formation (cf. Figure 4.6), we decided to look at other Cys 
residues along p62 sequence. The ZZ domain of p62 contained several conserved 
Cys residues (cf. Figure 4.3) close to C105 and C113, which could have been 
playing a role in sensing oxidation through redundancy. 
Hence, one more round of Cys-to-Ala site-directed mutagenesis was performed 
using the C105A-C113A p62 double mutant as a template, specifically on positions 
131, 142, 145, 154, 289/290 and 331. Oxidation was induced with H2O2 and PR-619 
after expressing the p62 mutants in HeLa cells, and the protein lysates were 
analysed by immunoblot (Figure 4.7A). The ratio between monomeric and DLC p62 
was quantified and normalised to the wild-type GFP-p62 (Figure 4.7B). Although the 
new mutants did not show any significant decrease in DLC formation compared to 
the C105A-C113A, some mutations resulted in a higher development of DLC upon 
oxidation. The point-mutations implicated in this increase of DLC formation (C131A, 
C142A, C145A and C154A) involved the Cys residues located in the ZZ domain, 
which appeared to be the most conserved among the species we analysed (cf. 
Figure 4.3). One explanation could be that the substitution of such Cys residues 
would result in the destabilisation of the zinc finger, leading to the exposure of other 
Cys residues previously involved in the binding of the Zn2+ ions. 
In short, additional mutations of Cys residues along p62 sequence did not suppress 
DLC formation. Instead, mutation of the conserved Cys residues in the ZZ domain 
induced an increase in DLC production, possibly due to the destabilisation of the zinc 
finger. 
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Figure 4.7 | Redundancy of cysteine residues of p62 leads to variability in DLC 
formation. (A) HeLa cells were transfected with GFP-tagged wild-type or different p62 
mutants as shown, treated with H2O2 (1 mM, 1 min) or PR-619 (10 μM, 10 min) and 
subjected to immunoblot analysis for GFP-tagged p62. GAPDH was used as a loading 
control. Arrows represent monomeric and DLC p62. (B) The ratio between DLC and 
monomeric p62 was quantified and normalised to the wild-type GFP-p62. Error bars 
represent standard deviation, n=2. Data are representative of at least two independent 
experiments.  
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4.2.8 Single and double mutation of C105 and C113 in the N-terminal fragment 
of p62 determines loss of DLC formation 
To avoid the participation of redundant Cys residues in the formation of DLC, we 
employed the N-terminal fragment of GFP-tagged p62 (a.a. 1-122, 42 kDa) and 
carried out single and double Cys-to-Ala mutagenesis of C105 and C113 residues. In 
this way, we could avoid the presence of conserved Cys residues in the ZZ domain 
which could also become available for DLC formation, although the three Cys 
residues in the PB1 domain were still present. 
HeLa cells were transfected with N-terminal GFP-p62 mutants, treated with H2O2 and 
PR-619 and analysed by immunoblot (Figure 4.8). Notably, the DLC produced by the 
p62 N-terminal fragment started appearing at ∼80 kDa, which resembled a dimer of 
p62 rather than a trimer or tetramer as we had found previously (cf. Figure 3.2A). As 
expected, the single mutation of C105 and C113 determined a decrease in the 
formation of DLC. Strikingly, the double mutation of the two Cys residues seemed to 
completely suppress p62 DLC formation, although a band slightly higher than the 
dimers was still visible. We could not define whether such band was an artefact or an 
actual DLC, since the Cys residues lying in the PB1 domain could have become 
available in the process. However the result further confirmed the importance of 
C105 and C113 in the formation of p62 DLC upon oxidation. 
In summary, the double mutation of C105 and C113 in the N-terminal fragment of 
p62 showed to greatly impair DLC formation, although it was not clear whether such 
impairment was complete. 
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Figure 4.8 | Mutations of C105 and C113 in the N-terminal fragment of p62 suppress 
DLC formation. HeLa cells were transfected with GFP-tagged wild-type or different p62 
mutants as shown, treated with H2O2 (1 mM, 1 min) or PR-619 (10 μM, 10 min) and 
subjected to immunoblot analysis for GFP-tagged p62. GAPDH was used as a loading 
control. Arrows represent monomeric and DLC p62. Data are representative of at least two 
independent experiments. 
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4.3 Discussion 
Cysteine (Cys) residues have important roles in the regulation of proteins, as they 
can affect their structure and function (Cremers and Jakob, 2013). The high 
versatility of these residues is determined by their thiol groups (SOH), which often 
participate in enzymatic reactions as well as form disulphide bonds between different 
Cys residues (Paulsen and Carroll, 2010). In Chapter 3, we have found that p62 can 
sense oxidation by forming disulphide-linked conjugates (DLC), since they were 
sensitive to reducing agents. Thus, we wanted to determine which residues where 
involved in the formation of p62 DLC. 
In this chapter, we have identified two Cys residues in p62 sequence which appeared 
responsible for DLC formation during oxidative stress conditions. By producing 
different deletion constructs of p62 (Figure 4.1), we found that the N-terminus of p62 
(a.a. 1-122) was essential for DLC formation (Figure 4.2). Following Cys-to-Ala point-
mutagenesis of p62, we have found that C105 and C113, located in an unstructured 
region between PB1 and ZZ domains, were mainly involved in the process (Figure 
4.4, 4.5). However, mutagenesis of both C105 and C113 was not sufficient to 
completely suppress p62 DLC, suggesting the involvement of additional Cys 
residues. The subsequent mutation of other Cys residues in the N-terminus of p62 or 
along its sequence did not show any further inhibition of DLC formation (Figure 4.6, 
4.7). However, several Cys-to-Ala substitutions in the ZZ domain paradoxically 
increased the tendency of p62 to form DLC (Figure 4.7). The substitution of both 
C105 and C113 in the N-terminal fragment of p62 (1-122p62) determined an almost 
complete loss of DLC formation, although we could not exclude the involvement of 
other Cys residues in the PB1 domain (Figure 4.8). 
The ZZ-type zinc finger domain of p62 contains 6 conserved Cys residues engaged 
in coordinating two Zn2+ ions, whose involvement in redox sensitivity has been 
previously suggested (Filomeni et al., 2015). It could be possible that the 
mutagenesis of certain Cys residues in the ZZ domain could induce the 
destabilisation of the zinc finger and the subsequent exposure of metal-binding Cys 
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residues, which would then become available to form disulphide bonds in place of 
C105 and C113. Thus, we can hypothesise a redundancy in Cys residues which can 
become involved in DLC formation following modifications in p62 structure. In a 
similar manner, redundancy of Lys residues involved in ubiquitination in different 
proteins has been suggested to take place following Lys mutagenesis (Fung et al., 
2005; Li et al., 2012a; Guharoy et al., 2016). Thus, the precise site of ubiquitination in 
proteins is generally overlooked, since multiple Lys residues can become ubiquitin 
acceptors in the absence of the typical ubiquitination sites (King et al., 1996).  
A way to overcome this redundancy could be the substitution of all the 14 Cys 
residues in p62 sequence and the subsequent reintroduction of C105 and C113. In 
this way, we could assess whether the sole presence of these two residues is 
sufficient for DLC formation. The following reintroduction of other Cys residues would 
then clarify the presence of additional residues involved in the process. Several 
studies have employed Cys-less mutant proteins in order to understand their 
structures and functions, indicating the efficacy of such approach (Loo and Clarke, 
2006; Arendt et al., 2007; Nishi et al., 2008). Interestingly, the production of a Lys-
less protein mutant has also been employed in order to completely abolish its 
ubiquitination (Li et al., 2012a), again suggesting the similarity between Cys and Lys 
residues redundancy and a common route to overcome the issue. Alternatively, the 
genetic deletion of the linker region between PB1 and ZZ domains of p62 could 
provide the means to assess the importance of this unstructured region in sensing 
oxidative stress. 
We have also analysed the K7A,D69A double mutant of p62, which lacks the ability 
to self-oligomerise via the PB1 domain (Lamark et al., 2003), and found that 
formation of DLC was not affected by the mutation (Figure 4.5). This would suggest 
that self-oligomerisation of p62 is not necessary for DLC formation. By contrast, a 
recent study has shown that K7A,D69A mutant p62 could not form high-molecular 
crosslinks, suggesting that p62 crosslinking would be dependent on its self-
oligomerisation (Donohue et al., 2014). Since the authors induced p62 crosslinks with 
the autophagy inhibitor verteporfin, we can hypothesise that such treatment would 
have different effects on the ability of p62 to form DLC. 
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Our multiple alignment analysis of p62 sequences in different organisms has shown 
a high degree of conservation of C105 and C113, although they were not found in 
invertebrates such as D. melanogaster and C. elegans (Figure 4.3). Both residues 
are located in a linker region predicted to be natively unstructured due to the high 
presence of polar, charged amino acids (Romero et al., 2001; Vucetic et al., 2003). 
Disordered regions are very common in proteins, and despite their functional role has 
been overlooked for a long time, they have been shown to be involved in important 
processes such as cell signalling, regulation and molecular recognition (Dunker et al., 
2005; Uversky et al., 2005). Thus, we propose that p62 DLC formation could be a 
protective mechanism against oxidative stress acquired later in evolution with 
important consequences for p62 function, such as aggregate formation and 
autophagy induction. 
Due to the high reactivity of their thiols, Cys residues are not very abundant in 
proteins, showing a lower frequency of appearance during evolution compared to 
other amino acids, and tend to be very conserved (Miseta and Csutora, 2000). Thiols 
reactivity depend on their pKa (acid dissociation constant), which represents the 
tendency of losing a hydrogen atom and form the thiolate ion (S-), a strong 
nucleophile (Roos et al., 2013). Charged and uncharged polar amino acids in the 
vicinity of Cys residues can strongly influence thiols reactivity by producing hydrogen 
bonds, which reduce the pKa by stabilising the thiolate ion (Snyder et al., 1981; Billiet 
et al., 2012; Roos et al., 2013). Interestingly, residues C105 and C113 are located in 
close proximity to electrically-charged as well as polar uncharged amino acids, all 
showing high degree of conservation among different species (Figure 4.2). Notably, 
C105 is surrounded by both positively- (K102, K103, R106 and R107) and 
negatively-charged (E101 and E104) residues. Also, one negative (D108) and two 
positive (H109 and R110) residues are located between C105 and C113, while one 
uncharged polar (Q115) and one negative (E116) residues are located right after 
C113. Thus, it is possible that the vicinity of C105 and C113 to these charged polar 
residues could lower their pKa, resulting in increased thiols reactivity and disulphide 
bond formation during oxidative stress conditions. 
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Additionally, perturbations in the ionic environment can lead to changes in thiols 
reactivity, thus impacting on the ability of Cys residues to form disulphide bonds 
(Cremers and Jakob, 2013; Roos et al., 2013). Recently, a charge-reversal mutant of 
p62 (R106E/R107E) has been employed in order to destabilise the assembly of PB1 
filaments of p62, determining the formation of larger aggregates than wild-type p62 
(Ciuffa et al., 2015). In fact, the authors identified the unstructured region flanking the 
PB1 domain as an electrostatic bridge, whose role is crucial for the correct formation 
of PB1 filaments and ultimately p62 aggregates (Ciuffa et al., 2015). In a similar 
manner, mutations of charged amino acids in the vicinity of C105 and C113 could 
have an impact onto the stability of p62 DLC, as well as on its ability to form 
polyubiquitinated aggregates. 
Interestingly, a charge-reversal heterozygote mutation of p62 (K102E) has been 
identified in a sporadic amyotrophic lateral sclerosis (SALS) case, associated with 
large round p62 inclusions in neurons affected by the disease (Teyssou et al., 2013). 
Evidence from our lab have shown that overexpression of p62 K102E mutant 
impaired DLC formation following oxidative stress (unpublished), thus suggesting the 
important role of charged residues in regulating the reactivity of C105 and C113 and 
the potential importance of DLC formation in protein homeostasis and neuronal 
survival. 
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Chapter 5. Formation of DLC is Important for p62 Function in 
Autophagy 
5.1 Introduction 
In the previous chapter, we have identified two cysteine (Cys) residues of p62, C105 
and C113, which were found to be required for its ability to sense oxidation and form 
DLC. Such Cys residues, lying in an unstructured region between PB1 and ZZ 
domains, appeared to be highly conserved in vertebrates but not in invertebrates, 
suggesting that the ability of p62 in sensing oxidative stress might have been 
acquired later in evolution. Since p62 oxidation seemed to contribute to aggregate 
formation (cf. Figure 3.3), we wanted to understand whether the double Cys mutant 
of p62 would not only impair DLC formation but also aggregation of p62 and its 
substrates. It is known that p62 aggregation is a crucial step for its function as a 
selective autophagy receptor (Ichimura et al., 2008; Itakura and Mizushima, 2011), 
which leads to a tighter interaction with the autophagy marker LC3 (Wurzer et al., 
2015). Thus, we hypothesised that the loss of the oxidation-sensing properties of p62 
would also impair its ability to form aggregates and drive cargos to degradation. In 
this chapter we analysed the relevance of p62 oxidation to its function as an 
autophagy receptor protein, and investigated whether the loss of DLC formation 
would impact on protein degradation and cell survival during oxidative stress 
conditions. 
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5.2 Results 
5.2.1 Production and validation of FLAG-p62 stable cell lines 
To investigate the role of C105 and C113 in p62 function as receptor for selective 
autophagy, we used p62-/- (knock-out) mouse embryonic fibroblasts (MEFs) to stably 
express either wild-type or Cys mutant p62, in order to avoid the presence of 
endogenous p62 and instead focus on the effect of the p62 oxidation-insensitive 
mutant compared to the wild-type protein. 
Thus, we performed lentiviral transduction to stably introduce a transgenic FLAG-
tagged p62, either wild-type or C105A-C113A mutant in p62-/- MEFs (Figure 5.1A). 
To do so, we transfected the VSV-G (vesicular stomatitis virus G glycoprotein, used 
to amplify the host range due to its wide infectivity) (Burns et al., 1993) and 
packaging plasmids plus the FLAG-tagged p62 transgenes (or empty vector) in 
HEK293FT (human embryonic kidney) cells (optimised for virus production), in order 
to produce and concentrate the lentivirus containing p62 transgenes. The virus 
particles were then used to infect p62-/- MEFs, integrating the viral genome into the 
cells. Transduced cells were then selected with antibiotics until their expansion. The 
presence of the FLAG-p62 transgene in the stable cell lines was then confirmed by 
immunoblot, although it showed lower levels of expression compared to the 
endogenous p62 from wild-type MEFs (Hewitt et al., 2016). To validate the effect of 
the C105A-C113A mutation in the stable cell lines, we induced oxidation with H2O2 
and PR-619 and performed immunoblot analysis (Figure 5.1B). As expected, the 
formation of DLC in the FLAG-C105,133Ap62 cell line was greatly reduced compared 
to FLAG-p62 wild-type, although DLC were not completely suppressed, similarly to 
what we have seen in HeLa cells after overexpression of the GFP-p62 double mutant 
(cf. Figure 4.5). 
In short, we produced stable cell lines expressing FLAG-p62 and FLAG-
C105,113Ap62 in order to investigate the effects of the double Cys mutation on p62 
function during oxidative stress.  
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Figure 5.1 | Stable cell lines produced and validated in this study. (A) Schematic 
representation of the lentivirus packaging and transduction protocol followed to produce 
stable cell lines used in this study. Adapted from www.biocat.com. (B) p62-/- MEFs stably 
expressing either wild-type or C105,113A FLAG-p62 were treated with H2O2 (1 mM, 1 min) or 
PR-619 (10 μM, 10 min) and immunoblotted for p62 in non-reducing conditions. GAPDH was 
used a loading control. Arrows represent monomeric and DLC p62. Data are representative 
of at least two independent experiments. 
 
5.2.2 Mutation of C105 and C113 of p62 determines impaired formation of 
insoluble aggregates 
After producing the stable cell lines, we sought to investigate whether the double Cys 
mutation of p62 would impair not only the formation of DLC but also the function of 
p62 as a receptor for selective autophagy. We previously showed that oxidation 
increased the formation of p62 aggregates in HeLa cells (cf. Figure 3.3A), and that 
formation of DLC was also correlated with the shift of p62 from the soluble to the 
insoluble fraction (cf. Figure 3.3B). It is known that the presence of p62 is necessary 
for the formation of polyubiquitinated aggregates (Komatsu et al., 2007b; Korolchuk 
Chapter 5. Formation of DLC is Important for p62 Function in Autophagy 
 
 
136 
 
et al., 2009), and that p62 aggregation is a crucial step for the degradation of 
substrates through autophagy (Bjorkoy et al., 2005; Itakura and Mizushima, 2011). 
Thus, we investigated whether the loss of p62 sensitivity to oxidative stress through 
DLC formation would impact its ability to form polyubiquitinated aggregates. 
Wild-type and C105,113A FLAG-p62 stable cells lines were treated with H2O2 and 
PR-619 to induce protein aggregation, stained for p62 and ubiquitin, analysed by 
confocal microscopy and the percentage of p62 aggregates quantified (Figure 5.2A). 
In control conditions, both cell lines showed a modest presence of protein 
aggregates. Following oxidative stress, a high increase in protein aggregates positive 
for p62 and ubiquitin was detected in the wild-type cell line. In contrast, formation of 
protein aggregates in the C105,113A mutant cell line was significantly impaired 
compared to the wild-type, suggesting that the loss of DLC would impact on the 
ability of p62 to form polyubiquitinated aggregates. 
To further confirm the role of oxidation and DLC in protein aggregates, we performed 
ultracentrifugation to separate the soluble from the insoluble fraction following 
treatments with H2O2 and PR-619, and quantified the ratio between DLC and 
monomeric p62 in the insoluble fraction (Figure 5.2B). Similarly to what we had 
previously seen in HeLa cells (cf. Figure 3.3A), we could detect the accumulation of 
p62 DLC in the insoluble fraction of the wild-type cell line (lane 3 in both blots), 
although the effect of H2O2 was only moderate, again suggesting that oxidation of 
p62 increased its insolubility. On the contrary, the C105,113A mutant cell line did not 
show formation of DLC in either whole-cell or insoluble fraction following treatments 
(lane 6 in both blots), suggesting that the loss of the Cys residues sensitive to 
oxidation would impair p62 insolubility and formation of insoluble aggregates. 
In summary, the loss of p62 sensitivity to oxidation was correlated with reduced 
formation of polyubiquitinated aggregates and protein insolubility, suggesting that the 
function of p62 in aggregating cargos for degradation was impaired. 
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Figure 5.2 | Loss of p62 redox-sensitivity reduces the formation of insoluble 
aggregates. (A) p62-/- MEFs stably expressing FLAG-tagged wild-type or C105,113A p62 
were treated with H2O2 (1 mM, 30 min) or PR-619 (5 μM, 30 min), immunostained for 
ubiquitin and p62 and analysed by confocal microscopy. Nuclei were stained with TO-PRO-3 
iodide. Cells with positive aggregates for p62 were counted and their proportion quantified. 
Error bars represent s.e.m., n=3, **p<0.01, ***p<0.005. Data are representative of at least 
three independent experiments. (B) Stable cell lines as in (A) were treated with H2O2 (5 mM, 
1 min) and PR-619 (10 μM, 10 min), lysed and subjected to ultracentrifugation to separate 
the soluble and insoluble fractions. Whole cell, soluble and insoluble fractions were then 
immunoblotted for endogenous p62. GAPDH was used as a loading control. Arrows indicate 
the positions of monomeric and DLC p62. The ratio of DLC to monomeric p62 was quantified 
and normalised to wild-type FLAG-p62. Error bars represent standard deviations, n=2. Data 
are representative of at least two independent experiments. 
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5.2.3 K7A,D69A mutant suppresses the formation of p62 aggregates during 
oxidative stress and autophagy inhibition 
Since disulphide bond formation following oxidative stress appeared to contribute to 
p62 aggregation, and considering that self-oligomerisation of p62 through its PB1 
domain is known to be essential for cytoplasmic bodies formation (Bjorkoy et al., 
2005), we examined the relationship of these two mechanisms further. We had 
previously shown that the PB1 domain mutant K7A,D69A, which disrupts the ability 
of p62 to self-oligomerise (Lamark et al., 2003), could normally form DLC following 
oxidative stress (cf. Figure 4.5), suggesting that PB1-mediated oligomerisation and 
DLC formation where two separate mechanisms. Hence, we wanted to examine 
whether the PB1 mutant, which does not form cytoplasmic aggregates following 
overexpression and autophagy knock-out (Lamark et al., 2003; Ichimura et al., 2008), 
could still aggregate upon oxidative stress.  
Thus, we overexpressed GFP-tagged wild-type or K7A,D69A p62 in HeLa cells, and 
compared the effects of H2O2 and PR-619 on aggregation with those of autophagy 
inhibition through bafilomycin A1 (Baf) by confocal microscopy analysis (Figure 
5.3A). Interestingly, the absence of PB1-mediated oligomerisation determined the 
disappearance of p62 aggregates compared to the wild-type in conditions of both 
oxidative stress and autophagy inhibition. This suggested that the PB1 domain would 
have a primary role in the process of aggregate formation as shown previously 
(Ichimura et al., 2008), even in the presence of DLC. 
To compare the ability of the C105,113A mutant in forming polyubiquitinated 
aggregates during autophagy inhibition, we treated the stable cell lines expressing 
FLAG-tagged wild-type or mutant p62 with Baf, analysed them with confocal 
microscopy and quantified the cells with aggregates (Figure 5.3B). Autophagy 
inhibition greatly enhanced the formation of aggregates positive for p62 and ubiquitin 
both in wild-type and C105,113A p62, showing that oxidation sensitivity of p62 did 
not have a role during such conditions. 
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In summary, accumulation of p62 following autophagy inhibition drove its aggregation 
predominantly through the PB1 domain. At the same time, p62 DLC appeared to be 
important for aggregation during oxidative stress, although the microscopically-
detectable aggregates also required the function of the PB1 domain of p62. 
 
 
Figure 5.3 | The PB1 domain of p62 is required for intracellular aggregate formation. 
(A) HeLa cells were transfected with GFP, GFP-tagged wild-type or K7A,D69A p62 and 
treated with H2O2 (5 mM, 1 min), PR-619 (10 μM, 10 min) and bafilomycin A1 (Baf, 400 nM, 4 
hours). Nuclei were stained with TO-PRO-3 iodide. Cells were fixed and analysed by 
confocal microscopy. (B) p62-/- MEFs stably expressing wild-type and C105,113A FLAG-
tagged p62 were treated with bafilomycin A1 (Baf) as in (A) or left untreated (Ctr), 
immunostained for ubiquitin and p62 and analysed by confocal microscopy. Nuclei were 
stained with TO-PRO-3 iodide. Cells with positive aggregates for p62 were counted and their 
proportion quantified. Error bars represent s.e.m., n=3, NS: not significant. Data are 
representative of at least three independent experiments. 
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5.2.4 Degradation of C105,113A p62 is impaired compared to wild-type p62 
Since aggregate formation upon oxidation appeared to be impaired in the presence 
of the double Cys mutant of p62 (Figure 5.2), we questioned whether the function of 
p62 in autophagy would have been affected by the mutation. The degradation of p62 
is known to be correlated with its function as an autophagy receptor, as autophagy 
inhibition leads to the accumulation of p62 (Bjorkoy et al., 2005; Komatsu et al., 
2007b; Komatsu and Ichimura, 2010). Thus, we tested whether the degradation rates 
of the double Cys mutant of p62 would have been affected during oxidative stress. 
For this purpose, we used cycloheximide (CHX) to block protein synthesis in the cells 
and to determine the decay of p62 over time (Zhou, 2004). Cycloheximide is an 
antibiotic produced by Streptomyces griseus which blocks protein translation by 
binding to the 60S ribosomal subunit, causing cell growth arrest (Schneider-Poetsch 
et al., 2010). We performed a CHX chase experiment to determine the rate of 
degradation of p62 in the wild-type and the mutant stable cell lines. Thus, we treated 
the cells for 1, 4 and 8 hours with CHX and analysed them by immunoblot (Figure 
5.4A). The ratio of p62 to the loading control was quantified and normalised to the 
untreated samples. Interestingly, we discovered that C105,113A p62 had a 
significantly slower degradation compared to the wild-type after 4 and 8 hours of 
treatment, suggesting impaired autophagic function. This could reflect an impairment 
of the autophagic removal of the mutant p62. 
Another way to investigate p62 degradation in our stable cell lines was to label the 
newly synthesised p62 and look at its degradation over time. Thus, a Click-iT assay 
was performed by labelling newly synthesised proteins with AHA (L-
azidohomoalanine), using biotin to pull-down p62 over a period of 6 hours and then 
detecting the signal with streptavidin (Figure 5.4B). Also in this case, the C105,113A 
p62 mutant showed a slower degradation compared to the wild-type protein, 
significantly at 2 and 6 hours after labelling with AHA. This result further supported 
the role of p62 redox-sensitivity for its normal function as an autophagy receptor. 
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In brief, the loss of DLC formation impaired the degradation of the C105,113A p62, 
suggesting that the autophagic degradation of our mutant was impaired. 
 
 
Figure 5.4 | Degradation of C105,113A p62 is delayed compared to wild-type. (A) p62-/- 
MEFs stably expressing FLAG-tagged wild-type or C105,113A p62 were treated with 
cycloheximide (CHX, 50 μg/ml), lysed at the indicated times post-treatment and 
immunoblotted for p62. GAPDH was used as a loading control. The amounts of p62 protein 
were quantified and normalised to the untreated. (B) p62-/- MEFs stably expressing empty 
vector plus stable cell lines as in (A) were analysed by Click-iT assay, where AHA (L-
azidohomoalanine) reagent was incorporated into newly synthesised proteins, monitored via 
biotin pull-down over a chase period of 6 hours and probed with streptavidin for detection. 
FLAG-tagged p62 protein was used as an Input. The amount of newly synthesised p62 (p62-
Strep) was quantified and normalised to the untreated. Error bars represent s.e.m., n=3, 
*p<0.05. Data are representative of at least three independent experiments. The work in (B) 
was carried out by Dr Fiona Menzies at Cambridge University. 
 
5.2.5 Wild-type and C105,113A p62 show no difference in ubiquitin binding 
Since the C105,113A p62 mutant showed impaired aggregation and degradation 
during oxidative stress conditions in our previous experiments (Figure 5.2, 5.4), and 
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both are considered important features for proper function of p62 as a receptor for 
selective autophagy (Komatsu and Ichimura, 2010), we questioned whether the 
double Cys mutation would affect the ability of p62 to bind to polyubiquitinated 
substrates. 
Thus, we performed an immunoprecipitation (IP) using α-FLAG magnetic beads in in 
order to purify FLAG-tagged p62 from our wild-type and Cys mutant stable cell lines. 
Following the purification of FLAG-p62 wild-type and C105,133A, we performed 
immunoblot analysis for ubiquitin and p62 followed by quantification of ubiquitin-to-
p62 protein levels (Figure 5.5). Importantly, the binding to ubiquitin showed no 
differences in both stable cell lines, suggesting that the double Cys mutation did not 
influence the binding of p62 to polyubiquitinated proteins. 
To conclude, the ubiquitin binding was not affected in the C105,113A p62 cell line 
compared to the wild-type p62, suggesting that the impaired aggregation and 
degradation of the Cys mutant was not dependent on its ubiquitin-binding properties. 
 
 
Figure 5.5 | Ubiquitin binding is not affected by the double Cys mutation of p62. (A) 
p62-/- MEFs stably expressing empty vector, FLAG-tagged wild-type or C105,113A p62 were 
subjected to immunoprecipitation (IP) using α-FLAG magnetic beads followed by immunoblot 
for ubiquitin and p62. Asterisk indicates an unspecific band. The ratio of immunoprecipitated 
ubiquitin to p62 was quantified and normalised to wild-type FLAG-p62. Error bars represent 
s.e.m., n=4, NS: not significant. Data are representative of at least three independent 
experiments. 
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5.2.6 Loss of DLC formation and self-oligomerisation of p62 inhibits 
autophagy function 
After determining that p62 aggregation and degradation was impaired due to loss of 
DLC formation, and that polyubiquitinated proteins could bind independently of p62 
oxidation, we wanted to investigate whether the double Cys mutation of p62 could 
affect its function as an autophagy receptor. Additionally, we compared the oxidation-
insensitive mutant with the PB1 mutant in order to understand if both covalently- and 
non-covalently-mediated interactions of p62 were important for autophagy induction. 
Thus, p62-/- MEFs stably expressing empty vector, FLAG-tagged wild-type, 
C105,113A or K7A,D69A p62 were treated for 5 hours with H2O2 in serum free media 
to induce autophagy during oxidative stress, then lysed and analysed by immunoblot 
analysis for ubiquitin, LC3 and p62 (Figure 5.6A). The levels of ubiquitin, LC3 and 
p62 were then quantified and normalised to the untreated p62-/- cells (Figure 5.6B). 
Interestingly, the reintroduction of wild-type p62 in the cell line could efficiently induce 
the autophagic degradation of polyubiquitinated substrates, as shown by the 
reduction of ubiquitin and increased levels of LC3-II (lane 6). In contrast, both 
C105,113A and K7A,D69A mutants of p62 failed to induce autophagy, as the 
ubiquitin levels were higher than in control conditions and the accumulation of LC3 
was modest (lanes 7 and 8). As a confirmation, also p62 levels were higher in the 
mutant cell lines compared to the wild-type, highlighting the impaired degradation of 
p62 in the absence of DLC formation or self-oligomerisation. Unfortunately, we were 
not able to assess the levels of LC3 directly binding to p62 by IP in our mutant cell 
lines compared to wild-type (data not shown). 
To confirm the impaired induction of autophagy in the two mutant cell lines compared 
to wild-type, we immunostained them for p62 and LC3 in order to look at the 
autophagosome formation (Figure 5.6C). While we could detect the presence of 
autophagosomes after reintroduction of wild-type FLAG-p62, the mutants C105,113 
and K7A,D69A failed to form autophagosomes, suggesting an impairment in the 
process of autophagosome formation. 
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Another way to understand the rates of autophagic degradation of substrates in 
different cell lines has been recently experimented in (Lim et al., 2015). In this study, 
the authors induced accumulation of polyubiquitinated proteins by blocking the 
proteasome, and then looked at the rates of autophagic degradation of such proteins 
by either activating or inhibiting autophagy. We used MG132 (also known as 
carbobenzoxy-Leu-Leu-leucinal), a peptide aldehyde which selectively and reversibly 
blocks the 26S proteasome complex, to induce accumulation of misfolded and 
polyubiquitinated substrates in the cells (Lee and Goldberg, 1998; Goldberg, 2012). 
Hence, p62-/- MEFs stably expressing empty vector, FLAG-tagged wild-type or 
mutant p62 were treated with MG132 for 24 hours in medium with serum in order to 
accumulate polyubiquitinated proteins. Then, cells were switched to serum-free 
medium in the absence or presence of Baf (-Baf, +Baf) for another 24 hours, in order 
to either activate or block autophagy, respectively (Figure 5.6D). As expected, 
MG132 induced accumulation of polyubiquitinated proteins in all three cell lines 
(lanes 2, 6 and 10). After recovery in serum free medium (-Baf), cells started 
degrading the substrates via autophagy, although in the presence of wild-type FLAG-
p62 such degradation was more pronounced (lane 7) compared to p62-/- and 
C105,113A cell lines (lanes 3 and 11). This resembled an impairment of autophagy in 
the mutant cell lines compared to wild-type, which was also confirmed by the higher 
accumulation of p62 following proteasome inhibition (cf. lanes 6 and 10) and its 
slower degradation following autophagy induction (cf. lanes 7 and 11). In conditions 
of autophagy inhibition (+Baf), both wild-type and mutant cell lines accumulated 
polyubiquitinated substrates, although accumulation in the mutant cell line was more 
marked. However, technical difficulties during such experiment (due to significant cell 
loss after treatments and subsequent poor extraction of proteins) led to high 
variability in our results and unreliable quantifications regarding the rates of 
substrates degradation. Nevertheless, other repeats similarly indicated an 
impairment in autophagy activation in the presence of the C105,133A p62 mutant. 
In conclusion, the loss of either redox-sensitivity or the self-oligomerisation of p62 led 
to the impairment of autophagy and autophagosome formation, suggesting that both 
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properties would be important for the function of p62 as an autophagy receptor 
protein. 
 
Figure 5.6 | Oxidation and self-oligomerisation of p62 are important for autophagy 
induction. (A) p62-/- MEFs stably expressing empty vector, FLAG-tagged wild-type, 
C105,113A or K7A,D69A p62 were treated with H2O2 (1 mM, 5 hours), lysed and 
immunoblotted for ubiquitin, LC3 and p62. Actin was used as a loading control. (B) The 
amounts of ubiquitin, LC3 and p62 were quantified and normalised to the p62-/-. Error bars 
represent s.e.m., n=3, *p<0.05, **p<0.01, ***p<0.005, NS: not significant. (C) Stable cell lines 
as in (A) were grown on coverslips, fixed then stained for p62 and LC3 and analysed by 
confocal microscopy. (D) p62-/- MEFs stably expressing empty vector, FLAG-tagged wild-type 
or C105,113A p62 were treated with MG132 (2.5 μM, 24 hours), then media was replaced 
with or without bafilomycin A1 (-/+ Baf, 100 nm, 24 hours). Cells were lysed and analysed by 
immunoblot for ubiquitin and p62. GAPDH was used as a loading control. Data are 
representative of at least three independent experiments. The work in (A, B, C) was carried 
out in collaboration with Elsje G. Otten. 
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5.2.7 Loss of redox-sensitivity and self-oligomerisation of p62 affect cell 
survival under oxidative stress 
Since both oxidation and self-oligomerisation of p62 appeared to be important for the 
induction of autophagy (cf. Figure 5.6), we questioned whether the loss of these 
properties would affect cell viability in conditions of oxidative stress. In fact, 
autophagy is a catabolic process of vital importance in the cell, whose inhibition is 
linked to apoptosis (Boya et al., 2005). 
Thus, p62-/- MEFs stably expressing empty vector, FLAG-tagged wild-type, 
C105,113A or K7A,D69A p62  were exposed to oxidative stress (H2O2) for 5 hours, 
stained with fluorescence dyes to assess cell death and analysed by light microscopy 
(Figure 5.7A). The percentage of dead cells was then quantified and normalised to 
the p62-/- MEFs (Figure 5.7B). Oxidation appeared to have a strong effect on cell 
viability in the absence of p62 (p62-/-), while the reintroduction of wild-type FLAG-p62 
significantly prevented cellular loss. These data suggested the importance of p62 for 
cell survival, potentially by driving the degradation of substrates affected by the 
oxidative environment. Strikingly, neither C105,113A nor K7A,D69A p62 could 
rescue cell viability, confirming the role of both ROS-sensitivity and PB1-domain 
dependent p62 self-oligomerisation in cell survival. 
In short, redox-insensitive and oligomerisation-deficient mutants of p62 failed in 
protecting cells from oxidative stress, possibly due to autophagy impairment 
determined by p62 mutations. 
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Figure 5.7 | Loss of redox-sensitivity and self-oligomerisation of p62 reduce cell 
viability. (A) p62-/- MEFs stably expressing empty vector, FLAG-tagged wild-type, 
C105,113A or K7A,D69A p62 were treated with H2O2 (1 mM, 5 hours), and cells were stained 
with ReadyProbes fluorescent dyes to assess cell death. Blue fluorescence indicates total 
cells while green fluorescence indicates dead cells. Images were taken at x20 magnification 
by fluorescence microscope. (B) The percentage of cell death was quantified and normalised 
to the p62-/-. Error bars represent s.e.m., n=3, *p<0.05, **p<0.01, ***p<0.005. Data are 
representative of at least three independent experiments. The work was carried out in 
collaboration with Elsje G. Otten. 
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5.3 Discussion 
Selective autophagy is a catabolic process that requires autophagy receptors in order 
to recognise and accumulate cargos for degradation (Johansen and Lamark, 2011). 
Autophagy receptors, such as SQSTM1/p62, NDP52 and OPTN, bind to 
polyubiquitinated substrates and link them to the forming autophagosomal 
membrane, driving the engulfment of cargos (Stolz et al., 2014). In chapters 3 and 4, 
we have found that p62 senses by oxidative stress by forming disulphide-linked 
conjugates (DLC) in response to ROS. We have then identified two Cys residues in 
an unstructured region of p62, C105 and C113, important for DLC formation. Since 
oxidative stress also appeared to induce formation of p62 aggregates, which are 
essential for the autophagic degradation of cargos (Bjorkoy et al., 2005; Ichimura et 
al., 2008), we questioned whether the loss of DLC formation would have impaired the 
function of p62 as an autophagy receptor. 
In this chapter, we have investigated the effects of the loss of p62 DLC by producing 
stable cell lines (MEFs) in a p62 knock-out background (p62-/-) expressing either wild-
type or mutant C105,113A p62 (Figure 5.1). In this way, we could question whether 
insensitivity to oxidative stress would have affected the aggregation and function of 
p62. By inducing oxidation in our stable cell lines, we were able to detect lower 
formation of p62- and ubiquitin-positive aggregates in mutant C105,113 p62 
compared to wild-type, suggesting that DLC had an important role in driving p62 
accumulation and aggregation (Figure 5.2A). Such aggregates were also positive for 
ubiquitin, in accordance with the requirement of p62 for their formation (Komatsu et 
al., 2007b; Korolchuk et al., 2009). Additionally, the loss of DLC formation did not 
induce the shift of p62 to the insoluble fraction, suggestive of impaired formation of 
insoluble aggregates (Figure 5.2B). Since formation of p62 aggregates has been 
linked to its ability to degrade its substrates (Bjorkoy et al., 2005; Ichimura et al., 
2008), we hypothesised that the function of p62 as an autophagy receptor could be 
affected by the loss of DLC. 
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Until now, p62 aggregation has been linked to its ability of self-oligomerise mediated 
by the PB1 domain (Lamark et al., 2003; Ichimura et al., 2008). We therefore 
employed the well-characterised K7A,D69A PB1 mutant of p62, which lacks the 
ability to self-oligomerise and form intracellular aggregates (Lamark et al., 2003), in 
order to compare it with our Cys mutant. Since the PB1 mutant retained the ability to 
form DLC following oxidation in our previous analysis (cf. Figure 4.5), we were 
curious to understand whether it would have been important also during aggregation 
in the same conditions. Oxidative stress failed to induce aggregation of mutant p62 in 
K7A,D69A stable cell line (Figure 5.3A), showing that PB1 domain-mediated 
oligomerisation of p62 was essential for aggregate formation in such conditions. 
Additionally, autophagy inhibition induced by Baf failed to induce aggregation of p62 
in the K7A,D69A cell line as shown in literature (Ichimura et al., 2008) (Figure 5.3A), 
while both wild-type and C105,133A p62 mutant cell lines accumulated aggregates of 
p62 to the same level (Figure 5.3B), suggesting that DLC of p62 were dispensable 
for the process. Thus, we hypothesised that p62 DLC-mediated oligomerisation could 
facilitate aggregate formation in conditions of oxidative stress, while PB1 domain-
mediated interactions would be further required for the assembly of oligomeric p62 
into microscopically observable aggregates. 
Accumulation and aggregation of p62 have been directly connected to its function in 
autophagy, where p62 is not only a receptor but also a substrate of autophagic 
degradation (Komatsu and Ichimura, 2010). In fact, the K7A,D69A mutant p62 has 
been shown to have a delayed degradation when compared to wild-type, confirming 
the role of p62 aggregation in autophagy (Ichimura et al., 2008). Therefore, we 
assessed whether the degradation of the oxidation-insensitive p62 mutant was 
affected, which could have indicated impaired autophagy. Interestingly, we were able 
to detect a lower degradation rate of p62 in C105,113A cell line compared to wild-
type during CHX chase, suggestive of impaired autophagic degradation (Figure 
5.4A). Notably, it has been reported that CHX treatment could inhibit autophagy 
(Lawrence and Brown, 1993), which could have affected the rate of p62 degradation. 
Therefore, as an alternative approach we employed a pulse-chase labelling 
technique (Click-IT assay), which allowed us to isolate the newly synthesised p62 
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and monitor its degradation rates, thus avoiding the need to inhibit protein synthesis 
(Figure 5.4B). Also in this case, the degradation of C105,133A p62 was slower 
compared to the wild-type, again suggesting that DLC formation was important 
during autophagy. 
Since accumulation and degradation of p62 were both connected to p62 autophagic 
function and affected by the Cys mutation, we questioned whether the loss of DLC 
could inhibit the binding to polyubiquitinated substrates. Immunoprecipitation of p62 
from wild-type and C105,113A mutant cell lines did not show any differences in 
ubiquitin binding (Figure 5.5), suggesting that the loss of DLC formation did not 
influence the sequestration of polyubiquitinated substrates. A previous study has 
instead shown that p62 high-molecular crosslinks impaired the association of p62 to 
polyubiquitinated cargos, thus leading to the inhibition of autophagosome formation 
(Donohue et al., 2014). Additionally, the authors have shown that the PB1 domain 
K7A,D69A mutant of p62 did not form high-molecular species, linking the loss of self-
oligomerisation with the disappearance of p62 crosslinks (Donohue et al., 2014). In 
contrast, we were able to detect the impairment in ubiquitin-positive aggregate 
formation in our redox-insensitive mutant cell line (cf. Figure 5.2A), as well as the 
formation of DLC of the K7A,D69A mutant following oxidation (cf. Figure 4.5). As 
discussed in Chapter 4, such discrepancy might be due to the different treatments 
used by the authors, such as the autophagy inhibitor verteporfin, which can have 
additional effects on the formation of autophagosomes. 
Following these findings, we investigated the effects of the loss of p62 redox-
sensitivity on the degradation of autophagy substrates during oxidation. Both 
C105,113A and K7A,D69A mutants failed to induce autophagy following H2O2 
treatment compared to wild-type p62, shown by the accumulation of polyubiquitinated 
substrates and lower accumulation of lipidated LC3-II (Figure 5.6A, B). Additionally, 
autophagosome formation appeared reduced in the Cys mutant and PB1 mutant cell 
lines (Figure 5.6C), indicating an impairment in autophagosome assembly. Thus, we 
suggest that p62 not only works as a receptor protein for the selective degradation of 
autophagy substrates, but also functions as a core component of the autophagy 
machinery. Recent evidence has shed light on the importance of p62 oligomerisation 
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for the proper formation of autophagosomes and membrane bending (Wurzer et al., 
2015). In a similar way, we propose that p62 forms DLC in conditions of oxidative 
stress in order to promote its oligomerisation and aggregation together with the PB1 
domain, contributing to the assembly of autophagosomes. Although we could not 
assess the levels of p62 Cys mutant binding to LC3 (data not shown), our data 
indicate a clear impairment in the function of p62 as an autophagy receptor. It would 
be important to further investigate how the impairment of p62 oligomerisation and 
aggregation leads to the defect in LC3 lipidation, and how it may impact on 
membrane bending and engulfment of cargos. 
The role of p62 in autophagy induction is still unclear. For instance, it has been 
reported that p62 can disrupt the association between Bcl-2 and Beclin1, positively 
regulating the autophagy process (Zhou et al., 2013). However, it has also been 
suggested that p62 can promote mTORC1 activation and translocation to the 
lysosomes, thus blocking autophagy (Duran et al., 2011). Thus, a potential role of 
p62 in regulating autophagy upstream of autophagosome assembly cannot be ruled 
out. It would be interesting to examine whether the loss of DLC formation would 
affect the ability of p62 to properly interact with molecular partners, and if such 
impairment could affect the autophagy process.  
Finally, we investigated the effects of the Cys mutant on cell survival during oxidative 
stress. Indeed, autophagy is an essential pro-survival process during conditions of 
nutrient deprivation and in response to stress, involved in the removal of damaged 
proteins and organelles as well as providing nutrients through recycling of cellular 
components (Levine and Yuan, 2005). Hence, the role of p62 in inducing autophagy 
in conditions of oxidative stress could have important implications in cell viability. 
Additionally, a previous study has indicated that formation of p62 aggregates 
increased cell survival (Paine et al., 2005), further showing the importance of p62 
aggregate formation. Our analysis showed impaired cell viability in C105,113A p62 
as well as K7A,D69A cell lines, which was consistent with the loss of DLC and 
oligomerisation of p62 (Figure 5.7). Therefore, we propose that the ability of p62 to 
sense ROS and form DLC could serve as a protection mechanism during oxidative 
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stress, enhancing the aggregation of substrates and their disposal through 
autophagy, thus promoting to cell survival.  
It has been previously shown that self-oligomerisation of p62 through the PB1 
domain is important for its localisation to the autophagosomes formation site (Itakura 
and Mizushima, 2011). More recently, a study has shown that p62 oligomerisation 
stabilises its interaction with LC3 clusters on the autophagosomal membrane, thus 
inducing the bending of the membrane and the engulfment of polyubiquitinated 
cargos (Wurzer et al., 2015). In this chapter, we have shown that DLC formation in 
conditions of oxidative stress is a mechanism allowing p62 to oligomerise and induce 
aggregation of associated-polyubiquitinated substrates, while simultaneously 
promoting autophagosome formation and ultimately degradation of autophagy 
cargos. We propose that DLC formation, in concert with PB1 domain-dependent 
oligomerisation, drives the accumulation of p62, important for the stabilisation of the 
autophagosomal membrane during oxidative stress (Figure 5.8). It could be 
speculated that the underlying mechanism could be mediated by an increased avidity 
between p62 DLC and Atg8-family proteins on nascent autophagic membranes 
(phagophores). This would facilitate the assembly of autophagic vesicles around the 
cargos, leading to their sequestration and degradation through autophagy.  
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Figure 5.8 | Schematic 
representation of p62 function in 
autophagy during oxidative 
stress conditions. We propose 
that oxidation induces formation of 
disulphide-linked conjugates (DLC) 
of p62 (tetramers and higher order 
oligomers) which are regulated by 
the peroxiredoxin/thioredoxin  
(Prx/Trx) system. Such DLC are 
important for p62 accumulation and 
autophagic degradation of cargos. 
Formation of DLC and 
oligomerisation of p62 through PB1 
domain interactions work in concert 
to serve as docking sites for the 
nascent autophagic membranes 
(phagophores). The interaction with 
LC3 leads to the engulfment of p62 
and its substrates and their 
subsequent degradation through 
autophagy. 
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Chapter 6. Conclusions 
The oligomerisation and aggregation of proteins are important features of 
neurodegenerative diseases (NDs), which are untreatable and devastating conditions 
affecting the nervous system. Here, specific neuronal proteins tend to lose their 
native conformation (a process known as misfolding) and form fibrils, which can 
further aggregate in neurons leading to the formation of insoluble inclusions (Douglas 
and Dillin, 2010). However, little has been understood whether such protein 
aggregates are harmful or protective for the cells, and whether they are the cause or 
the consequence of the disease ((Ross and Poirier, 2005). Oxidative stress, which 
arises when reactive oxygen species (ROS) accumulate in the cell, can lead to 
protein misfolding and aggregation through the irreversible oxidation of cysteine 
(Cys) residues (Reddie and Carroll, 2008). However, healthy levels of oxidation are 
also required for the regulation of proteins, where Cys residues are oxidised and form 
disulphide bonds, a reversible modification which often leads to protein functional 
changes (Paulsen and Carroll, 2010). The catabolic pathway autophagy, in which 
specific receptor proteins drive the degradation of substrates, is in charge for 
degrading protein aggregates and alleviate the cellular toxic burden (Johansen and 
Lamark, 2011; Stolz et al., 2014). 
In this thesis work, we have investigated the mechanisms of oligomerisation and 
aggregation of the selective autophagy receptor SQSTM1/p62, and for the first time 
shown that p62 can sense and be regulated by oxidative stress. In fact, sensitivity of 
p62 to oxidation has recently been postulated, however no experimental evidence 
has been shown before (Filomeni et al., 2015). Evidence of autophagy regulation by 
oxidative stress is also scarce, with Atg4 regulation by ROS being the only 
mechanism shown experimentally so far, while other autophagy players have only 
been suggested to be regulated by it (Scherz-Shouval et al., 2007; Filomeni et al., 
2010). 
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Autophagy is a catabolic pathway aimed at degrading anything from long-lived 
proteins to whole organelles. Its sub-pathway macroautophagy (usually referred to as 
simply autophagy), is a tightly regulated process that involves the engulfment of 
substrates by double-membrane organelles known as autophagosomes, and their 
fusion to lysosomes to form autolysosomes where degradation occurs (Ravikumar et 
al., 2009). Specific receptor proteins, such as p62, bind to polyubiquitin-tagged 
proteins (i.e. tagged for degradation) and drive their degradation through autophagy, 
thus allowing the selective autophagy of substrates (Johansen and Lamark, 2011). 
However, impairment of autophagy leads to the accumulation of p62 and its 
substrates due to their inefficient degradation, often leading to aggregate formation 
and cell death (Levine and Kroemer, 2008).  
Here, we have found that p62 can be covalently modified by ROS, determining a 
slower electrophoretic mobility of p62 in immunoblot analysis. Following induction 
with H2O2 or the oxidative stress inducer PR-619, p62 forms disulphide-linked 
conjugates (DLC) through disulphide bonds between cysteine (Cys) residues. These 
formations, which were sensitive to reducing agents such as β-mercaptoethanol, 
were distinct from the monomeric p62, and were visible in brain tissue from aged 
mice as well as in cell culture. Additionally, p62 DLC formation appeared to be 
important for aggregate formation, since oxidation could shift the presence of p62 
from the soluble to the insoluble fraction in our cell lysates. Unfortunately, we were 
unable to isolate p62 DLC and examine their exact composition, however their MW 
size resembles trimers and tetramers of p62, together with higher MW structures 
which often remained confined in the stacking gel. Additionally, p62 DLC were also 
visible after purifying bacterial GST-p62 and inducing oxidative stress, thus 
suggesting the absence of other interacting proteins. 
The increase of DLC formation following inhibition of TrxR suggests that p62 is 
indeed oxidised in our experimental conditions, and the intracellular antioxidant 
system (Prx/Trx) is constantly involved in the reduction of p62 DLC. The formation of 
covalent oligomers of p62 has been already shown in literature, although such 
modifications were not investigated further (Paine et al., 2005; Gamerdinger et al., 
2009). A recent work has shown the formation of p62 covalent crosslinks following 
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oxidative stress, although we found several differences with this thesis work, 
especially in the function of these covalent modifications of p62 (Donohue et al., 
2014). 
Through the generation of p62 deletion constructs and several rounds of 
mutagenesis, we have identified two conserved Cys residues C105 and C113 
(located in an unstructured region of p62 between the PB1 and ZZ domains) to be 
pivotal for DLC formation. This linker region appears rich in conserved, charged 
amino acids that could be important for C105 and C113 reactivity towards ROS. The 
same linker region has been recently identified as an electrostatic bridge, where the 
high presence of charged amino acids is crucial for the correct formation of PB1 
filaments (Ciuffa et al., 2015). The disruption of the PB1 filaments following mutation 
of two charged amino acids in the electrostatic bridge, together with our experimental 
evidence of DLC loss following C105A-C113A mutation, suggests that the 
electrostatic environment of this unstructured linker region of p62 could be critical not 
only for the non-covalent PB1-mediated oligomerisation, but also for the covalent 
disulphide-mediated oligomerisation of p62. The incomplete block of DLC formation 
following mutation of both C105 and C113 could resemble a redundancy between 
neighbouring Cys residues, which might become available for DLC formation. The 
absence of C105 and C113 in lower animals such as invertebrates suggests that p62 
gained the ability to sense ROS during evolution, in order to maintain protein 
homeostasis in more complex and long-lived organisms. 
Following the production of stable cell lines expressing transgenic p62 either wild-
type or C105A-C113A mutant, we have shown that mutagenesis of these residues 
impairs both aggregation and insolubility of p62, as well as its degradation rates, thus 
affecting its function as an autophagy receptor. Indeed, p62 aggregation has been 
connected to its ability to degrade substrates through autophagy (Bjorkoy et al., 
2005; Ichimura et al., 2008). Activation of autophagy was also impaired in the 
presence of C105A-C113A p62, although we were not able to assess the levels of 
binding between p62 and LC3. Finally, cell survival was also affected by the absence 
of DLC formation, since the cells expressing mutant p62 were more susceptible to 
oxidative stress. 
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Since aggregate formation is also dependent on p62 self-oligomerisation through its 
PB1 domain (Itakura and Mizushima, 2011), we propose that DLC formation would 
act in concert with p62 self-oligomerisation for substrate aggregation and subsequent 
disposal by selective autophagy. The enhanced oligomerisation of p62 would 
increase its binding to LC3 and stabilise the autophagosomal membrane (Wurzer et 
al., 2015), leading to the engulfment and degradation of cargos.  
Thus, we propose that DLC formation would be another mechanism of p62 
oligomerisation distinct from the PB1-mediated, which would serve to enhance the 
aggregability of p62 during conditions of oxidative stress and promote the 
degradation of substrates. Additionally, we provide evidence that the aggregation of 
p62, which is enhanced by DLC formation following oxidative stress, could be a 
protective mechanism. This new function of p62 would then serve to combat the 
burden of misfolded proteins caused by oxidative stress, thus improving cell survival. 
Importantly, we have also found that DLC of p62 were also accumulating in human 
brain tissue affected by NDs, such as Alzheimer’s disease and Parkinson’s disease, 
together with increased levels of oxidative stress. In fact, p62 has been found in all 
protein aggregates associated with NDs, and its antibodies have been recommended 
to stain human brain tissue as a general diagnostic marker (Kuusisto et al., 2008). 
The new mechanism of p62 aggregation proposed in this thesis work could 
eventually lead to the development of new diagnostic tools for the early detection of 
pathological processes in patients. For example, the production of antibodies 
directed towards the oxidised form of p62 could be used to detect increased levels of 
p62 oxidation in patients, suggestive of increased oxidative stress, which could 
correlate with the onset of neurodegenerative disease. 
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Chapter 7. Appendices 
 
Appendix A | Plasmid map of GFP-tagged 1-122p62 deletion construct produced in 
this study. 
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Appendix B | Plasmid map of GFP-tagged 1-200p62 deletion construct produced in 
this study. 
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Appendix C | Plasmid map of GFP-tagged 114-440p62 deletion construct produced in 
this study. 
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Appendix D | Plasmid map of FLAG-tagged p62 construct used in this study. 
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Appendix E | Plasmid map of FLAG-tagged p62 lentiviral vector produced in this 
study. 
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